Computer Simulation Model of the Immune Response of Mice to Western Equine Encephalitis (WEE) Computer Simulation Model of the Immune Response of Mice to Western Equine Encephalitis (WEE) Virusirus by Ho, Gilbert Chi Kuna
South Dakota State University 
Open PRAIRIE: Open Public Research Access Institutional 
Repository and Information Exchange 
Electronic Theses and Dissertations 
1975 
Computer Simulation Model of the Immune Response of Mice to 
Western Equine Encephalitis (WEE) Computer Simulation Model 
of the Immune Response of Mice to Western Equine Encephalitis 
(WEE) Virusirus 
Gilbert Chi Kuna Ho 
Follow this and additional works at: https://openprairie.sdstate.edu/etd 
Recommended Citation 
Ho, Gilbert Chi Kuna, "Computer Simulation Model of the Immune Response of Mice to Western Equine 
Encephalitis (WEE) Computer Simulation Model of the Immune Response of Mice to Western Equine 
Encephalitis (WEE) Virusirus" (1975). Electronic Theses and Dissertations. 4877. 
https://openprairie.sdstate.edu/etd/4877 
This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research 
Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses 
and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional 
Repository and Information Exchange. For more information, please contact michael.biondo@sdstate.edu. 
COMPUTER SIMULATION MODEL OF THE IMMUNE RESPONSE OF MICE 
TO WESTERN EQ,UINE ENCEPHALITIS (WEE) VIRUS 
This thesis is approved as a creditable and independent 
investigation by a candidate �or the degree, Master of. Science, and 
is acceptable as meeting the thesis requirements for this degree, hut 
without implying that the conclusions reached by the candidate are 
, necessarily the conclusions of the major department. 
Head, Microbiology Department Date. 
.L nesi s .A.�L.JUl.Jiat.t,;;g�r=------ v pate 
ACKNOWLEDGEMENTS 
I wi s h  t o  expres s  my s incere grati tude t o  my major .advi sor, Dr. 
Gokaldas c. Pari kh, for his counsel and advi ce during the ·course of 
thi s s tudy and for hi s pati ence and understand ing during the prepara­
t i on of thi s thes i s. 
I wi s h  t o  thank Mr. Tom S orensen for proofreading my thes i s  and 
Mr. S teve Duvall for his pas t  effor t and advice in this researc h  pro­
jec t. 
I am also gra teful t o  Mr. Wi l bur Rei t zel for hi s techni cal a s s i s t­
ance and advi c e  in the hand l ing of an ima l s  and the computer exper t i se 
of Mr. Landon Nus z. 
I am in de bted t o  Dr. Paul R. Middaugh for his proofreading of 
this thesis and t o  Mrs. Charlo tte Denni s for typ i ng and proofread�ng 
this thes i s .  
The financial support of the Naval Weapons Laboratory, Offi ce of 
Naval Research in this research projec t i s  gra teful ly acknowledged . 
I a l s o  wish to extend thi s gratitud e  to Dr. David Reed of t he 
Veterinary Sci ence Labora tory,  Professor Eugene W hi tehead and Dr. I. 
Palmer of Station Bi ochemistry , Dr. J. Grove of the Chem i stry Depar t­
ment, and Dr. S. Friefeld for their valuable advice and their provi s ion 
of facili t ies, equipment and chemicals, which are vital to their 
studies. 
Las t ly , I wi sh to thank my wife ,  M e i  Yu , for her pat i ence , under­
standing , e ncouragement , and help d uri ng the preparat i on of thi s 
the sis. 
GCH 
TABLE OF CONTENTS 
INTRODUCTION • 
Primar� Immune Response 
Secondary Response. 
The Im une Response Model • 
LI TERA TlJRE REVIEW. 
Modeling. 
Immune Response Models. 
Theory of Irrununity - Interaction of Lymphocytes 
with Antigen. 
Interacting Components of an Immune Response. 
Immunoglobulins • 
The Immunocompetent Cells • 
The Lymphocyte Network. 
The Genetic Control of Immune Response. 
Y.LA TERIALS AND METHODS. 
Animal. 
Virus • 
Chick Embryo Fibroblast (CEF) • 
The Counting Chamber. 
Mouse Anti-WEE Virus Antiserum. 
Mouse Blood Lymphocyte. 
. . 
. . . 
• 















3 5  







TABLE OF CONTENTS (Con't. ) 
Page 
Procedure for the Study of the Elimination Rate of 
WEE Virus in the Circulatory System of Mice • • • • • • 61 
Procedu�e for the Calibration of Ocular Micrometer 
· for Cell Measurement. • • • • . . . . . . . 
Procedure for Radioimmunoprecipitation Test 
• • • • 
for Antibody Detection. , • , • • • , • , • • • • • 
Procedure for the Estim�tion of the Generation Time 
. . 62 
63 
of WEE Virus Activated Lymphocytes in vitro • , • • • • 6L� 
RESULTS AND DISCUSSION • •  . . . . . . . . . . . . . . • • • 6 5  
Immune Response Model • • • • • • , • • , , • • , , • • 65 
Experimental Values Used in the Immune Response Mpdel • 93 
t>imulation Data • • • . . . • • • • • • • • . . . . . . 
CONCIJJSIONS. • . . • • • • • • • . . • • • • • • • • • . . . 
APPENDIX • •  . . . . • • • • • • • • • • • . . . . . • • • • 
Table 1. COULTER COUNTER PROGRAM • . . . . . . . . . . 
Table 2. HISTOGRAM PROGRAM , • • , . . • • • • 
Table 3. IMMUNE RESPONSE MODEL PROGRAM • . . . 
LITERATURE CITED , • • • , • • . . . . . . . . . . . 
. . • • 
• • • • 




























LI ST OF TABLES 
Different clas ses of immunoglobulins • • • • • • • • 
Desc�iption of abbrevia tions of the immune response 
mode 1. • • • • • • • • • • • • • • • • • • • • • • • 
Symbol key of the block diagrams of the immune 
response model • • • • • • • • • • • • • • • • • • • 
The lymphocy te sector. • • • • • • • • • • • • • • • 
The immunocompetent cel l  type sec tor • • • • • • • • 
The probabilis tic progeny cell sector. • • • • • • • 
The primary immune response sector • • • • • • • • • 
The secondary immune respo�se sector • • • • • • • • 
Estima tion of average mouse weight • • • • • • • • • 
Mouse weight his togram • • • • • • • • • • • • • • • 
Es tima tion of the average radius of mouse 
lymphocy tes. • • • • • • • • • • • • • • • • • •. • • 
Ca lcula ted average volume of mouse lympocy tes. • 
Elimina tion ra te of WEE virus in mice. • • • • • 
. . 
. . 
Elimination rate of WEE virus in mice using da ta of 
CPM in a whole mouse • • • • • • • • • • • • • • • • 
Calculation of the elimination rate of WEE virus 
in mice using the fir s t  order exponential decay 
equation • • • • • • • • • • • • • • • • • • . . 
Summary of the elimina tion rate of WEE virus in mice 
Ca tabolic rate of mouse lg in normal mice. . • . . • 
Catabo lic rate of mouse IgG ·in WEE hyperimmime mice. 































LI ST OF TABLES (Con't. ) 
Calculation of the catabolic rate of mouse IgG • • •  
Coulter Coun ter data f or the estima tion of the 
average generation time of mouse lymphocytes • • • • 
Growth rate of mouse lymphocyte. • • • • • • • • • •  
Growth rate of mouse lymphocyte. • • • • • • • • • • 
Calculation of the growth rate of mouse lymphocytes 
using the fol lowing natural growth equation. • • 
Titration of WE� virus by plaque as say • • • • • • •  
Detection of WEE-antibody formation by RIP • • . • • •  
Standard conditions of t he immune response model • Ii 
The effect of mouse weights on the number of 
lymphocy tes. • • • • • • • • • • • • • • • • • • • • 
29 Computer output on the number of ABFC formed and the 
number and nanograms of IgM antibody molecules formed 
in a primary response. • • • • • • • • • • • • • • • 
3 0  Computer output on the number of ABFC formed and 
the number and nanograms of IgG antibody mo lecules 
formed _in bo th primary and secondary immune 
Page 










· response • • • • • • • • • • • • • • • • • • • • • • 135 
Figure 
1 
LI ST OF FI GURES 
A conceptual flow diagram of the irrunune respon s e  
model • · • • • • • • • • • • • • . . � . • • • . . . 
2 Linear structure and functional topography of an 
Page 
9 
IgG mol ecule • •  , • • • • • • • • • • • • • • • • • 22 
3 Illus tration of .the origin and stages of develop­
men t  of mou s e  lymphocytes • • • • • • • • • • • • • 
4 Lymphocyte network and how it responds to an 
25 
antigen • • • • , • • • • • • • • • • • • • • • • • 29 
5 Illus tration of the differentiation and developmen t 





Block diagram of the 'irrunune response model'. . . . 
Block diagram of the 'lymphocy te s ector' • • •  • • • 
Block diagram of the 'irrununocompetent cell type 
s ec tor' • • • • • • • • •  , • • • • • • • •  
Block diagram of the 'probabilis tic progeny 
cell sec tor' • • • •  , • • • • • • • • • • •  
• • 
• • • • 






s ec t or' • • • . . . . . . . . . . . . . 
Block diagram of the 'secondary immune 
response sector' • • • • • • • • • •  , • 
• • • • • • 
. . . . . . 
Histogram of the body weight range of mice. • • • • 
His togram of measured radii of mouse lymp hocytes • •  
His togram of calculated volume range of mouse 
lymphocy tes • • • • • • • • • , , • , • •. • • .. • , 
The elimination curve of pa_s sively injected. 
1251 












1 6  
1 7  
1 8  
19 
20 
LIST OF FIGURES (Con't.) 
Catabo lic rate of mouse immunoglobulin G (IgG). . . 
Groivth rate of mouse lymphocytes in vitro • • • • • 
Cell volume distribution profile for the 
estimation of the generation time of mouse 
lymphocytes • • • • • • • • • • • • • • • • • • • • 
Cell volume distribution profile for the 
estimation of the generation time of mouse 
lymphocytes • • • • • • • • • • • • • • • • 
Detection of anti-WEE antibody formation by 





2 1  Standard curves of Igti and IgG antibody-forming 







irmnune response • • • • • • • • • • • , • • • • • • 133 
22  Standard curves of IgM and IgG antibody forma­
tion in hyperimmunized (against WEE) mice in a 
primary im une response • • • • • • • • • • • • • • 134 
23 Standard curves of IgM and IgG antibody forming 
cells in both primary and secondary immune responses 13 6 
24 . Standard curves of Igti and IgG antibody formation 
in both primary and secondary immune responses. • • 13 7 
INTRODUCTION 
The lymphat i c  system of an animal i � o- timally d� .. '-lo ed to pro-· 
tect the body from antigenic invasion. The cpit e ial and su pi­
thelial comp�r tment of the Dody are pro ided i th a as t .un'Jer of 
wandering cells and a ne twork of ccntralizc.l lymphorectic il=J.r tiscues. 
All o f  these are capab le o f  rea ting to intr ing for ign artige1s. 
Upon antigeni c  challenge, immunocompetent cells rrcc) or a .. n. .igen·� 
specific lymphocytes are ac tivat ed ; this leads eith r to ct:�lJ muJ:i.atnd. 
and /or humeral antibody immune responses. The subseq 1.1 1: effe<::t ·i.,3 n. 
accumulatiur 0.1.. t:he respo1di.L1g cells, both by local p:c·1.LferaLion a.nd 
rec;:·ui tment from t ci rcula tion .  Through the inter;:icc-' !J . o both 
ceJ.lnlar and llumoral component s  of t. immune syGtem the phagocyti::� 
cell:.> anr:.l the ··)mp tQm0nt system ar acti.vat<�d, �-er1.::by 112a.dine to t. -> 
locali .. �:Li.on , d�st�uc:' on, and eliminatiu1 of LlJ·, aC' ... ii:;c1- Con,� .. �:iv�- .. 
of t1is r_spon��, imrn..1110 o �.cal:!.y .:or.udt·t:ed C!t�ll . . ..> .J.rG n�leased f_cm 
initially activat...:�d lynphoid t:5.sc-:tw viz. t.18 r:�fft:�r�nt lymphatic d ctt3 
and the bloodscre.:is.1 to other l:tmnhoid O.Cf!.�,n.s v:1i�.h r.e·�u1tL1g 1 �::·Tithrnic 
0...1 p1ificat' on of the J.nm1un-?. response and c.he. ue I·:  . .' lOJ?!le nt ot 1.:oe cap2.c-
ity to re�pcnc� much more eff.'lc.'f'_.1Lly to a s-�cor·i enco.1nl:er v•ith the� 
out the c mplex re21.cti::m of phaf�o.cytos.is by the nacrcphage'� �tnr.:�, pr:ob·­
ably, Ly the monccytes-
Primary Immune Response 
With mo s t  antigens, t.L1e initial exposure evoke s  a smal ler anti­
body re sponse than do subsequent identical exposur e s, and the anti­
bodie s thus formed differ in their avidity. The immune response to 
the firs t expo s ure of an immunogen is known as a primary re sponse and 
thus a secondary exposUI:e induces a s econdary re spons e. The manife s­
tation of ari immune recponse fol1ow5.ng antigenic s timulation may vary 
from one to thirty days. I t  is predictable for antibodie s to be de­
tected three to four days af ter s timulation of erythrocy tes, five to 
seven day s after soluble antigens, and ten to fourteen days aft er bac­
terial cells. I n  contras t to most antigens, bacteriophage f/J X 174 
evokeu detectable anc..il>ocly ior:mat1on 24 hours atter an intravenous 
injection. The antibody formed in a primary respons e  i s  dominantly 
of the 19S immunoglobulin �l (lgi.'1) class of antibody, and their concen­
tra tion usually increases exponentially for four to five day s before 
leveling off. 7 S im uno glo bul in G (IgG) antibody could be de tected 
shortly afterwards. The synthesis of I&.f antibody usually diminishe s  
one or.two weeks after inunu.�ization while the l evel o f  IgG i s  s till 
increasing. Experimental evidence suggests that I gG, by s ome kind of 
direct'feedback mechanism, i. nhibits the synthe sis of IgM. 
Secondary Response 
Secondary o r  anamnestic immune responses have charac t eris tic fea­
ture s which differ from the initial response. As a whole, secondary 
re spon ses requir� a lower threshold dose of antigen, have a shorter 
time lag period, have a higher l evel of antibody production, and have 
2 
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a longer persistence of antibody synthesis. I n  addition, the antibody 
formed has a much higher avidity and is usually predominantly of the 
IgG classo The higher :)..evel of I gG  formed during a 8econdary response 
is due to the increased number of antibody-forming cells rather than 
due to an increase of the product.on rate per cell. Although some 
antigens sud as pn umococcal polysaccharides and lipopolysaccharides 
I 
do not elicix a secondary response, most antigens elicit a pronounced 
secondary response many weeks, or even years, after a primaJ:y stimulus. 
This capaci. ty provides a 10ng-lasting immunity against infection. 
Under normal circumstances, an animal will not form antibodies to 
a substance that is antigenically related to its own. Thus, the baRic 
characte1:istic of an im1;iunogen is its foreignneos to a host. The de-
gree of fo1:eignness is impossible to define but is strongly related to 
the phylogenic similarity between 'Che anti.gen and the resrJoncling host. 
For example, serwn protein of .h irnan is a much bet ter irnmunogen to rab-
bits and guinea pi.gs than to monkeys since only a few of the protein 
potential antigenic determinants are foreign to monkeys- Different 
varieties of antibodies could be formed to almost any biological macro-
molecules, and antibody is always heterogeneous in nature even when 
producbd against the. same antigen� Protein is, by far, the most out-
standing for its potential antigenicity. Lar�e m0lecular w�ight, 
corr.plexi.ty of struct1 re, and fon!ignness. to a bo.st are some basic char-· 
acteri�1 tics of an irnrnunogE:n al though thesP. propt.rtie.s a.re always pro-
visional � Many subs tanc<�s that were thought to be non�j_m unogenic: had 
b(.��n ·folL1d 1 at er to inducP. ant·i ])ody formation at least in certain 
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animal hosts or different individuals under particular experimental 
conditions such as the appropriate choice of dosage ,  route, adjuvant 
and carrier . Following the intravenous injection of a dose of antigen , 
the elimination curve of this antigen is usually triphasic. Firs t ,  
there i s  a rapid decline due to diffusion into the extravascular space; 
then, there is a period of metabolic decay fol lowed by a sharp decline 
which signal s the formation of the antibody. During the terminal 
phase, the antigen exists in the form of an an tibody-antigen complex , 
and as the antibody level becomes detectable, the antigen level usually 
diminishes. This does not ,  however, mean that the antigen has been 
completely eliminated from the body . Antigen molecules or their frag­
ments usually persist for a long period of time within t:he phagocytic 
cells  of the reticuloendothelial sys tem (Kupffer cells and the macro­
phages) and retain some of the antigenic determinant s .  C ellular and 
partic ulate antigens such as bacteria\ , erythrocy tes , and bacterio­
phages do not exhibit the initial phase of decline bec�use they do no t 
diffuse into t he extravascular space. These partic les are much more 
rapidly removed from the bloods tream than are soluble antigens because 
they are phagocy tized much more effectively by the macrophages . 
The Immune Response Model 
Despite the recent advances in immunology , there have been a lot 
of doub t s  and controversy concerning the control mechanisms involved 
in an immune response . The purpose of this s tudy is to simulate a 
computer model o� the inunune response of mice (as hosts) to wes tern 
equine encephalitis virus (WEE) - the antigen. 
5 
The choice of the Mouse-WEE system for this study has several 
reasons, as follows: 
1. Much is known about the physiological and immunological capac-
ity of mice. 
2. Mice are inexpensive and easy to handle. 
3. The antigenic property of WEE to mice or other rodents is not 
yet known in detail. 
4. WEE virus is of great significance in epidemiology for both 
animals and humans. 
In compliance with the future development and extension of the 
Coated Latex Adsorption Method (CLAM) to include the application of 
viral c!Cltc�ction .in vivo, this model could provide a clear insight of 
the limiting parameters through a cybernetic analysis. In other words, 
this model could provide information concerning important elements 
such as the earliest detectable humoral antibody response, the level 
of circulating antibody at the peak of a primary response, and the la-
tent period required for the activation and maturation of the irrununo-
competent cells of an animal. 
Under the guidelines of this in vivo model, the CLAM sys tem can 
be expanded to detect viruses and their antibodies in vivo. The basic 
CLAM will oe modified, if neces sary, to make it suitable for in vivo 
detection. The immediate purpose of malcing this model is to find out 
the time of early antibody formation after an animal or a human was 
infected. This provides, theoretically speaking, an early warning 
signal for pos s ible vi ral in f e cti on . A latent period or symptom-free 
s tage has commonly been �ssociated with viral di sease s .  I f  patients 
6 
at thi s s tage could be screened out for early medi cal treatment , lives 
and cos t s  might be saved . 
Thi s model  is a stochastic model and i s  simulated by a computer 
program which has been formulated for a Hewlet t-Packard (Mode l 9830) 
desk-top prograrrunable calculator and was writ ten in the B a soc Language . 
The aim of the in vivo model  i s  to unders tand the mechani sms of immune ---
re sponse and the interac tions among them . Each step in  an eval uation 
process represen t s  a small  bui lding block in which one ma jor p henomenon 
was expec ted to be observed . The re sul tant expression of this phemom-
enon i s  interpreted in numerical terms . 
The comparison of experiment.al and s imulated data
. can wel l  reflect 
the reliabi l i ty of specific  mechani sms involved in any type of :i.mmuno-
logi cal respon s e .  An unders tanding of the se mechani sms could greatly 
ass i s t in the s t udy of preventive measures, both experimen tal ly and 
theoreti cally against various a i lments . Laten t  vira l  dis eas e s  such 
as viral hepatitis can be analyzed by the compu ter in a s ubroutine 
of t he p roposed CI.AM in yivo model system which pred i c t s  how long a 
pat i ent has been infected and whe ther a patient i s  a potential carrier. 
A s tudy of t hi s  sort would be of immunological and clinica l , a s  well 
as epidemiological , values .  
I n  order to provide maximum insight o f  the irrununologi cal expres-
sion of mice to WEE virus; a careful selection of immunological para-
meters i s  vi tal . The major diffi cul ty confronting mode l ing i s  the 
expres s i on of a phenomenon in quanti tative terms before mathematical 
7 
formulation could be d rived, and in order to do so, cert ain asswnp-
tions and simplifications have to be made. 
The theoretical background of this model is the clonal selection 
theory of immune response. According to this theory, the lymphocyte ' 
population of a host is heterologous in nature and is composed of dif-
ferent groups or clones of cells, each of which is capable of synthe-
sizing one or a few antibodies o f  one antigenic spec ificity. Each 
clone is made up of immunocompetent cells capable of reacting with 
specific antigens whicl have binding a ffinity to the cel l surface re-
ceptor.s. Inununocompetent cells are lymphocytes which could react wi th 
an antigen in a specific manner and, in so doing, could initiate an 
immune response. There are basically two systems.of immuni.ty - hurnoral 
and cell mediated. 
H u.moral ant ibody re"ponses consist of reactions mediated by immu-
noglobulin proteins containing various types of specific antibodies. 
Examples of these reactions include atopic diseases such as allergic 
rhinitis and allergic a sthma , antitoxic protection against certain 
bacterial diseases and some antiviral activity, some drug reactions, 
immune complex diseases such as systemic lupus erythematosus, and some 
autoirr,mune processes such as autoimmune hemolytic anemia or erythro-
blastosis fetalis. 
Cell mediated immuni ty includes graft re j e ction , delayed hyper-
sensitivity, cy t otoxi c activity against intracellular organisms , and 
possibly offering surveillance to endogenous twnor formations. 
Furthermore, most humoral antibt)dy re�.ponses cannot bE! initiated. 
without the cooperati on of cellular components. Thes e  two types of 
immunity are mediated re spectively by the bursa ( or its equivalent 
in mammal s ) dependent B cells  and by the thymus dependent T ce l l s. 
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The outline of thi s  model is shown in the conceptual flow diagram 
(Fig. 1). The initial step in this ·model i s  to estimate the number 
of antigen speci f i c  B lymphocyte precursors that are capable of trans­
forming into pla sma cells. Thi s i s  made possibl.e by the fact that 
there are avai lable data on the weight of the lymphoid tis sues, the 
weight of a lympho cyte, and the percentage we i ght of lymphocyte s in 
the lymphoid t i s sues. Lymphocytes pre sent in the bloodstream are esti­
mated from the total volume of blood whi ch is based on the body weight 
of the animal.. The total number pf lymphocytes pr.esent in an animal 
is the sum of the lymphocyte s pre sent in the se two compartments ( lym­
phati c  and c irculatory). Studie s with surface markers and rosette­
forming method, the ratio of T and B lymphocyte s in the various lym­
phatic t i s sues  such as the bone marrow, spleen, lymph node s, thymus, 
gut a s so ciated lymphoid ti s sues, and the peripheral blood are known. 
Since the prime intere st in an immune response i s  the anti body forming 
cells, thi s mode l does not follow the activity of the T cells in de­
tail; the magnitude of an immune response depends only on the number 
of B lymphocytes and the dose of the antig�n. 
It i s  known that only a small portion of the se lymphocytes could 
re spond specifi cally to any one anti gen. Thi s  population of antigen­
spe cific or, in thi s  case, the WEE-specific anti body forming pre cursor 
lymphocytes is referred to as immunocompetent ce l l s  (ICC). 
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Figure 1. A conceptual flow diagram of the immune �esponse model. 
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In a given dose of antigen, most wi l l  be e liminat ed through bio­
logical degradation and only a small portion is e ffective in s timu� 
lating the lymphocy tes of the host. After the initial admini stration 
of the an tigen, a latent period i s  required for the immunocompe tent 
cell s to be activated and ano ther time lapse is needed for these acti­
vated cells to differentiate and proli ferate before plasma cells  ap- · · 
pear. Fur thermore, these lymphocytes may ei ther be  ac tivated or para­
lyzed depending upon the number of surf ace re ceptors occupied by the 
antigens. The di stribution of antigens among the host lymphocytes i s  
predic ted t o  fol low a Pois son di s tribution which a s sume s that the oc­
currence of individual contacts of antigen with the ce l l  surface recep­
tors are entirely independ.en t ev�nts and are dependent only on thP. 
mean value of the average number of anti gens available per antigen­
specific lymphocy tes. Based on this assumption, four types of ce lls 
are a s s i gned to the antigen-specific lymphocyte population by Po isson 
dis tribution equations. The first  type i s  cal led the v.irgin cells or 
cell s that have made no contact with antigens. The second type is the 
low zone tol erant cells whi ch have come in contac t with the antigen 
but the signal i s  no t s trong enough to elicit an effec tive ac tivation. 
The third type is the anti body-forming ce lls which have the po tential 
to divide and transform, and their progeny cells wi l l  either become 
memory cel l s  or plasma ce lls. The last ·type is the high dose tolerant 
cell s which have received·ov�r-s timulating signal s  and the consequence 
is either ce l l  death or abortive prolifera tion of the tolerant cells. 
Whether an animal can re spond to a given dose of antigen depends upon 
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the resul tant fraction of cell type that  dominates the immunocompetent 
cel l  population .  The fraction o f  virgin cells i s  con sidered potential 
memory cells , and toge ther with memory cel l s  that are produced during 
the cour s e  of a primary re sponse , they are the potential anti body­
forming cell  precursors in a secondary response. Since no d a ta i s  
avai lable a s  t o  the ratio of the ntunber of plasma cel l s  to memory 
cel l s  formed , i t  is assumed that during the entire course of a primary 
immune response , thi s ratio remains constant .  In  o ther word s ,  t he 
number of memory cel l s  is  preswned to increase proportionally wi th the 
number of antibody-fo1111ing ce lls . 
The activated an tibody-f?rming cell precursor usua l ly undergoes 
nine to eleven successive divis ions before d ivision s tops. The gen­
eration time of a plasmablast  i s  about ten hours , and a ma ture plasma 
cell has a life  span of about two to three day s .  S ucce s s ive prolifera­
tion of the plasmabla s t  i s  asswned to be dependent on a continuous 
s timula t ion of the antigen . The number of antibody-forming cells · 
formed from one precursor depends mainly upon the effective dose of 
the anti gen and the e l imination rate of the antigen whi ch defines the 
duration and extent of a continuous antigeni c challenge . 
A "P o i sson probabi l i ty equation i s  used to s imulate  the number of 
plasma cells  formed from a single precursor cell. Thi s model accepts 
the hypothe s i s  tha t during a primary response some Igt:I producing cells 
are swit ched to  IgG forming precursor cel l s  and t ha t  no I gG antibody 
would be formed before the sixth day after antigeni c challenge . The 
rate of antibody forma tion of both IgM and I gG i s  a ssumed to be equal 
and cons tant . The prolongation of the antibody level in b lood is  
based on  the amount of  antibody produced and the half-lives of the 
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two classes  of  antibody formed . Thi s mode l  takes into account a secon­
dary response in which the basic  format i s  the same a s  the primary 
response . Only the number of anti gen-specific B cells are s ubs ti tuted 
by the nwnber of memory cells , and the latent period of plasma ce ll 
formation is  s hortened . 
1 3  
LI TERATURE REV I EW 
M od e li ng 
S i nce the e ra of I ssac N ewt on, the sc i e nce o f  P hysics has pro ­
gressed from verbal expre s s i ons to symbolic and ma the ma tical lang uages . 
B i ology , on the o ther hand, has remai ned largely in a d e scrip t i ve 
stat e .  U nl i k e  many physical phenomena, bi olog i cal sy s tems are far 
more compl ex to be rela ted from compon ent intera ctions. Even a s imp le 
bi ological sys t em s uch as the vi tal f unc t i ons of a small microorganism 
is mathema t i cally intrac t a b l e even if all co mponent in t erac t i on s  a1:-e 
known . Desp i t e thi s  h andi cap ,  mat hema t i cal d e scriptions of bi o lo g i c a l  
syst ems have b ecome an i ncreasingly i mportant t ool o f  the ore t i ca l  b i ol ·­
ogy. Mathema t i cal model s  provid e  a clear insi gh t of a bio l og i cal 
sys t em, whe ther in an approximative or confi rma t ive s ense, whi ch ce:.n -· 
no t be ob tained o therwise . C onsiderable successe s have been 3.�hi eVc!d 
in mak i fig par t i a l  models of a large vari e ty o f  b i ological systems , 
b u t they s e ldom provide re liable pred i c t i on of unknown quantit a t ive 
data. Ava ilable invariants among all po s s ible pertinen t  simi l arity 
criteri a a re few and no t enough to assure real physical or opera t i onal 
similarity i n  the g�neral sens e . That i s  what makes them 'mod e l s ' 
( 7 2 ) . 
M ode l ing i s  a syn the t i c method and i s  capable of provid i ng i ns i gh t  
i n to s i tua ti on s f a r  more complex than manage ab l e . C omp u t e r  modeling 
of both phy s i c al ( d etermina t ive ) aild cyberne tic ( s tochas ti c )  sy stems 
has add ed broad n e �  capab i l i t i e s  t o  the syn the t i c  s im ul a t i on approach 
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and promises  to be of much value for biologica
.
l s imulation in all i ts 
varieti e s . 
A model of  two s imU ar systems can be transformed or applied to 
each other ;  any two sys t ems which are simi lar to each other , as  in 
the case of an im une response of two re sponding anima l s  to the same 
antigen, share a t  leas t one invariant of some sort which i s  maintai.ned 
during certain s tated transforma tion .  I n  modern sci ence , the mere 
verbal s tatement of a theory is no longer considered adequate and 
ma thema tical cons tructions of various kinds are expected . These may 
be in the form of conventi onal mathematical equations or presented 
in axiomat i c  statements ,  and all the s e  representations may be encom­
passed by computer simulation .  I � i t  is granted tha t  t heoret i cal biol­
ogy does now, or wi ll shortly, fulfi ll these  s cien tific req uirement s ,  
modeling analy s i s  may b e  cons trued a s  a means of comparing ' thc.ori e s ' 
or speci f i c  symboli c representation of sys tems wi th the goal of d i s­
covering their s imi lari ties . A l ternatively, one may say the goal i s  
to find i somorphi sm among various descrip tions o f  biologi cal sys tems . 
Al though many scienti s ts associate modeling theory mainly wi th the 
laboratory fabri cation of small model s ,  the important progress  i s  _ 
largely along theoret i cal mathemat i cal line s .  I t  i s  very important 
to know what kind of  model  to make before commencing to build i t  and 
to be able  to predi c t  what condi tions mus t  be ful f illed before i t  can 
yi eld q uanti tative data that i s  acceptable in a practi ca l  sense ( 67 , 
7 2 ,  74 ) . 
I t  i s  of  cri ti cal importance to inves tigate q ui te pre ci se ly the 
se t of phenomena which a model describes and to find out what type of 
model could adeq uately describe these phenomena . I t  i s  usually qui te 
difficul t to s ta te wi th certainty whether or not a given mathematical 
model i s  adeq uate before some observational data are o btained . 
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There are basically two types o f  models  - determini s tic and prob­
abili s tic ( or commonly known as s tochas tic) models . A de terminis tic 
mode l  i s  one which s tipulates that the condi tions under which an ex­
periment i s  performed de termine the outcome of the experiment . For 
a large number of phenomena , the de termini s tic model i s  s u i table , but 
for mos t  biological systems that are usually time dependen t , goal seek­
ing , and the cri tical condi tions are usually unknown , a s tochas tic 
model is more adeq uate � I t  i s  this  type of model  t hat th i s  s tudy i s  
based on . 
S tochas tic models are numerical formulations in which the main 
�nphasis  is p laced on the probabi li ties of changes in cer tain para­
meters wi th time . There are many models of thi s type in medicine and 
bi ology ( 50) . 
Immune R e sponse Mode.ls  
H�ge and C ole ( 3 2 )  deve loped a continuous model which eq uates  
the number of anti body-forming cells and the ti ter of circulating 
antibody . They used data of Jerne ' s  antibody plaq ue forming cells  
in  mouse spleen following sheep erythrocyte immuni za tion to match the 
simulated data and found them in close agreement . The information 
describing average cellular rate of antibody synth e s i s  was unavailable 
at that time and so was selected arbi trari ly . Recent ly ,  H iromoto 
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e t  al . ( 3 5)  tested thi s model wi th a murine myloma sys tem,  f i t t ing in  
experimental Igti immunoglobulin forming ra te by plasmacy toma cel l s .  
They found that s imula ted values agreed wi th the experimentally de ter­
mined anti body level . Thi s model does not provide much i ns i ght to the 
interacting e lements  i n  an immune response . 
B e l l  ( 5 , 6 )  had s imulated a series of mathematical models  account­
ing for the various aspects of an immunologi cal response . These  model s  
s tarted a t  a cel lular level . The im unologi cal background i s  hi ghly 
theoret i cal and i s  thus diffi cul t to be tes ted experimentally .  How­
ever, the se were among the few model s that emphasi zed on the quanti­
tative a spect  of an immune re sponse . 
·
Marcllalunis and Gledhill  ( 47 )  �imula ted an e l emen ta.r·y s tochas ti c 
model on the induc tion of immuni ty and tolerance based on the hypoth­
esi s of Mi tchi son ( 53 ) and of Nossal ( 57 ) .  The main concep t of thi s 
model i s  that anti body production and tolerance can be induced s imul­
taneously in a cellular level and that these phenomena �re dose depend­
ent and are related to the s tati s tical d i s tribution of antigen mole­
cule s among the potential reactive cells . The second s e ctor of the 
present model follows closely to · thi s  concept .  Thi s hypo the s i s  has 
yet to ·be  subs tantiated experimentally . 
Ano ther mode l  by Cohen e t  al . was formula ted to de s cri be immuno­
logi cal tolerance based on the freq uency and confi gurati on of  the 
di s tribution of antigens on cell surface recep tor si tes  ( 14 ,  15, 16 , 
17 ) . 
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A series of interes ting models were formulated by Jelek and S terzl 
( 41)  and by S terzl e t  al . ( 73) to describe the various aspect s  of an 
immune response based on their own experimental findings . These in-
eluded the probabil i ty of the number of antibody-forming cel l s  pro-
duced from one precursor cell and the memory cell s  formed during the 
course of an immune response . The former is  adapted i n  . the probabi -
li stic  progeny cell sector of this s tudy .  
Theory of Immuni ty - I nteraction of Lymphocytes wi th Antigen 
F rom the selection theory of antibody formation ( 10,  37 , 38, 39) 
i t  was pos tulated that lymphocytes  are precommi t ted to respond specif-
. . 
i cally to a single antigenic determinant leadi ng to the pron. 1 1.c ti.on 
of a class  of specific antibody . Mi tchi son ( 53 ,  54) proposed that the . 
ini tial recogni t i on of an antigen by responding lymphocytes  was 
through re ceptors which are im unoglobulin in s tructure . The best  
experimental evidence supporting thi s  theory was the demons tration 
by s everal techniq ues  that only a small frac tion could bind a given 
antigen in any normal lymphocyte population in any anima.l species . 
Although the val ue of  thi s frac tion vari ed with the technique s used 
and th� kind of ant igen involved , it was however a sound evidence . 
Inununoglobulin receptors had been detected on the s urface of 
lymphocytes  from man , rabbi t ,  guinea pigs , mice and chickens using 
various anti inununoglobulin sera . Nota e t  al . ( 59)  found that  when 
mouse splenic lymphocy tes were mixed wi th sheep red blood cel l s  (SRBC), 
some of these lymphocytes were s urrounded by SRBC in a roset te-like 
formation . Thi s phenomenon had presented an improved me thod over the 
trad i tiona l plaque forming c e l l  (PF C ) te chniq ue firs t used by J erne 
( 4 0) and had been used a s  an immune response index since the number 
of ros e t te -f orming c e l l s  (RFC ) increased subs tantially in hyperimmu­
ni zed animal s .  
Thi s me thod was exten s if i ed by · the work o f  B i oz z i  e t  al . ( 7 )  
and Paulovsky e t  a l . ( 60) .  They found tha t  the popula t ion of RFC in 
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a normal mou se spleen i s  he terogeneous , consi s ting of lymphocy te s ,  
blas t c e l l , plasmocy t e s  and macrophage s .  R o s e t t e  forma ti on d epend s 
upon the t empera t ure o f  in cuba t i on as we ll a s  the int erference of cyto­
phi l ic an t ibody . Working wi th homogeneous mouse spleen lymphocyt e s  
that were fre e from ma crophage s  and b y  incubat ing wi th SRB C a t  4 C 
to e l in1i.nate the bio logi cal ly act�ve anti body-forming c e l l s ,  W i ls on 
( 81 ,  82)  was able to demons trate tha t  ro s e t t e  formation wa s d ue to 
the a c t i on of cell surfa ce recep tors ra ther than the absorp t i on of 
cy tophi l i c an ti body .  The speci f i c i ty o f  RF C  was demons tra ted by the 
fac t tha t when lymphocytes were exposed to two di s tingu� s hable typ e s 
of erythrocy te s ,  no he terogeneous ro s e t tes were found whi l e  macrophage s  
mixed wi th cytophi l i c  ant i body formed mixed ro se t t e s . The deve lopment 
of thi s me thod opens t he way to the determinat ion and q uant i ta t i on 
of antigen-s pe c i f i c  lymphocy tes . 
Intera c t ing C omponen t s  o f  an Immune R e spon se 
A s impl i f i ed revi ew of an immune re sponse may be de s cribed as 
the inte ra c t i on of three component s :  the an ti gen , the ant i body , and 
the irrununocompe t �n t  c e ll s .  There i s  a q uanti tative balance be tween 
the s t imulation of an immune re sponse and the induction of low or 
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high dose tolerance following the in troduction o f  a foreign antigen 
to an animal hos t. This balance varies wi th each antigen as well as 
wi t h  each hos t. The molecular s truc t ure, molecular weieh t, and for­
eignness of an an tigen are the crucial fa ctors in determining the 
immunological a c tivi ty of the an tigen : the exten t of which is dependent 
upon the dosage, rou te of administration and the biologi cal catabolic 
ra te of the an tigen in vivo. Aggrega tes of this an tigen could pro­
tec t itsel f from enzyma tic degrada tion and tend to provide a slow but · 
effec tive release of stimula tion over a longer period of time. 
I mmunoglobulins 
O ne character i s ti c  of an immunological response is the exq uisite 
specificity of the rea c tion between an antigen and its corresponding 
antibody molecules which may either be free in circulation or a c t  
as recep tors on the cell surface . The antibody molecule belongs to 
a class of proteins collectively known as immunoglobulins and is com­
posed of two heavy and two light polypep tide chains that are joined 
to one another by several disulfide bridges. I n  the molecule the four 
chains are rela ted in bilateral symmetry . E a ch chain is divided in to 
two portions - the cons t an t  region and the variable region ( 2 5 ,  6 5) . 
The l ight chain of an a n t i body mo le cule may be  e i t her kappa or 
lambda . and in any on e molecule both li ght cha ·.ns are always of the 
same type . F ive types of heavy chains ex i s t . They are as fol lows : 
the mu, gamma , a lpha , d e l ta, and epsilon an d spe c i fy ,  respectively ,, 
five classes of i mmunoglobulin mole c ule s :  I gM ,  I gG, I gA ,  I gD ,  and 
I gE. Some immWloglob ulins have a d d i tional po lypep t i d e s  ( I l.?]1 and I gA ) 
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and some form oli gomeric a s socia tion of from two to f ive uni ts , each 
uni t  consi s t ing of paired light and heavy chains . I n  add i ti on , wi thin 
one cla s s  of immunog lobulins there might be subc l as s e s  and allelic  
variation or  d i fferent idiotype s wi thin each s ubclas s .  The eeneral 
proper t i e s  of the immunoglobulins are swnmarized in Table l e  
The constan t  region o f  an an tibody molecule has t he s eq uence of 
amino acid s whi ch i s  e s sen t i al ly the same in all anti bod i e s  of a given 
clas s .  The variable region in whi ch the amino acid s eq uence varie s  
i n  d ifferent ant i body molecules  i s  the re gion whi ch provi d e s  the spe­
cif i ci ty req uired f or the b ind ing of spe ci f i c  ant igen s . The cons tant 
portion is mainly invo lved in effec tor func tion s  s uch as the bind ing 
and ac tiva tion of  the complement sys tem . The vari ous re gi ons of  an 
anti body mo lecule are shown in F igure 2 .  
The c onceptual framework of the antibody can be s ummari z ed a s  
follows : 
1 .  Anti bod i e s  are spe c i fi c  and the sp e c i f i ci ty i s  based on the 
amino acid seq uenc e and three dimen s iona l  s tr uc t ures of t he 
mo lecul e . 
2 .  Antibod i e s  may bind anti gens that are clo sely rela ted to the 
e l i c i ting an t i gen and the avidi ty i s  usually lower . 
3 .  Antibod i e s  are he terogeneous in na t ure . Many clas s e s  and 
group s of immunoglobulins are produced in respons e  even 
agains t the s ame an tigeni c de termi nan t . 
Recently i t  wa s found that the anti gen recep tor s i t e s  of an ant i ­
body mo lec ule are poly f�c t i ona l o r  they contain s ubsi te s  a t  whi ch 
Tab le 1 .  Different c las ses o f  immuno globulins (20) . 
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Figure 2 .  (A) rep r es ent s the l inear s t ructure of an I gG mo l e cul e 
and (B·) sh ows th e f unct i onal top ography o f  the s ame 
· mo le cule ( 3 9) .  
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s tructurally diverse antigenic d e terminants bind . Thi s concept pro­
vides  a s imple , uni fying explanation for a number of seemingly unre­
lated immunologi cal phenomena ( 61) . 
The Immunocompe tent C e l l s  
2 3  
A couple of  decades ago i t  was generally believed t ha t  antibodies 
were produced by phagocytic cell s  or the macrophage s . The fir s t  evi ­
dence was brought forth by F agracus sugge sting tha t  the antibody form­
ing cel l s  are a fami ly of specialized cells called the plasma cells 
which are derived from another family of cells called the lymphocytes . 
Since then , the role of the lymphocytes in an irrunune response was well 
defined .  
The functional heterogenei ty of the lymphocy te population had 
long been suspec ted but i t  was not until 1961 through the work of 
Miller ( 51 , 52 ) that these cells had been classically divided into 
T and B cell s .  
T and B lymphocyte s are morphologically alike but can be distin­
guished by an array of surface markers ( 58 ,  62,  63 ) .  Some of these 
markers are antigens analogous to  blood group antigens and are col­
lectively known as ' di fferentiation antigens ' since their expression s  
. are confined only t o  some cell types .  The ' the ta anti gen ' and the 
' thymic leukemia ant igen ' in mi ce are present only in the T cells  
where B cells  pos sess  o ther surf ace  antigens such as the ' mouse­
specific B lymphocyte antigen ' . The ultimate precursor of  both the 
T and B cells i s. the hemapoie tic s tem cells  of the bone marrow . I n  
both manunals  and bird s , these precursor cells firs t appear in the 
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yolk sac which is a membranous s tructure connec ted to t he int e s tinal 
cavi ty of the embryo (F i g .  3) . During embryonic development , the 
pluripot ential s tem cells  migrate through the bloods tream to  the l iver 
( in. mammal s )  and sple en ( in both birds and mammals )  before s e t tling 
permanently in the bone marrow . The pat tern of differentiation of a 
stem cel l  is  controlled gene tically but could be influenced by the 
mi croenvironment of the s i t e  to which the s tem cells  mi grate ( 2 0) .  
The development and functi oning of the T cells  ari ses  primari ly in 
the thymus . The structural framework of the thymus is formed from 
the epithe lial cells  that ini tially line the third and fourth pharyn­
geal pouches ,  embryonic s tructure s in the region whi ch eventually 
becomes the throat . Early in embryonic development ,  the s e  epi theltal 
cel l s  migrate down into the che s t  and develop into the thymus whi ch 
controls the · immunologi cal differentiation of the s tem cell s  into T 
lymphocy tes e i ther by direct  contact or by the acti on of thymi c hor­
mones .  The B cel l s  are developed in practically the same way, but 
their immunological differentiation is  dependent upon the influence 
of the bursa of F abri cius in avian species and the fie tal l iver and /or 
spleen in mammal s .  The se phenomena are illus trated in F igure 3 .  
I - cells  are highly moti le ; they are presen t  i n  practi cally all 
parts of the body and have a longer life span than the B cel l s . 
Thes e  properti es make the T cells the logi cal candidate for ini t ial 
anti gen i c recogni t ion and memory re tention for an anamne s ti c  immune 
respons e . The ma jori ty of the B lymphocytes do not recirculate and 





. LIVER \ .  
V �. I'; ·' 
AND/OR 
ERYTHROCYTES � 
,rs > �  
GRANULOCYTES � 
) �::.·... @·· .  • .  #- . . 
. : . 
::©.�·. MO:.WCilES ) .. Q .• • .... . t . •  , 
I STEl1 CF.LL • . 
LYMPHOCYTE 





















I . IMMUNITY 
HuMORAL ANTIBODY 
RESPONSE 
at @ B - CELL . . 
. . 
Figure 3 .  Illustration of the origin and s tages o f  deve lopment o f  mouse lymphocy tes .{20) . N 
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proli ferate . The proge y c e l l s  thus formed may ei ther di fferent iate 
into plasma cel l s  and die two or three days la ter or. may transf orm 
back to long-l ived smal l lymphocytes and remain in an inte�mi t o t i c  
s tate as memory ce l l s  ( 21 ,  22 , 43 , 48 ) . The undifferen t i a ted smal l  
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o r  virgin lymphocy te and t he p lasma ce ll repre sen t ,  re spe c t ive ly , the 
be ginning and t he end of the process  of lymphocyte d ifferen t ia t i on .  
Lymphopoi e si s ,  unl i ke normal erythropoi e s i s  or mye loidpoie s i s ,  occurs 
outside the bone marrow and l argely in the peripheral lympha t i c  t i s sue s  
such as t h e  lymph nod e s , the spleen , and the gu t a s sociated lymphoid 
t i s s ue s .  
A s  lymphocy tes  proceed a long the line o f  d ifferenti a t i on ,  the 
nwnber of s urface receptors decreases .  Immunoglobul in molecul e s  
serving as  recep tors on the c e l l  surf ace can be vi sua l i z ed b y  fluore s­
cent  mi cro s copy or by  au toradi ography . Experimen tal evidence s ugge s t s  
that s urface irnm unoglobulin mole cules  may d i ffer f rom tha t o f  the 
circulat ing an t i body molecule s . 
The Lymphocyte Ne twork 
There are t hree d ual i sms wi thin the immune sys t em ( 3 9 ) . One i s  
the f unc tional d iversi ty o f  t he lymphocy te s  into T and B c e l l s  med i ­
a ting , re spe c tive ly ,  ce l l  mediat ed and humoral ant ibody immune re­
sponse s .  The other i s  the dual i ty of the po tential response o f  a 
lympho cyte w�1e n i t s re cep t ors  re cogni ze an epi tope ( or an an t i geni c 
determinan t ) . I t can ei ther r e spond pos i t ively ( being a c tivated ) or 
nega t ive ly ( ?aralyzed ) .  The imm w�e sy stem a l s o  di splays a third d ual­
ism, c..nd that is t he same �m t i body mole cu le d i splay s  bo th epi tope s 
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and receptors . This i s  true for both antibody mole cules  serving as 
surface receptors and the freely circulating antibody molecule s .  
Epitopes occur on bo th the constant and the variable region s  of an 
antibody mole cule ( Se e  F ig .  2) . Epi topes of the variable regions are 
numerous and the set of epi tope s ort a given antibody mol e cule is named 
the idio type of tha t  molecule . Due to these complex properties  of the 
antibody molecule s ,  there exi s t s  a ne twork of lymphocyte s  and anti­
body molecules which recognize o ther lymphocytes and o ther ant ibody 
molecule s· which in turn ·recognize s till others . This ne twork , as a 
whole , f unctions in a way that i s  peculiar to and characteri s ti c  of 
the internal interaction of the e lements of the inunune sys tem i tself . 
All  these  re sult  in a contin uous in teraction of lymphocy t e s  and anti­
body molecules wi th idiotopes or combining s i tes that fi t .  
Under normal .condi tions , the immune sys tem of an animal i s  in 
a dynami c s teady s tate as i t s  elements interact .  F orei gn antigens 
could modulate t hi s  ne twork by activating some of the lymphocytes and 
disbalancing the s teady s tate . They leave imprints  to the lymphocyte 
population . and induce the expansion of selected clones whi ch is  a 
mechani sm of the re tention of inununologi cal memory. Thi s  i s  not ,  
however·, the only imprint made by the foreign epi tope . The s e t  of 
combining s i te s  that recognizes the epi tope also recognizes a s e t  of 
idiotope s wi thin the system,  a s e t  of idiotopes that  cons ti tut e  the 
' internal image ' of the foreign epi tope . The lymphocytes  representing 
the internal image wil l  therefore be affected secondarily and so forth 
in succe ss ive recogni t ion waves throughout the framework . The 
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modulation of the ne twork b y  forei gn signals  represents the adaptat ion 
of the immune sys tem to the outside environment and thereby builds 
up a memory tha t  is  sustained by transmi ssion to progeny c e l ls . An 
outline of thi s ne twork is presented in F igure 4 .  
The f irst  de tectable step for the differentiation of B cells 
into p lasma cel l s  i s  the production of I gM  antibodi es ,  mos t  of which 
are incorporat ed into the cell membrane where they serve as specifi c 
antigen re ceptors . S till  under the influence of the microenvironment , 
the clonal precursors undergo a series of mi toti c divi s ion ,  producing 
from one cel l  to a fami ly of progeny cells . The ma jori ty of these pro-
geny cel l s  migra te to the peripheral tis sue s  and some take a further 
-
s tep of di fferentiation by swi t:ching from I gM  producing ce l l s  to I gG 
plasma cel l  precursors . The change i s  believed to involve only the 
expres s i on of the two genes that spe cify the cons tant region s  of the 
'mu ' and ' gamma ' heavy cha ins . The exac t mechani sm i n  whi ch anti gens 
induca . R .cells . . to . divide . and . .  dif£eren tiate is uncertain) two types of 
signals  are probably involve d .  One i s  the d irec t intera c tion o f  anti-
gens with surface receptors of  the B cells  pre sumably through some 
correspondence of shape . A nti gens wi th closely spaced repeating ant i -
genie de terminants such as polysaccharide s are mos t  eff i c i en t  in this 
mode of s timulation . Another signal i s  through the intera c t ion of the 
T cells , e i ther by d irect contact or by some T cel l  factors . The re-
quiremen t of the participa tion of the T cel l  varie s  wi th d i ff eren t  
clas ses o f  antibodies  involved . The production o f  ! gt!  ant i body i s  
least  depend ent and I gA antibody response i s  most dependent . The 
ANTIGEN 
LYMPHOCYTE NETWORK: 
E D t 
UNSPECIFIC PARALLEL SET 
Fi�ure 4 • ( 3 9 ) is diagrammed in an effort to indi· 
cate Ilow i ts  steady-state ("eigcn") behavior is estahl i�hed and how 
khe network responds to an ant i gen . A n  'epitopc '(E) on the nntigen 
is recogn ized by a set (p1 ) o f  comb in i n g  sites on ant ibody moll!· 
cu lcs, both circula t ing  nnt i hody and cell-surface rcC'ept or::. Cells 
with receptors of  the reco gn i zin g f;Cl p1 are potential ly capable of 
respond i n g  to the anti genic stimdus ( arrowh eml ) o f  t-p itope E, hut 
tl1cre a rc eonstr:i ints. Tlie same molecules that carry combi n i n g  
si tes p1  c:irry a s e t  o l  idiotopcs ( i1 } .  These are recognized w i t h : n  
the system hy :t s e t  of combining sites ( p 3 ) ,  c:il lc<l t h c  �mt i-idiolypic 
set because they tend to suppress ( reverse arroivhead) the eel ls vf 
set i1• (These idiotypes i1 ,11re also found on molccu!es with ·com· 
BUFFERING SETS 
b ining sites that do not heJ ong to the rceo �nizing �et p1 b ut rather 
arc unspeci fi c  with re�ard lv ep i tope E. ) On the other hand, the set 
p1  also rcroimizcs internal cpit opcs i'.!, which therefore const i �ute 
an in tern a l im:i�e of the foreif:n cpit opc E. In the st eady state, m ole· 
culcs of t he intcrn:il image tend to st imula te cel ls  of set p1 nnd t h us 
to hal :tm·c the su pprci:::ive l<'n<len cy o f  the a n t i - i <l io typic  set.  When 
thl! forei gn f\nt i �en enters the sy�tem, i ts st imulatory efTcC't on rec· 
op.n i?. in�  set p1  allows cells of that set to cscnpc from su pprcs:.i on. 
( The snmc tliing hap pens to u nspeci fi c  cells o f  t he par:i llcl  set JJ .r• > 
The resul t ing  immune response to the a nt igen is moJul:ttc<l by the 
buffering effects of m�!nY more sets of comhin iug sites and id i o· 
topes ( ri;hi ), which have a controlling in fluence un t he rcs1>onse. 
N 
\0 
deve lopment and d i fferentia tion of a lymphocyt e  are i l lus tra ted in 
F igure 5 ,  
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I t  i s  be l ieved tha t the primary differenti a tion o f  s tem c e l l  into 
diversi f ied  lymphocyte popul�tions i s  gene tically de termined . The 
synthe s i s  of mos t protein mol e cules  or single po lypep tide chains i s  
de termined b y  a s ingle gene . Thro ugh heredi ty s tudi e s  and amino acid 
seq uence analy s i s ,  it is found t hat the synthe s i s  of immunoglobulin s  
i s  q ui t e  peculiar . The cons tan t and vari able regions o f  e ac h  poly­
pep tide  chain are speci f ied  by d ifferent gene s ,  and there are i n  fac t  
thre e to four s tructural gene gro ups tha t code for the an tibody mo l e ­
cule s ( 20,  3 1 ) . O ne group codes for the kappa l ight chains ,  t he second 
codes for the lambda , the third codes  for the various clas s e s  and s ub­
classes  of heavy chains ,  and finally a fourth group might be invo lved 
in cod ing the J chain ( in I gM  and I gA )  or for the linkage of the light 
and heavy chains  and the carbohydrate por t ion of the anti body molecule . 
Gene s wi thin t he same group are linked , bu t the groups are no t and 
are probably loca t ed in s epara te chromosome s .  The lymphocyt e s , like 
_ mos t soma t i c  ce ll s ,  are diploida l ,  and the chromosome s are paired . 
For a he terozygote : a plasma cel l  expre sses  on ly one o f  t he a l l e le s .  
In other words , plasma cel ls  d i sp lay allel i c  exclusion .  
The G ene tic  C ontrol o f  I mmune Re sponse. 
The inf l uence of inheri tance on im une r.e spons e  had been observed 
mere t han ha l f  a century ago . I t  w2 s do cum e n ted by C ooke and Van der 
Veer ( 1 9 )  that  human s i ckne s s e s  such a s  hay fever , bronchial a s thma , 
and ga s tro-enteri s have been gene t i cally re la ted .  La ter , the gene ti c  
• • • 
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Figure S .  Illu.s t rat i on o f  the d i f fe ren t iat ion an d deve l opmen t o f  
an ant igen- a c t ivat e d  p l asma ce l l  p re cur s o r  • 
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control of antibody response s  to diptheria toxoid ( 6 8) , to pnewnococcal 
polysaccharid e  ( 2 8 ) , and to insulin ( 4 ) were discovered . Since then, 
there have been s i gnificant progres s  in the elucidation of the com­
plexi ty of gene t i c  control of immune response . Thi s progres s  has 
mainly been achieved in three areas - ( 56) as follows : 
1 .  The preparation and characterization of syntheti c polypep tide 
ant i gens of determined size , structure , and amino a cid se.­
quences  which possess  l imi ted nwnber of antigenic d e termin­
ant s . 
2 .  The development o f  inbred and congenic strains o f  rodents , 
some of which differ di stinctly withi.n a limi ted and defined 
region of the genome . 
3 .  The partial  d i ssection of the immune proces s  into s teps which 
require immunogen induced activation of dis tinct lymphoid 
cell populations . 
Thus , i t  i s  not surpris ing tha t  mos t contributions to the genetic  s tudy 
of the immune re sponse i s  through the s tudy of inbred s trains of gui­
nea pigs and mice to various synthetic  haptens � 
The antibody responses of inbred and congenic s trains of mice 
to a series of related synthe tic polypep tides have been shown to be 
determinant specifi c ,  and are linked to the ma jor H-2 ( hi s tocompa t i ­
bili ty locus )  hi s tocompatibi l i ty region o f  the ninth mouse linkage 
group (4 9). The gene s associated wi th the responsiveness ,  ei ther in 
high or low re sponder , to synthe ti c  polymers are called the ' I r ' or 
irrunune respon se  gene s .  
Different inbred s trains of mice could produce equal amount s  of 
antibody against the same antigen but are directed towards different 
determinants wi thin the complex immunogen. 
G enetic  regulation of immunological responsivene s s  i n  mice to 
complex multideterminant protein antigens had been demons trated by 
immunization wi th low do ses  of native albwnin pro teins and bovine 
pancre tic ribonuclea se ( 7 9 ) .  Responsiveness was dominant and was 
determined by a H -2 linked gene . All s trains irrespec tive of their 
H-2 type s were found to respond eq ually to a second irrununization or 
to a primary immunization wi th a high dose of antigen . 
A number of experiments had been de signed to a s sociat e  the ex­
pres sion of immune antibody resp�nse genes at  the cellula·c l eve l .  
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This was done by transferring limi ted donor lymphoid cell s  of the 
thymi c  and/or bone marrow origins to syngenei c  normal or X-irridiated 
recipients  to charac teri ze the immune re sponsivenes s  of these  lymphoid 
cell s .  S o  far , information of the gene tic control a t  � c e l l ular level 
i s very .limi ted . I t  was found that both T and B cell  typ e s  play a 
role in this control but the mechani sm remains unclear. I t  is now 
obvious that immune re sponsivene ss i s  genetically linked t o  the ma jor 
histoc6mpa tibili ty loci and that two functionally di s tinc t populations 
of antigen sensi t ive cells are involved ( 13, 7 5) .  One recogni z e s  
foreign antigens and expresses V-genes coding for an t i bodie s  agains t 
hi s tocompa tibi l i ty anti gens of the same individual ( se lf ) , and the 
other expres se s V-genes coding for reac tivi ty agains t hi s to compati­
bili ty antigens which the individual doe s  not posse s s  (non-self ) .  
Gene ti c  contro l of immune responses may be quali tative or quanti ta­
tive and may determine the clas s  of immunoglobulin produced . 
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MATERIALS AND METIIODS 
Animal 
Male and female mice ( 8-12 weeks old ) of an inbred c 3HSW s train , 
rai sed and bred iP our laboratory , were u sed in all experiment s . 
These  mi ce wei ghed be tween 24 and 34 grams . Mice to be in jec ted wi th 
radioi sotope I odine-125  were fed with water containing 1 mM of potas­
sium iod ide (KI ) for 72 hours before use . 
Virus 
3 5  
W e s tern equine encephali ti s  (WEE ) virus was used i n  a l l  experi � 
ments and the virus was propagated routinely in our laboratory by 
succes s ive p 3. s s ag 0 s  through euckl ing mouse brains . The bra.in material 
was then harve s ted and suspended in borate saline pH 9 . 0 to  a 1 0-20% 
concentration and was s tored at -7 0 C .  
Chick Embryo F ibroblas t  (CEF )  
Primary cul ture chick embryo fibroblasts  were prepared from embry­
onated Leghorn eggs incubated for 9-12 days before use .  The egg embryo 
was minced and trypsinized to form single cell suspension and was main­
tained in E agle ' s  minimum e s sential medium supplemented wi th 10% fetal 
calf serum. Monolayers of CEF were used for virus propagation and 
ti tration .  
The Coun ting C hamber 
A counting chamber or hemacy tometer was used to a s s e s s  the number 
of cells . Thi s i s a rec tangular glass s lide wi th two deep transverse 
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d i tc he s running acro s s  i t s  en t i re wid t h .  B e tween the d i t c he s , the 
g l a s s  i s  gro und d own and p o l i s hed so that t he l eve l is 0 . 1 nm l ower 
than tha t  of t h e  rema i n i ng s l i d e s urface . A p lane g la s s  c over - s l ip 
i s  p l a ce d  ove r  t he c en t e r  part of the s l i d e , crea t i n g  an enc lo s ed spa c e  
into whi c h t he cel l s u sp en s i on i s  in trodu ced . An e t ched la t t i ce pat-
tern on t h e  center s e c ti on e nab l e s  the  c e l l s  t o  be count ed . The cen-
ter s e c t i on i s  fr eq uen t ly subdivided by a tran sver s e  d i t c h ,  e a c h  s e c -
t i on having a l a t t i ce engraved upon i t s s urfac e .  
M o u s e  A n t i -WEE V i r u s  A n t i s erwn 
A gro up o f  s i x ty mi c e  were immun i zed wi th s i ng l e  i . v . i n j e c t i on s  
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of 0. 3 ml WEE vi ra l va c c ine ( 8 . 8 x 1 0  pfu/ml ) thro ugh the caudal 
ve ' ns .  A t  var i o u s  t ime in tervals , six mi ce were ex s angu i n a t e d and the i r  
serwn wa s p o o l ed . Ten s e rum s amp l e s  were co l l e c t ed b e twe en d ay 1 and 
day 16 after t he immuniza t i on to be t e s ted for the f o rma t io n  o f  an t i -
serum agains t WEE v i r u s  b y  t he rad i o immunopr e c i p i t a t i on t e s t .  
Mouse B l o od Lymphocyte 
Mouse lympho cy t e s w e r e  ob tained from card i a c  b l o od o f  m i c e ; t he 
heparini zed b l ood wa s puri fi ed in f i col l-hypaq ue gradi en t  and was 
maintained in RMPI l M O  medi tim  s uppl ement ed wi th 5% fre s h  human s e rum . 
Thi s lymphocy t e  c u l ture wa s u s ed to ' e s t ima te a c t iva t ed lymp ho c y t e  
ge nera t i on t ime , the la ten t p e ri od req uired b.�f ore a c t iva ted lympho -
cy tes s tart  t o  pro l i f era t e , and how many ce l l  gene ra t i ons  an a c t i va t ed 
lymphocy t e  wo u ld g o  t hrough bef ore d ivi sion s t opped . 
3 7  
Rabbi t A n t i -Mo us e  I mmunoglobulin ( Ig) Anti serum 
A n t i -mous e  lg an ti serum wa s obtained from two rabbi ts whi ch had 
re ce ived four in traveno us i n j e c tions of normal mouse I g  at an interval 
of one i n j e ct i on per week . The anti serum was harves t ed two weeks 
af ter the las t  i n j e c t i on .  The LD
50 
of thi s serum was f o und to be 
0 . 2 ml when given to mi ce in travenously . 
Reagen t s  and M edia 
A .  Anti biot i c s  
P eni ci l lin G ( Sod i um  Salt ) 
P repared a s  a s tock solution containing 1 00 , 000 uni t s /m l . 
U sed a t  a fina l concentration of 1 00 uni t s /m l . 
1 .  Di s s o lve individual vi als  of ant i b i o t i c  i n  s teri l e ,  
d e i oni zed water . 
2 .  S tore frozen a t  approxima te ly -20 C .  
Add 1 ml of s to ck solut ion to each l i ter o f  medi um  to give a 
f inal conc entra t i on of 1 00 uni t s /ml . 
S trep tomy c i n  ( S ul f a t e ) 
P repared a s  a s tock solu tion conta ining 1 00, 000 pg/ml . U sed 
a t  a f inal conc entra tion of 100 pg /ml . 
1. Di s so lve individ ual v i a l s  of ant i b i o t i c  in s teri l e , 
d e i on i z ed wa t e r .  
2 .  S tore frozen a t  approximately -20 C .  
A dd 1 ml o f  s to ck s o l u tion to each l i t er of medi um to give a 
f inal conc entra t ion of l CO µg /ml o 
Mycosta t in 
Thi s ant i b io t i c is a lmo s t  insoluble in water . I t  i s  prepared 
as a s tock s uspension containing SO, 000 uni t s /ml a·nd used at 
a f inal , poncentra tion of 25 uni t s /ml . 
1 .  S uspend individ ual vials of an tibioti c i n  s teri l e ,  
deionized wat er .  
2 .  S tore fro zen a t  approximately -20 C .  
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Add 0 . 5 m l  o f  s tock s uspension t o  each l i ter o f  med i um t o  give 
a final concen tration of 2 5  uni t s /ml . 
Kanamy c i n  
Prepared a s  a s tock solut ion containing 50, 000 pg /ml . U sed 
at  a f i nal concentration of 50 µg /ml . 
1 .  Di s s olve ind ivid ual vials  o f  an t i b io t i c  i n  s terile , 
d e i onized wa ter . 
2 .  S tore frozen a t  approximately -20 C .  
Add 1 ml of s tock solution to each li ter of medi um to give a 
final concen tra tion of 50  µg/ml . 
B .  Eagle ' s  M inimum E s se n t i a l  M ed i um  (MEM ) 
Solut ion A 
L-arginine HC l 1 .  05  g 
L-hi s t i d i ne H C l o .  3 1  g 
L-ly s ine H C l 0 . 5 8  g 
L-tryp tophane 0 . 1 0  g 
L-pheny l alanine 0. 3 2  g 
L-threonine 0 . 4 8  g 
L-l e uc ine 0� 52  g 
L-valine 0. 4 6  g 
L-rne thi onine 0 . 1 5  g 
The above amino acids are wei ghed out freshly as  required . 
Solution B 
L-tyrosine 
L-cy s t ine 
0. 3 6  g 
0. 24 g 
Di ssolve in 2 00 ml of 0 . 07 S ·N /l HC l ( prepared by adding 2 ml 
of  commercial concen trated hydrochloric acid to  3 1 5 . 4  ml of 






Pantotheni c  acid 
C holine 
L-ino s i tol 
R i boflavin 
0. 20 g 
. o.  20 g 
0. 20 g 
0. 20 g 
0. 20 g 
0. 40 g 
0. 02 g 
1 .  Di ssolve i n  200 ml of deionized water. 
2. Di spense in 10 ml volumes . 
3 .  S tore at  approximately -20 c .  
Solution D (Folic acid , 0 . 20  g) 
1 .  Di s s o lve in 200 ml of Hanks ' saline , pH 7 . 8 . 
2 .  Di spense i n  1 0  ml volumes . 
3 .  S t ore a t  approximately �20 C in tightly s toppered bottle s . 
Glutamine Solution (L-glutamine , 12 . 0 g) 
1 .  Di s solve in 400 ml o f  deionized water. 
2 .  S terilize  by posi tive pressure filtration. 
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3 .  Di spense  asep t i ca l ly in S O  ml volumes .  
4 .  S tore a t approx ima te ly - 2 0  c .  
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Prepara tion o f  1 0 X concen tra ted Eagle ' s  MEM from the above solu-
tions 
1 .  Di s so lve the fol lowing in solution B :  
NaC l 
KC l 
M gS0 4 • 7H 2 0 
6 8 . 0 g 
4 .  0 g 
2 .  0 g 
2 .  D i s s olve 1 . 25 g o f  NaH zP04 i n  S 5  ml o f  de ioni z ed wa ter 
and add  to th� above pool . 
3 .  Pi s s olve 10 . 0 g of gluco se i n  S O  ml o f  deionized water 
and add 2 0  ml of 1% phenol red . Add the mix ture to the 
p o o l .  
4 .  D i lute t he poo l t o  600 ml wi th de ioni zed wa ter and add 
the fol lowi ng : 
Soluti on C 
Sol ution D 
1 0  ml 
10 ml 
5 .  D i s s olve 2 . 0 g o f  C aC 12 
i n  1 6 0  m l  o f  d eion i z ed wa ter and 
add to the pool s lowly wi th continuous s t irring . 
6 .  A d d  the amino aci d s  of Solut ion A to the poo l . 
7 �  D i l u t e  the �ool to exact ly 1 , 000 ml wi th deionized wa ter 
to give a 10 X concen tra ted s tock so lution .  S teri l i ze 
by pos i tive pre s s ure fi l tration and s tore a t  4 C .  
C .  C hi ck Embryo F ibroblast  C ulture Mediwn 
10 X MEM 90 ml 
Heat inactivated fe tal calf serwn 
( 56 C for 30 min ) 
P eni cillin 
S treptomycin 
Kanarnycin 
D .  Amino A cids Supplement for Lymphocyte Cul ture 
S to ck Solution ( 1 00 X )  
L-asparagine 
L-glutamine 
L-arginine HC l 
RMPI 1 64 0  comple te 
medium 
( s tored a t  4 C ) 




10. 0 ml 
0. 1 ml 
0. 1 ml 
0. 1 ml 
Add
.
l ml to each of 100 mls of med iwn to give a final concentra-
t ion of : 
L-asparigine 
L-glutamine 
L-arginine HC l 
E .  Lymphocyte  C ul ture M edium 
36  mg /l 
216 mg /l 
1 1 6  mg/ l 
Roswe l l  Memorial Park Insti tute (RMPI ) 
1 6fi.O medium 
Hea t inac tiva ted ( 56 C for 3 0  min) human serum 
Phy tohemagg l utinin-P ( 50 pg /ml ) 
Amino acid supplement 
Penici llin 
S treptomy cin 
Kanamycin 
Mycos tatin 
93 . 0  _ ml 
S .  0 ml 
1 .  0 ml 
1 .  0 ml 
0 . 1 ml 
0 . 1 ml 
0 . 05 ml 
0 . 1 ml 
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F .  Tri s (Tri s Hydroxyme thyl Amino Methane ) B uffer 




KH 2P0 4 
Glucose 
1% Pheno l red 
Deioni zed water 
7 0. 0 g 
3 . 7  g 
1 . 19 g 
0 . 23 7  g 
10. 0 g 
10. 0 ml 
990. 0 ml 
Di s solve the sal t s  and glucose in water in the order l i s ted , 
and add the phenol red . Thi s i s  a 1 0  X concentrated s to ck 
solution and i s  s tored a t  4 C .  For use , di lute the s tock 
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solution ten t ime s  wi th de ionized water and s terilize  by auto-
claving. S tore at  room temperature or at  4 C .  
G ey ' s Solution B 
Nac 12 � 6H 20 
MgS04 • 7H 20 
C aC l2 
Deioni zed wat er 
0. 42 g 
0. 14 g 
0. 34 g 
100, 0 ml 
1. D i s solve the salts  in water in the order l i s ted . 
2 .  S teri lize by au toclaving . 
3 .  S tore a t  room temperature or 4 C .  
Preparation of 0. 1 M / l Tri s B uffer 
1. Prepare modified G ey ' s  saline by adding 20 ml of solution 
B to 3 60 ml of Solution A .  
2 .  Di s solve 4 . 84 g of Tris in approximately 100 m l  of mod i -
f i e d  Gey ' s  saline . 
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3. Add 7 6 . 8 ml of 0. 2 M / l  HCl ( prepared by di luting commercial 
concentrated hydrochloric acid 50 times wi th de ionized 
water) to the Tri s so lution. 
4 . Add modified Gey ' s  saline to give a total  vol ume of 4 00 ml . 
Thi s repre s ents  a 0 . 05 M /1 s tock solution of Tris a t  
pH 7 .  6 .  
S . Steri l ize by posi tive pressure filtration . 
6 .  Di spense in 1 00 ml vol wnes tak ing asep t i c  precautions . 
7; S tore at  4 C .  
G .  C alcium and M agne sium Free Saline (GKN )  
1 0  X s tock solution 
NaC l  
KC l 
G l ucose 
80. 0 g 
4 . 0 g 
10 . 0 g 
Prepare in 1 , 000 ml d i s t il led water and steri l i ze by auto-
· claving. For use ,  dilute 1 : 10 in sterile di sti lled water. 
H.  Wright ' s S tain 
Wri ght s tain dye 
Gly cerol 
M et hy l  alco hol  ( 1 00% ) 
0. 3 g 
3 .  0 g 
97 .  0 ml 
Grind the s tain in a mortar wi th gly cerol thoroughly . Add abso-
lute me thyl alcohol , mix wel l , s tore overnight . S hake 1 5  min 
every day for 1 wee k  and fi l ter. S tore at  room temperature . 
I • Trypan B lue 
Prepared as 0 . 5% solution . 
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Trypan blue , vi tal · O. � g 
Phosphate-buffered saline 1 00, 0 ml  
1 .  Dissolve the trypan blue i n  phosphate-buffered saline . 
2 .  S tore a t  room temperature . 
3 .  F i l �er a few ml through paper on the day o f  use . 
J .  May-Grunwald and G iemsa S tain 
Solution A 
May-C runwaJ. d  s tain powder 
A bsolute methyl alcohol 
1 . 25 g 
500. 0 . ml 
1 .  Grind the s tain in a mortar wi th a smal l  q uant i ty o f  methyl 
al cohol until the powder i s  uniformly suspended . 
2 .  Transfer to a flask with the r��aining me thyl alcohol and 
place on a magne tic s tirrer a t 3 7  C overnight . 
3 ,  Di spense in 100 ml vol wnes and incubate  a t  3 7  C for at 
least  a month before use . 
4 .  S tore in tightly stoppered bo ttles a t  room temperature . 
Solution B 
G i emsa s tain powder 0. 6 g 
G lycerol 50, 0 ml 
A b solute methyl alcohol - 50. 0 ml 
1. Grind the Giemsa po�der in a mortar wi th the glycerol . 
2 .  Transfer completely t o  a flask containing a few gla s s  
beads and place on a shaking machine at  37  C overnight . 
3 .  Add the me thy� alcohol  and continue shaking until  mixed . 
4 .  S tore in tightly s toppered bo ttles at room temperature . 
A llow to ripen for two weeks before us ing. 
Sol ution C 
NaHC03 
Deionized water 
5 . 6 g 
1 00 .  0 ml 
1. Di s solve the bicarbonate in water . 
2 .  S tore at  room tempera ture . 
Procedure for U se 
1 .  Rinse cul tures twi ce with phosphate-buffered saline to  
remove protein. 
2.  F ix 3-5  minute s in absolute me thyl alcoho l . 
L�5 
3 .  Trans fer to fresh absolute me thyl al cohol for 3 -5 minute s . 
4 .  Dry in air . 
S .  Cove r wi th M<1y-Grunwald s tain for ten minutes .  
6 .  Wi t hout washing,  transfer to fre shly prepared d ilute Giemsa 
s tain for 20  minutes . (Prepare s tain by d i lut ing ten time s 
wi th deioni zed water . Add four drops of S . 6% sodium bi-
carbonate  per 100 . ml of di luted stain. ) 
7 .  Wash in running tap water . 
8 .  Two changes i n  ace tone , three minutes each.  
9 .  Two change s  in xylene , three minutes each . 
· 1 0. Mount . 
Nuclei  s tains red-purp le ; cytoplasm stains blue . 
P ro cedure for the A s s e s sment of Viable C e l l  Number s  ( 3 6 )  
1 .  P repare the coun t ing chambe r  by dry ing i t s  part s .  Then pre ss 
the cover-s lip gen tly but  firmly on to the s l i d e  s o  tha t i t  
adhere s .  
2 .  A d j u s t  the c e l l  concen tra t i on to s l i ghtly in exc e s s  o f  an e s ti ­
ma ted to tal count of 1 . 0 x 1 06 cell s /ml . 
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3 .  P repare t he c e l l  suspen s i on for coun ting b y  add ing 1 . 0 m l  o f  
s uspens ion to O . S ml of trypan b l ue s o l ution .  P hospha t e -buffered 
s a l ine is a sui ta b l e d i l uent . 
4 .  M ix thoroughly and immed iat ely in troduce a drop of t he s tained 
c e l l  suspens i on into the co unting chamber.  T hi s is done by 
bringing a loaded P a s teur pipe t te to the edge of the space imrned-
i a t e ly benea t h  the cover- s l ip .  
lary ac t ion . 
The f l uid is  drawn i n  by capi l -
S .  C o un t  inuned i a t e ly und er the l ow power ( 200X..) of the micro s cope . 
NOTE 1 :  I t  i s  e s s en t i al tha t  the d i fferential co un t  be  mad e irrunedi ­
ate ly a f t e r  trypan b l ue has been added to the ce l l  suspens ion 
s ince pro longed exposure res u l t s  i n  s i gn i f i can t n um bers o f  
heal thy c e l l s  ta king u p  the dye , thereby leading to an erron­
eous ly low a s s e s sment of the propor t ion of via ble ce l l s . 
NOTE 2 : Only t he large sq uare s at each c orner of t he l a t t i c e  are 
used i n  coun ting ; each of t hc� se , 1 . 0 sq . mm. in area , i s  
made up o f  1 6  sma l ler sq uar e s . F o r  convenience each l � O 
sq . nun .  should c ontain about 1 00 cel l s , and for be s t  r� s ul ts 
4 7  
a t o ta l  o f  about 4 00 cells ( four squares o f  1 . 0 sq .  nun .  
each) should be  counted . Counting i s  most  readily done by 
ass e s s ing the cel l s  in each of the 16 smal l  sq uares sepa� 
rately , proceeding along each row of squares in a left-to­
right dire c t ion and then �nto the line of sq uare s next below .  
In order tha t  cell s  lying upon the lines interse ct ing the 
smal l  squares are not counted twice , only tho s e  lying on 
the upper and right hand lines of each square are included 
in the count . By covering all 16 small squares in thi s way ) 
i t  i s  obvious that there will  be no exclusions from the to tal 
count . 
NOTE 3 :  Trypan blue i s  selectively absorbed by the non-viable cell s , 
which are s tained an intense blue color, whi l e  the viable 
cells  remain unstained . 
Procedure for the Purifica tion of Mouse  Lymphocy tes  ( 9) 
1 .  Prepared layering solution by mixing 6 ,. 8 parts of 50% Hypaque 
or sodium di atrizoate (Winthrop Laboratories , New York) wi th 
24 parts of 9% w/v ficoll (Pha.rmicia F ine C hemic al s , Sweden) 
giving a dens i ty of 1 . 08 .  
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2 .  H eparini zed cardi ac blood ( 1 0 pg/ml ) was drawn in  a n  a s ep t i c  
condi ti on from anaes the tized mice and was di l uted 1 : 1 wi th s ter­
i l e  phy si ologi cal saline con tai ning 5% hea t inactiva ted ( 56 C , 
3 0  min) fetal calf serum.  
3 .  Three volumes o f  diluted blood were layered carefully over 2 
vol llfl).es of layering solution in steri le plastic  tubes  (Falcon , 
B ec ton , Di ckinson and C o . , talifornia ) . 
4 .  The tubes were centrifuged in a centrifuge (I nterna tional Eq uip­
ment C o . , B oston , Mas s . ) wi th a swinging bucke t  rotor at 900 r . p . m .  
for 4 0  min at  room temperature . 
S. F ollowing centrifugation ,  the lymphocytes should appear as  a whi te 
band at the interface be tween the ficoll-hypaque gradi ent and the 
serum portion of  the blood . 
6.  The lymphocyte s  were removed aseptically by a s terile  Pas teur 
pipe t te and were washed three time s by 2% GKN supplemented wi th 
heat inactivated fe tal calf serwn . 
7. A sample  of lymphocy tes was s tained wi th 0. 5% trypan blue exclu­
s ion s tain and the numb·er of living cells were counted in a 
hemocy tome t.er.  
8 .  The homogenei ty of the lymphocyte population was examined by 
G i emsa s tain.  U sually 80-90% of the cells  were lymphocyte s when 
col l e c t ed by thi s me thod . 
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Procedure for the C ul t ure of Primary C hick Embryo F ibroblas t ( 3 6 )  
1 .  Rinsed the e gg shell  thoroughly with 7 0% al cohol . 
2 .  O pened the egg o n  the side of the ai r sac by punching the she l l  
wi th the back o f  a heavy s terile forcep . 
3 .  P ee led off  the she l l  and removed the whole embryo by q ui ckly 
t urning the egg up side down in to a 1 00 mm s t eri l e  pe tri d i sh .  
4 .  The embryo was t hen d ecapi ta ted , evi s cera ted and placed into a 
beaker of 2% GKN to remove i t s  fa t conten t . 
S.  The embryo wa s then cut into small  p i eces and wa s removed wi th 
a s teri le  magne t i c  s t irrer into a 50 ml beaker containing 5 ml 
_ of pre-warmed 0 . 2 5% tryp sin . 
6 . The mince was gen t ly s tirred and the tempera ture was maintained 
at 3 7 C .  
7 .  R emoved a te s t  s ample  after 5-1 0 mi n to as sure tha t  t he tryp sin 
was working . 
8. Tryp s ini zat ion should be comple ted af ter 4 5  min t o  one hour . 
9. The cell  s uspension wa s collected in  plas t i c  cen tri fuge t ubes  
con taining cold MEM med i um and wa s centri f uged a t  1 00 0  r . p . m .  
for 1 0 min . 
10. The s uperna tant should be almo s t  cl ear and should be  d i scarded . 
11 . �esuspended t he cell  pelle t in MEM ( about 5 ml ) and p ip e t ted 
vi gorously to promo te single cell suspension.  
12 . Took a samp le of the cell  suspens ion and counted immedia t ely in 
a hemocy tome ter . 
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13 . A bout 50 x 1 06 cells were s eeded in 3 5  ml of MEM medi um in 250 ml 
bot tles  ( F alcon , Becton , Dickinson and Co . , C al ifornia) � 
14 . C e l l s  were then incubated at  37 C in a 5% co2 incuba tor. 
1 5 .  Confluent monolayers should b e  formed in 48  hours and sho uld be  
ready for use . 
Procedure for the Prepara tion of Rabbi t A n t i serQm 
to Mouse Immunoglobulin ( l g ) 
1 .  A group of 4 0  normal mice  was exsanguina t ed by card i a c  punc ture 
and the blood wa s colle� ted in small s erum t ube s .  
2 .  The blood was se t a t  room temperat ure to clo t ,  wa s then refrig­
era t ed overnight a t  4 C to al low maximum contra c t ion o f  t he c l o t  
to occur .  
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3 .  T he s erum from each t ube wa s pooled and centri£uged a t  3 000 r . p . m .  
f o r  1 5  m i n  a t  4 C to remove con taminati ng ery throcy t e s  and t he 
fat conten t . 
4 .  T he sert.un wa s cons tantly s t irred whi l e  an eq ual vol ume of 7 0% 
cold ammon i um s ul fate  solut ion wa s added dropwi s e  ( 3 3 ) .  
S .  The mix ture was s e t  at room tempera ture for 4 hr and t hen cen tri­
fuged at 3 000 r . p . m .  for 15 min . 
6 .  D i s carded t he s 1  pernatant and re suspend ed the pre.cipi tate  wi th 
a volume o f  d i s t i lled wa ter approximately equal to the original 
serum vol ume . 
7 .  Ano ther eq ual vol ume of  ammoni um sulfa t e  was added dropwi s e  
The mix t ure was cen tri f uged immed ia te ly and t h e  s up erna tant was 
d i s c�rded . The p re c ip i ta te wa s d i s solved and brought to vo l ume 
as before . The m ix t ure was trea ted in the same way as  be fore for 
a t hiLd pre cip i t a ti on .  
8 . The pre ci p i tate from t he las t fractiona tion was dialyz ed agains t  
phy si olog i ca l sal i ne ad j usted to pH 8 . 0 .  Freq uen t  change s were 
made unti l  sulfate  was no l onger d e te c table in the d ialy sa te . 
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9 .  To test for the pre sence of sulfate , one ml of s aturated bariwn 
chloride wa s added to an eq ual volume o f  we ll-m ixed �aline dialy­
sate . The appearance of cloudine s s  was an indication of re sidual 
sulfate ( 3 4 ) . 
1 0 .  The immunoglobulin solution was diluted to 2 0 m l  and was used 
as  inocul wn. 
1 1 .  Two normal rabbits were co l l e cted and blood was taken from the 
ear to o btain normal blood sampl e s. 
1 2 .  The rabbits were immunized with a n  intravenous i n j e ction with 
2 ml of mou s e  immunoglobulin solution through the ear vein s .  
Three more in j e ctions were given at one -week interval s. 
13 . · Ten days after the l a st in j e ction , the hyperimmunized rabbits 
were ex s anguina ted by cardi ac pun cture and the ant i s erum was 
colle cted in the same manner as  in steps 2 and 3 .  
14 . The an tis erum wa s t e s t ed against mo use immunoglobulin s o l ution 
by the precipita tion te st . 
Pro ced ure for the Prepara tion of WEE Viral Vaccine ( 1 2 )  
1 .  Ten ampoule s ( 2  ml ) o f  WEE viral suspension ( 8 . 8 x 1 07 p f u) were 
thawed in a 3 7  C wa ter ba th . 
2 .  The suspens ion was p i petted out by s teri le P a s te ur pipe t te s  into 
a beaker inunersed in an i ce bath . 
3 .  Added one -tenth vol ume of 1 . 0 Tri s buffer ( Tri s hydroxyme thyl 
amino me thane , F i sher S ci en t i fi c  Co . , C al i fornia ,  No . T3 9 5 )  and 
allowed i t  to s tand for 1 5  min . 
4. Prepared a 1 0% solution of be ta-propiolac tone ( BPL ) 1 in co ld 
phy s iologi cal sal ine . 
5 .  BPL w a s  add ed to the vi ral s uspension wi th Tri s buff er to  a f inal 
concentra tion of 0. 3% .  P laced the mixture on a magne ti c s t irrer 
at 4 C and agi ta ted gently for 72 hour s .  
6 . Removed an al iq uo t  for t e s t  and stored the remainder a t  - 2 0  c .  
7 .  Sample of the virus vacc ine wa s injec ted into s uckl ing mice and 
obs erved for ten day s to see �he ther li ve viruse s  we re pre sen t . 
1 
. 
B e taprone , F el lows T e s tagar , De troi t ,  M i c higan . 
Procedure for the E s t ima t ion o f  the Average Radius  
of Mouse Lymphocy tes  
1 .  A mouse was sacrifi ced by  decapi tation and blood  wa s co l l e c ted 
immedi a t e ly by a P a s teur pipe t te .  
2 .  One freely f l owing drop o f  blood wa s co l l e c ted o n  the surface o f  
a clear s l ide a t  one edge and wa s spread along t he s harp edge 
of an other s l ide a t  an angl e  of  about 45 degre e s . 
3 .  A l l owed the blood smear to air dry by blowing or waving in the 
air qnd s tained immedia tely . 
4 .  Added about 1 0 drops of  Wright ' s  s tain to the smear and a l lowed 
to s t and for 8 min .  
5 . A dded an eq ual amount of d i s t i ll ed wa ter and blowed cons tan t ly 
to mix . A f ter d i lu ting the s tain , al lowed the prepara t i on to  
s tand for f ive minute s . 
6 . A f t er s tainins; , rinsed qui ckly wi th  water and dri ed immed iately . 
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7 .  O b s erved t h e  smear under an inverted mi croscop e a t  a magnifica t ion 
of 2 00X .  Lymphocy tes  cou ld be di s t inguished by i ts b lue mono­
nucleus and sl ight ly redd ish cy toplasm .  
8 . The d i ame t er of 4 0 lymphocy tes  was mea sured by an o cular mi crom­
eter whi ch had been pre cal i br� ted wi th a s tage mi crome t er .  
Propagation and Ti trat ion of WEE Virus 
A .  Propagati on procedure ( 3 6 ) 
1 .  A dded 2 ml of 20% WEE mouse brain suspension ( 1 0  LD 50/ml )  to  a 
confluent monolayer of CEF . 
2 .  I ncuba ted the cel l s  a t  3 7  C in a  5% co 2 i n  air _ a tmosphere and 
80% humidi ty .  
3 .  C he cked the cells  after 3 6  hours of incubati on . P e el ing off of 
the monolayer was an indi cation of viral mul tipli ca t ion . 
4 .  H arves t ed the viral suspension when approxima tely one-half of 
the monolayer was peeled off . 
5 ,  The crude harve s t  was centrifuged at 5000 r . p . m .  a t  4 C in an 
I nterna tional refrigerated centrifuge , model PR-2 ( I nterna tional 
Equipment C o . , B o s ton , Mass . )  for 10 min .  The pre c ip i t ate was 
discarded . 
6 .  An eq ual volume of  dime thyl . sulfoxide (Fisher S cience C o . , New 
Jersey)  was added to the viral suspension . 
7. Di spensed the viral suspension into 2 ml ampoules .  
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8. The ampoules were flame sealed and were s tored a t  - 7 0  C for future 
use . 
B .  Procedure for the titration of the virus by plaque assay ( 36 )  
l e  Prepared confluent CEF monolayers i n  6 0  x 1 5  nun t i s sue cul ture 
di she s  (F alion ,  B ecton ,  Dickinson and Co. , Californi a ) . 
2 .  R emoved th� growth medi um as completely as  pos s ible . 
3 .  Rinsed each d i sh twice wi th 2% GKN . 
4 .  Prepared serial ten-fold di lution of the viral suspension in 
2 X MEM . 
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5 .  I noculated 0 . 2 m l  o f  each d ilution directly onto each monolayer ; 
rotated gently to allow even distribution . P la tes - were i noculated 
in dupl i cate . 
6 .  Incubated the cul tures at 3 7  C for one hour to allow adsorption 
to take place . Rocked gently at 15  min intervals . 
7 .  M ixed 1 . 8% Gum Tragcanth (National B iochem. C orp . , C alifornia) 
wi th an equal volume of 2 X MEM and allowed to eq uil i brate in 
a 44 C waterbath. 
8. C arefully overlaid 1 0  ml of the gum med ium onto each monolayer . 
9 .  I ncubated in a humidified a tmosphere of 0. 5 g C0
2 
i n  air .  
10. A fter a 3 6  hr incubation period , the gum overlay was poured off 
and the p laq ues were stained wi th crys tal viole t and counted . 
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P rocedure for Rad i oiodina tion of WEE V ira l 
P articles  and Mouse I gG  ( 7 1 )  
1 .  P repared fre s h  solut ions o f  chloramine -T (Eas tman Kodak , Roches ­
ter , New Y�rk , # 1 022 )  aqd sodiwn me tabi sulfi te (F i she r  S cien t i f i c  
C o . , F air Lawn , N ew J ersey ,  # S-24 4 )  a t  a concentra t i on o f  2 00 
ug/ml ( 5  mg/ 2 5  m l )  in d i s ti lled wa ter and s tored a t 4 c .  
2 .  Di spensed 4 m l  o f  WEE viral s uspension or 4 ml of mouse  I gG 1  
( 2  mg/m l )  to a vial contai ning a small  magne t i c  bar . The vial 
was s e t  on the top of a magne tic s tirrer anct was kep t  inside a 
refri gera tor . 
3 .  One-ha l f  m i lli curic (mci ) of carrier-free 
1 2 5
1 was added to the 
vial through a mi crosyringe whi le the solut i on wa s con s tantly 
s ti rred . 
4 .  I n j e c ted 0 . 5 ml o f  chloramine-T through a 1 cc disposable plastic  
syringe and al lowed to se t for 1 0  min . 
S .  A t the end o f  ten minutes , added an eq ual amount o f  sodi um  me ta-
bi s ulfi te to t he vial . 
6 .  Removed the content of  the vi al to a dialy s i s  bag � Spectrapor 
2 
membrane tubing , molecular we ight cutoff - 1 2 , 000 to 14 , 000) 
through a P a s teur p ipe t te and al lowed to dialyz e again s t  3 l i ters 
of phy si ologi cal  saline in a mul tiple di a ly ser ( S c i en t i f i c  I nc . , 
Lo s  Ange le s , C al i fornia ) a t  4 C wi th cons tant s t i rr ing . 
7 . C hanged ' the d ialysa te ( sal ine ) every 1 2  hr and col l e c ted a sample 
af ter 4 8  hours to b e  counted for rad ioac tive con ten t .  
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8 .  R ecovered the viral suspens ion as the radioactivi ty of the dialy­
sate was down tQ background level . S tored the radi oactive WEE 
virus solution at 4 C for future use . 
\ti le s  Labora tories Inc . , Kankakee ,  I ll .  
2
spec trum M ed ical I ndus tries  Inc. , Los Angeles ,  California .  
Procedure f or the E stimation of the B iological Half-Life 
of Mouse Immunoglobulin ( I gG)  
1 .  Two groups of  mice were prepared for thi s experiment .  One group 
was normal mi ce fed wi th wa ter containing po ta s s i um  i odide ( rrM /  
ml) for 7 2 hours . Ano ther group had received a s ingle intrave� 
nous injection of 0. 2 ml  of BPL inactivated WEE viral vaccine 
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( 8 . 8  x 1 0  pfu) . F ive days after the injection the se mi ce were 
treated in the same way as the other group and both groups were 
used on the same day . 
2 .  1 2 5 0. 2 ml of radi oactive I labeled mouse I g  wi th  a concentra tion 
of 1 mg/ml wa s in jected intravenously into both gro ups of mi ce . 
3 .  A t  various time intervals after the injec tion ,  groups o f  two 
mice were ana e sthesized by an intravenous injec tion of 0. 03 ml 
of sodium pentobarbi tal , and cardiac blood was taken and p la ced 
6 0  
in plastic tubes . The volumes o f  the blood samples  were recorded . 
4. After the animals were sacrificed , their body weights were re-
corde d  and their tails  were cut off and kept in plastic  tubes .  
S. After all blood samples were collec ted , the tub e s  containing 
the blood samples  and mouse tails were counted by a Packard Tri-
C arb s cinti llati on spectrophotometer . 
Pro cedure for the S tudy of  the E l iminat ion Rat e 
of WEE V irus in the C i rculatory Sy s tem o f  M i c e  
1 .  A group o f  normal mi ce was fed wi th water con taining potas s i um 
iodide (KI �· wi th a concentration of lmM /ml for 7 2 hr to  avoid 
non-specific up take o f  
125r by the thyroid . 
2 . Fol lowing t hi s  treatmen t 0 . 2 ml of rad ioact ive < 12 51 ) labeled 
7 WEE viral an ti gen ( l , 2 8 x 1 0 pfu/ml ) wa s injec ted i n to all mice 
intravenously t hrough the caudal ve in . 
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3 .  A t  various  t ime i n tervals after the injec tion , group s o f  two mi ce 
were anae s the s i zed by an in travenous in j ecti on of 0 . 03 ml of  
. sod i um  pentobarbi ta l  (Ane s the sal , Norclon Labora torie s ,  I nc . , 
Lincoln , N e braska ) and b lood sample s were col l ec ted by cardiac 
punc t ure and were p laced in p l as t i c  tube s .  Vol umes of t he bl ood 
samples  were re cord ed . 
4 .  A f ter the animal s  were sacr i f i ced , their body weights were re-
corded . 
5 . A f ter all  b lood samples were taken , the p las t i c  t ube s were coun ted 
by a Packard Tri -C arb s cinti lla tion spec tropho tome ter.  
P roced ure for the Calibra tion of O cular M i crome ter 
for C el l  Meas urement 
6 2  
1 .  M o unted an ocular mi crome ter wi th ad j us table s crew o n  a n  inver ted 
mi cro scope . 
2 .  S e t  up the s tage mi crome ter on the mi cro s cope s tage jus t l ike any 
s l ide . 
3 .  Ad j us ted the s crew gauge of t he ocular mi crome ter s o  tha t one 
end of the grid l ined up wi th any line of a divi s i on in the s tage 
microme ter . 
4 .  Turned the s crew gauge unti l the s cale on t he eyepiece went  acro s s  
one d ivi s ion ( 5  small  uni t s ) and recorded the reading from the 
s crew gauge . 
S .  Took ten or more read ings , from whi ch the average nwnber of 
mi crons p er uni t  was ca l culated . 
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P rocedure for Radioimmunopre cipi tat ion T e s t 
for Antibody De tection ( 23 ,  3 0) 
1 .  A volume of 0 . 05 ml of radioactive WEE viral solution was added 
. .  
to the s ame volume of Tri s buff er containing 1 mg o f  bovine serwn 
a lbumin per ml in a polye thylene micro-te s t  tube . 
2 .  .To . . the . .. above .. mix.ture. . was added .0.  0 5  m l  o f  hyperimmune mouse serwn . 
The preparation was mixed gently wi th a Vortex mixer and was 
incubated for 6 0  min at 37  C .  
3 .  A 0 , 05 ml amount of rabbi t antiserum was then added . After 
thorough mixing , the mixture was again incubated for 6 0  min at 
37 c .  
4 , After the final incubation the preparation was s e t  at  4 C for 
24 hr and was then centrif,uged in a Beckman 1 52 mi crofuge a t  
12 , 000 X g for 5 min. 
5,  The top half 0. 1 ml of the supernatant was carefully removed wi th 
a cap i llary pipet te and was placed into a plastic  tube . To the 
remaining pellet  was added 0. 2 ml of distilled water and was 
removed by a Pasteur pipe tte into a plast i c  tube af ter mixing . 
6 .  A l l  serum sample s were tes ted in duplicate in t he s ame manner . 
Three controls were prepared containing . the following : a .  WEE 
virus and T.ris buffer . b .  WEE virus and rabbi t anti-mouse I g .  
c .  WEE virus and rabbi t anti-mouse I g  and normal mouse serum . 
Procedure for the E s tim2tion of t he G eneration T ime 
of WEE Vi rus A c t iva ted Lymphocy te s in vi tro ... 
1 .  S ix hyperimmunized mi ce ea.ch had recci ved an i .  v .  in j ection of 
7 O.  3 ml of WEE viral vaccine ( 8 ,  8 x 1 0  pfu/ml ) and were exsanguin-
ated as eptically by cardiac punc ture 8 days after re ce iving the 
injection .  
2 .  B lood lymphocyte s were co llec ted after purification in a fi coll-
hypaq ue gradient ( density 1 . 08) . 
3 .  The cells  were suspen.cled in 5 ml of 2i; GKN and were centrifuged 
-
a t  2000 rpm at room tempe rature for 1 0  min. The s uperna tant was  
dis carded. The cells  were resuspended in a same volume of GKN 
and were centrifuged again . 
4 .  Af ter two washings , the cells were suspended in 2 m l  of RMPI 1 640  
lymphocyte cu lture medi um and the vi able cell number was a s se s s ed 
by trypan blue exclus ion s tain . 
S .  The lymphocy te suspen sion was then transferred to two 1 2  x 7 5 mm 
s terile  p la s t i c  tube s ( F alcon, Becton , Dickinson and Co. , C alif . ) 
each containing 2 ml of lymphocy te c ulture med i um and 0 . 1 ml of 
WEE viral vaccine ( 8 . 8  x i s7 pfu/ml ) so  that the final concentra-
ti�n is about 1 . 0 x 1 06 ce l l s /ml . 
6 . T�e tubes were loosely capp8d and were incubated in 5% co2 at 
3 7 C inclined a t an angle of 3 0  degree s .  
7 . Sample s were taken a t  various time inte:cvals and were counted by 
a C oul ter C o unter , Mode l F (Coulter Ele c tronics, I n c � , H ialeah, 
F lorida) to es tima te the increase in cell nwnber.  
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RESULTS M'in DI SCU SS! ON 
The f i r s t  st(�p t ow<J:cd s mal�i n g  an immune re spon s e  mod e l  i s  to 
gather a s  irruch · in forma t i on � s  p o s s i bl e  and arrange them 5.n an orderly 
manner . The be s t  way to achie�.rc thi s i s  to lay down a l l  pa.rame ters 
in the form of i nd ivid ual bl ocks . Among all t he informa ti on ga thered , 
.only those whi ch can be expre s s ed ln q uan t i t a t ive terms are u s a b l e .  
The se q uanti ta tive expre s s i o n s  may be ol> taineJ from one o f  t he fol l ow-
ing source s :  experimental data , l i tera t ure data , or theore t i ca l  va l u e s . 
1'heore ti cal va l ue s should be u s e d  wi th care . Onl.y t ho s e  whi ch are 
logical ly s upported by a t  lea 0 t s ome experimen t a l e vid e n ce s ho u l d  be 
used . L i  t e ra. t ur� va l e s  u s ua l ly have a d e f l.1H�d range whi ch may be wide 
or narrow depend ing upon Lhe t e s t  sy s t ems , experime n ta l  cond i t i ons , 
and the me t hod s u s ed . For thi s re ason , t he s e  val u e s  s ho u ld be supp l e -
mented by . £xperimen tal val ue s  to . f ind o u t  more preci s e ly wha t va l ue 
should be c ho s en . 
The nex t  task i s  to a s s embl e all the cho s en b lo c k s  and val ue s  
into one p i e c e  o f  i nforma t i on , whi ch not only convey s a l l  t h e  usab l e  
in forma tion b u t  a.re a l s o  l i nked in a seq ue n t i al manner .  T h e  seq uence , I 
in thi s mode l should c l o s e ly re s em b l e  t he ac t ua l  phenomena whi ch are 
occurring in na t ure . Due to the e normous compl exi ty of a l ivin g 
sys tem ,  c c r ta 1_ 11 a s s ump t i on ;.>  and s impl i f i ca t i o n s  have to be made in 
order to v i s ual i ze t he eencral o u t look of the who l e  sy s tem . 
A b lo ck d :i. a eram o f  thi s immune r e s p o n s e  mod e l  i s  s ho wn in F i g-
ure 6 and Tab le 2 •  Table 3 i s  a symbol key t o  the b l o ck d i a gram . 
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Table 2 .· Description of abbreviations of the immune re sponse mode l .  
I. - THE LYMPHOCYTE SECTOR 
Abb revi at ion 
1 • . WM 
. 2 ·.· WLT 
3 . · VB 
·4 .  NLLT 
. 5 . NLB 
6 .  TNL 
7 . TNTC 




10 .  NAS BC 
11 . TN ICC 
De s crip tion 
We i ght o f  mous e (gm) 
Wei gh t  of lymphoid tissues (gm) 
Volume o f  b lood (ml) 
Numbe r  of lymph ocytes in lymphoid t is s ues 
Number of lympho cytes in b lood 
Total number of lymphocytes in the two 
· compartments (b lood and lymphoid t i s s ues ) 
Total number of T ce lls 
Total number of B ce lls 
Numb e r  o f  an ti gen spe ci fic T cells 
Numb er o f  ant j_gen specific  B cells 
Tot al numb er of immuno competent cel ls 
. ll • . 'tlIE IMMUNOCOMPETENT CELL TYP� SECTORS (A) 
12 . DAPR 
13.  DASR 
14 . ANAMICC 
15 . FVC 
16 . FLZTC 
17 . FABFC 
18 .  FHZTC 
(Sect or B ) 
19 . NVC 
20 .  NLZTC 
2 1 . NABFC 
22 . NHZTC 
Dose o f  ant i gen in primary re spon s e  (p fu /ml) 
Dose o f  an tigen in secondary respons e (p fu/ml) 
Average number o f  antigen molecules p e r  
inununo comp etent ce ll (ICC ) 
Fract ion virgin cells 
Fract ion low z·one to lerant cells 
Fraction ant ib ody forming cells (p re curs ors ) 
Fract ion high z one t olerant cells 
Number o f  virgin cells 
Numb e r  of  low zone to lerant cells 
Numb er of  antibody forming ce lls (p re cursors ) 
Numb e r  o f  high zone tolerant cells 
III .  PROBABILISTIC PROGENY CELL SECTOR 
23 . EFA E f fe ct ive fract ion o f  antigen that can act ivate 
the ICC 
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Table 2 ( C on '  t . ) .  
Abb revi a t i on 
2 4 . ERA 
2 5 . GTPC 
2 6 .  TL I CA 
2 7 . TLIAA 
2 8 .  NG ICC 
29 .  L SABFC 
30 . P ICCA 
31 . PD IACD 
32 .  PABFCF 
33 . FPNABFC 
Des cript ion 
Elimina t i on rate of ant i gen ( % /h r )  
Generat ion t ime (h r) o f  the prol i fe rat ing 
(an t i genically activat ed ) cells 
Time (hr )  lap s e  b e tween I c e deve lop ing in t o  
immunologically activated ce lls ( IAC ) 
Time (h r) lap s e  IAC deve lop in g  int o  an t ib o dy 
forming cells (ABFC ) 
Numb e r  o f  gene rat ions an ICC undergoes 
b e fo re divis ion s top s and b e fo re an t ib ody 
ap pears 
Life span o f  ant ib ody forming ce l l s  
De lay period o f  ICC act iva t ion ( a  s in gl e  
cell) 
Delay p eri od o f  IAC de feren t iat ion 
De lay p e riod of ant ib ody f o rming ce l l  
format i on 
Th e funct ion o f  the prob ab le numb e r  o f  
ABFC formed from o ne p re cu�s or ce l l  
with in the innnune re sponse pe r i od , 
IV . PRIMARY IMMUNE RESPON SE SECTOR 
34 . NPMC Numb e r  of p r e curs ors of IgM pr oducin g c e l ls 
35 .  NP GC Numb e r  o f  p re curs ors of IgG p roducin g c e l l s  
36 . TNMC Tot al numbe r  o f  I gM producing ce lls f ormed 
versus t ime 
3 7 . TNGCP To t al numb e r  o f  IgG produ cing ce l l s  f ormed 
versus t ime (primary res pon s e )  
38 . TNMM T o t al numb e r  o f  IgM mo lecules f o rmed vers us 
t ime 
39 . TNGMP T o t a l  numb e r  o f  IgG molecules f o rmed ve rsus 
t ime (p rimary re sponse ) 
6 8  
Table 2 ( C on ' t . ) .  
V .  SECONDARY IMMUNE RESPONSE SECTOR 
Abb reviat ion 
40 . NPMC 
41.  TNMC 
4 2 . TNGC S 
4 3 .  TNGMS 
Des cript ion 
Number of potential ant ibody fo rming memory 
cells 
Tot al number of ant ib ody forming memory ce l ls 
formed that would participate in th e 
se condary immune response 
Total number of  IgG p roducing ce lls formed 
ve rsus time (se condary response) 
Total numbe r  of I gG mole cules formed ve rsus 
time (secondary response ) 
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Tab l e  .3 . Symbo l  key o f  the b lock diagrams of the immune respons e 
mode l . 
SYMBOL DE SCRIPTION 
D D I ,, I PROCES S BLOCK 
. . .  
D 
INPUT /OUTPUT BLOCK 
<> 
DECISION BLOCK 
o · INPUT 
c ___ ) TERMINAL , START , INTERRUPTI ON 
D OFFPAGE CONNECTOR 
0 CONNECTOR 
- - - - - - -) INFORMATIONAL FLOW 
. MATERIAL FLOW 
COMMUN ICATION LINK · 
7 0  
The mod e l  consi s t s  of five sectors . The first sec tor i s  called the 
' lymphocy �e s e c tor ' .  I n  thi s sector ,  the immune sys tem of a mouse 
is d ivide d  into two compartments : blood and the lymphat i c  ti s s ue s . 
The wei ght of the lymphoid ti ss�e s  of an animal i s  about 1-2% o f  the 
body wei ght ( 83 ) , and the volume of blood has the average value of 
ri '/. g 7 . 7 8 ml per kg of mouse  body weight ( 3 ) .  I t  was found tha t  even a t  
the peak o f an immune re sponse , the wei ght of lympho cy te s in any lym-
phoid ti s s ue i s  le s s  than 1% of the ti ssue wei ght ( 47 ) .  Wi th thi s 
data , i t  i s  po s s ible to e s timate the weight and the number of lympho-
cyte s pre sen t in the lymphatic compartment of a mouse .  M i ce have · 
exceptiona l ly high numbers of lymphocy te s in the blood ( 3 )  whi ch com-
pri se about 80�90% of all mouse whi te blood ce l l s .  I t  l s  dS s umed in 
thi s mode l  that the sp leen , lymph node s and gut-associa ted lymphoid 
ti s sue s  accoun t  for all ac tivi t i e s  of the immune sys tem of mi ce and 
that the number of T and B ce l ls in the lympha tic comp artment are 
assigned according to the ratio of T and B cel l s  in the s e  t i s s ue s  as 
reviewed by immunofluore scence ( 7 2,  73 ) .  I t was known that mos t  of 
the blood ·lymphocytes ( 80% ) are the T cells and that only a small  
frac tion are the B ce lls  { 21 ) . Not all  lymphocy te s are re sponsive to 
7 1  
any single ant i gen . A s  a mat ter of fac t ,  on ly a sma l l  fraction o f  all 
lymphocy te s co uld re spond specifical ly to one antigen or one ant igeni c 
de terminant ( 66 ) . For most  antigens , the number of spe cific pre cursor 
cells is  on the order of a few hundred per mi llion in normal mi ce and 
a few thousand per mi l lion in hyperimmuni zed one s .  The se speci f i c  
lymphocy te s are re ferred t o  a s  immunocompe tent cells (I CC ) in thi s 
mode l and repres ent the pre cursor population. whi ch could be  activated 
by WEE virus . These factors are explained schematically in  F i gure 7 
and are explained in Table 4 .  
7 2  
The s econd sector i s  the ' �mmunocompe tent c e l l  type sec tor ' which 
is d ivided into two parts . I n this sector , the calculated ICC popu­
lati on was assigned into four immunologi cal cell types  ( 47 ) : the virgin 
cells , low zone tolerant cells , antibody forming cells and high zone 
tolerant cell s .  Part A evalua te s the fractions of the different cell 
types based on the average number of probable conta c t s  be tween a 
given dose  of WEE virus and the ICC whi le part B give s the number 0£ 
cells pre s ent in each cell type . · This sec tor is  ba s ed on the hypoth­
P s i s  tha t i1mnuno lo:;i cal re sponsivene ss and tolerance could occur s :.mul ­
taneously at  a cel lular leve l . A schematic repre sentation of the 
various parame ters in thi s sector is  shown in F igure 8 and explained 
in Table s .  
There has been n o  direct  evidence supporting thi s hypothe s i s . 
But through the s tudi e s  of dose-dependent immunological tolerance , i t  
was found that between a wide range of antigenic dosage , two z one s of 
tolerance occurred ( low and high) and wi thin which normal immunologi cal 
reac ti ons were found ( 24 ,  69 , 7 0) .  Thi s phenomenon revealed that dif­
ferent leve l s  of immunologi cal expressions occurred a t  d ifferent 
threshold s  of anti geni c  stimulation.  All these sugges t  tha t  activation 
i s a continuous proces s  and occurs at a cellular leve l rather than 
in the animal as a whole . I t  is logical to assume tha t in a given 
Population of I CC different immunological cell types exi s t ,  resulting 
STJ.RT . 
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Figure 7 . B lo ck diagram of  the ' lymphocy te secto r ' • 
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1 1 .NBB 
16 . TNBC 
OUTPUT 
Table  4 .  The lymphocy te sec tor. 
Abbrevia tion 
1 .  WM 
2 .  WLT 
3 .  VB 
4 .  WL 
5 .  ARL 
6 .  ADL 
7 . · NLB 
8 .  AWL 
9 .  �'"LL 
10 . NTB 
11 . NBB 
1 2 . .NLS 
13 . 1TLL 
14 . NLG 
15 . TNTC 
16 . TNBC 
17 . NASTC 
18 . NAS BC 
19 . TN.ICC 
(1) Variable 
(2)  Reference 
Decription 
Weight of mouse (gm) 
Weight o f  lympho id tis sues {gm) 
Vo lume o f  b lood (ml) 
Weight o f  lympho cy tes in entire 
lyrr.pho id sys t em ( gm) 
Average rad ius o f  one lympho cyte ( 1) 
Average de:i. s i ty o f  lympho cyte ( gm/:nl ) 
Numb er o f  lymp ho cy te s  in blood 
Average wei ght o f  o ne lympho cyte ( :�) 
Numb er o f lympho cytes in the ent ire 
lympha tic sys tem 
Numb er o f  T cell in blood 
Number of B c el ls in b iood 
Number o f  lympho cytes in sp leen 
Numb er o f  lymphocyt es in lymp nodes 
Number of lympho cy tes in gut asso ciated 
lymp ho id t i s sues 
To tal number of T cells (in both blood 
and lympho id t i s sue s )  
To tal numb er o f  B c e l l s  ( in bo th blood 
and lymphoid tissues) 
Number of ant igen speci f ic T cells 
Numb er o f  antigen specific B cells 
To tal number of immunocomp etent cells 
Equatjon .Y.a.r_. (1) 
W, E 
w x 2% 11 
w x 0 . 07 7 8  . 14 
LI X 2% . L2 
Rl 
D 6  
L4 X 5 . 5 X 107 LS 
4 / 3X .Xrl3*D6 18 
L2 /L8 L3 
LS X 80% . · V4 
LS X 20% ' B4 
13 X 7 0% Cl 
L3 X 15% C2 
L3 X 15% C3 
0 . 5XC1+0 . 7C2X0 . 7XC3 VS 
0 . 5XC1+0 . 3XC2+0 . 3XC3 BS 
vsxio-4 s 1+s 2 
B5Xl0-4 S 3+S 4 
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Figure 8 .  Block diagram o f  the ' immunocompetent cell type s ec tor '. 
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Table 5. The immunocompe tent c e l l  type 
.. 
sector .  
ABBREVIATION 
1 .  DAPR 
2 .  DASR 
3 .  DRDB 
4 .  EDAP 
s .· EDAS 
6 . Al.�AMICCP 
7 .  ANAMICCS 
8 .  I 
9 .  M 
10 . B 
1.1 . FVC 
1 2 . FABFC 
13 . FL9 
DES CRIPTION 
Do s e  o f antigen in primary respons � (pfu/ml) 
D o s e  o f antigen in s econdary respoas e {p fu/ml) 
Do s e  range decis ion blo ck 
E f fective do s e  o f  antigen in primary respons e 
..... 
E f f ec t ive d o s e  o f  anti gen in s econdary response 
Average numb er o f antigen mo lecules p er 
ICC in p r imary r e spons e 
Avera g e  number o f  antigen molecules p er 
ICC in s econdary r es pons e 
To tal numb er o f  ICC (from lymphocyte s ector 
. No . 19)  
Numb er o f  memory c e l l s  ( from primar � response 
s e c to r  No . 10)  and number o f virgin c ells 
( in this s ec tor No . 14)  
Number of antigen sp ec if ic B cells ( f rom 
lympho cyte se c to r No . 18) 
Fra c t ion virgin cell 
Fraction ABFC 
Frac tion ( low and high zone) to leran.t cell 
EQUATION 
F7 = 0 . 002*DO 
F8 = O . Ol*D9 
R = F7 / 5  
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T ab le 5 . (Con ' t) . 
Des cr:tp t i on 
Fraction vi r gin ce ll 
Frac t i on LZT cel l  
Ft;nct i on ABFC 
Fraction HZT ce ll 
Eq uation 
F (V) 





= � e -rx rm L m ! 
m=l 
i=l 







= : e x r 
m !  
ffi':;:::7 
e = exp onen t i al 
r = average n umb e r  o f  
ICC 
== range o f  an t i gen 
ant i gen per 
th at de t e rmin e s  i , m 
the immun o l o gi c a l  s tate of an 
ICC 
' = factodal . 
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i n  different l eve l s  of a c t iva tion . The re sul tant iITL�une expre s sion 
depend s upon the ma j ori ty of I CC tha t i s  in a part i cular immuno logi cal 
s tate . 
The thi rd . .  s e ctor i s  t he , ' probabi l i s t i c  progeny c e l l  s e c tor ' . 
I n thi s s e c tor the deve lopment and di fferentiation o f  any ant i body­
forming pre cursor ce l l  wa s fol lowed . Under a given thre sho ld of anti­
geni c s t imula ti on , a s ingle precursor cel l could be a c tiva ted and 
pro li ferated into a colony of progeny ce l l s  whi ch could be mat ured 
into plasma cel l s . The probable number of progeny ce l l s formed and 
the po s s i bi l i ty o f  the i r  sub seq uent devel opment into p l a sma c e l l s  
depended upon t he ava i labi l i ty o f  a continuous an t igeni c  cha l l enge 
and the time period in whi ch thi s s t imulation is avai lable . I n  o ther 
word s , thi s s e c tor defines  the number of an t i body-forming c e l l s  formed 
from one precursor as a fun c t ion of time ( 41 ,  42 ) . F igure 9 explains 
this phenome non diagramma t i cally ; an explana tion of abbrevia ti ons i s  
given i n  Table 6 .  
T he immune re sponse o f  mice to WEE virus was known t o  b e  d epend­
ent  upon the coopera t i on of the macrophages ( 21 ) . T he nonspe c i f i c 
ac tion of the macrophage s p lay s an e s sential ro le in  re s i s tance to 
most bac terial and viral infections by degrad ing these an t i gens  into 
nonviable components whi le pre senting small fragment s of t he se anti ­
gens i n  pers i s ting immunogen i c  form . O the r humoral fac tors and hor­
mo se s s uch a� immunogenic  RNA ( 2 9 ) , cy cli c AMP , and tLe t hymus hor­
mone s ( 8 0) are al so ne eded for optimal immune respons e . I nforma t i on 
concerning the se parame ters are too limi ted to allow adeq ua t e  
.EJ 
I 
2 . TLIAA EJ ' 
' , .  
4 . NGICC S . LSABFC 
I I I f ' 
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Figure 9 . Block diagram o f  the ' prob ab ilistic progeny cell sector.' • 
10 .PERIOD V 
15 . MNABFC V 
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\0 
Ta b l e  6 .  The proba b i l i s t i c  progeny ce l l  s e c tor . 
ABBREVIATION 
1 .  TLI CA 
2 .  TLIAA 
3 .  GTP C 
4 .  NGICC 
5 .  LSABFC 
6 .  Perio d  I 
7 .  P eriod II 
8 .  P er iod III 
9 .  P er io d  IV 
10 . P eriod V 
11 . MNABFC I 
. 12 . MNABFC II 
13 . MNABFC III 
DES CRIPTION 
Time ( hr) lap se b e tween ICC �evelop ing into 
immuno lo gically ac tiva ted cells (IAC) 
Time (hr) lap s e  IAC d evelop ir.g into ant i­
b o dy fo rming c ells (ABFC) 
Generation t ime (hr) of the f ro l i ferating 
(antigenically a c t iva ted c ells 
Numb er of generations an ICC und er goes before 
d ivis ion s to p s  a:id b e f o r e  antibo dy app ears 
L i f e  span (hr) of antibody fo rming cells 
Time b ef o r e  IAC p ro lif era t ion 
Period at which IAC s tar t to proliferate 
Time dur ing which IAC divides 
T ime a t  whi ch IAC comp le t e s  i t s  las t  
divis ion and ABFC are fo rmed 
P eriod in which AFBC s ta r t s to die o f £  
Mean number o f  antibody producing c el ls 
fo rmed at p eriod I 
Hean numb er o f  antibody produ cing cells 
formed a t  period II 
Mean numb er of antibody produ�i.ng cells 
for�ed a t  p eriod I I I  
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Ta b l e  6 (Can ' t . ) • . 
ABBREVIATION DES CRIPTION 
14 . MNABFC IV Mean number of ant ibody produc ing cells 
formed at p eriod IV 
15 • .  MNABFC V Mean number o f  antibody producing cells 
formed at  p eriod V 
* Equations are shown on the next page . 
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Tab ie 6 (Con ' t )  
Des crip t i on 
PERIOD I 
PERIOD I I  
E quat:i.on 
· { a/1(1-e-atl (1-e-a(g-l )ta)) 
g-1 -a/l _e�---=-- --....---------2 e l-e-at1 (l-e-a(g-l)t8 · ) 
{ea/1 (1-e-atl (1-e-a{g-l )ta)) 
g-1 -a/l 2 e 1-e-atl (l-e-a(g-
l )t8 ) 
_ ea/l (1-e-atl (1-e-agta)J } . 
1 - e-atl (l-�-agt8) 
•{ 1 [ea/l (1+ ·ea(g-l)t8 ( eatl 
_
-1 )) e-a (t-t2 ) 
l - e-atl 1 + ea(g
-l)t8 ( eatl -1)  . 




1 + eagt8 ( eatl -1) 
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Table 6 (Con ' t) 
Descrip tion 
PERIOD I I I  
PERIOD I V 
Equation 
2g-l -a/l { 1 [---;;ir-;:-,..;lrr-----;----e 1-e-atl 1 + ea(g-l)t8 ( eatl �1 ) 
x ea/l ( l+ea(g-l )t8 (eatl -1 )) e-a (t-t2 ) 
a/l {l  + ea(g-l )ta (eatl -l )J e-a(t-t2-t9
) 
- e 
+ .ea/l (l-e-atl + e-a(t-t2-t9 )J 
_ ea/l ( l+eagt8 (eata.-1 ) ) e-a(t-t2 )J} l + e-atl (� - e-agt8)  
2g-l e-a/l { -----__,,_.......-=1------
1 - e-atl l + ea(g-l)t8 (eatl - 1 )  
. x 
a/l (l+ea(g-l )ta(eatl - l) ) e-a(t-t2) e . 
ea/l ( l+  ea(g-l )t8 (eatl -l ) J e-a(t-t2-t9)  
1 
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Tabl e  6 (Can ' t ) 
Desc rip t i on 
PERIOD V 
Equation 
{ a/1(1-e-atl ( 1-e-a (g-l )ta )) 
2g-l -a/l �e��--:-����...---=-���� e . 1-c-atl (l-e-a(g-l)t8 ' )  
8 4  
+ __ 1__  [ ea/l ( l + ea (g�l ) t8 ( eatl -1 )) e-a (t-t2 ) 
1 - e atl 1 + ea(g l )t8 ( eatl - 1 )  
ea/1 (1-c-atl + e-a ( t-t2 ))JJ 
2g-l e-a/l { ea/1 ( ( 1-e-atl )] a/l e-a(t-t2-t9) a (t 1 ) ( a/l e- - -;2 ) -at x e - e 1 - e 1 
+ 1 
(1 - e-atl ) (1+ ea(G-l)t8 (eatl - l � 
a/l ( l +ea (G-l )t8 ( ea
tl -1 )) e:--a (t-t2 ) 
: :a/l ( l +ea (g-l )t8 ( eatl - 1 )) e-a( t-t2 -t9 )} 
g == numb e r  o f  ce l l  ge n e ra t ion ; c = exp onen t i al ; a = an t ige n e l i m i n a t i on ra te 
1 = p rop c r t  ion a l  i. t y  cons t an t ( c f f  e c t i  vc p o r t ion of an t lgen) ; t = p e r i o d  of t i me 
t 1 == l a t en t  pe riocl fo r ICC t o b e come IAC t � la tent p e riod for IAC to b e come ABFC 2 
t 8= gene ra t io n t ime o f  a c t iva t e d lymp h o cy t e s  t = maxi mum n umb e r  o f  c e l l  gene r a t i on s 9 
an IAC w i l l  und e rgo 
8 5 
quan t i ta tive s tudi e s  so  they are no t incorpora ted into this model .  
In a s imp l i f i e d  vers i on ,  a c t i ons of the macrophage s  and the humoral 
fac tors i nvo lved in an immune response may be incorpora ted into the 
effe c ti ve por t i on o f  a given dose of anti gen and the e l imina t ion ra t e  
' 
or the p eriod of  ava i l abi l i ty of thi s an ti gen , s inc e t he func t i on o f  
the s e  two fac tors i s  t o  define the level o f  ac tiva t i on of  the ICC . 
The four t h  s e c tor i s  the ' primary immune re sponse s e c tor ' whi ch 
ga thers i nforma t i on o b tained from the previous s e c t ors to s imulate 
J 
the number o f  an t ibody-forming ce l l s  and the l eve l of ant i bod i e s  ( bo t h  
I gM  and I gG ) at  d i fferent t ime periods in the course of a primary 
immune response .  A s  shown i n  F igure 1 0  and Table  7 t he d ura t i on o f  
the primary imm,une re sponse i s  de fined by the period and s tep o f  run 
in the c omputer program . This de termine s the probable  number o f  gen-
erat ions an a n t i body -forming precursor c e l l  wi l l  und ergo and the num-
ber of an t i body -forming ce l l s  that wi l l  be formed .  T he persi s tence of 
the an t i body l evel depend s upon the amount of  an t i bod i e s  formed and 
their ca tabol i c  rat e  in vi vo . The production rat e s  of b o t h  I gM  and 
I gG are a s s umed to be eq ual but their ca tabol i c  rate s are d i fferent .  
The l a s t s e c tor i s  the ' s econdary immune re spon s e  s e c tor ' whi ch 
descri be s a s e condary immune re spons e  and has the same forma t as tha t  
of the primary re spons e .  I n  thi s sector , only the I gG prod ucing ce l l s  
are taken i n to accoun t , and the nwnber of precursor c e l l s  i s  the s wn  
of the vi rgin ce l l s  and the memory ce l l s  formed during the course o f  
the primary re sponse . A l l  fac tors involved i n  thi s s e c tor are shown 
in F igure 1 1  an · Table 8 .  The number of an ti body forming progeny. cells  
. .  
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Figure 1 0 .  Blo ck diagram o f  the ' p rimary innnune. response s ector ' . 
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Ta b l e  7 .  The primary immune re spon s e  s e c tor . 
ABBREVIATION 
1 .  ERA 
2 .  EFA 
3 .  IRTLS T 
4 .  N'GCTL 
5 .  FPNABFC 
6 .  LSABFC 
7 .  TNABFCP 
8 .  p 
9 .  �1C 
1 0 . NMCF 
11 . Thl}lMP 
DES CRIPTI ON 
Elimina t ion ra te o f  anti gen 
E f f ec tive f rac tion o f  anti gen t ha t can 
ac tiva t e  the ICC 
Immune r e s p onse time li�i t wi ct sp ecified 
interval 
Nt:nher o f  generations comp let·�d in this 
time limi t 
The f unc t ion o f  the probable �u�b er o f  
ABFC formed from one pr ecur s o : �  � e l l  within 
the iTIL�une respons e p eriod 
, Li f e  span of ABFC 
To tal numb er of ABFC f o rmed f:::-om 1 precus or 
(primary) 
Numb er of I gM c ell p r ecur s o r  from the 
immuno comp e tent cell sector 
Total number o f  I gM producing c ,�lls 
formed versus time 
Number of memo ry c e l l s  f ormed 
To tal number o f  I gM molecules furmed 
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Ta b l e  7 .  (Con ' t . ) .  
ABBREVIATION 
12 . TNGCP 
13 . TNGMP 
14 . CRA 
15 . PRA 
DESCRIPTION EQUATION 
To tal number o f  I gG p ro ducing cells 
fo rmed versus time D (N .,-2] X2 .  52Xl06 
To tal number o f  IgG molecules formed 
versus time (primary response) D{N , 6] X2 . 52X106 
Catabo l ic rate o f  antibody (mo lecules / hr) N0- e-htNt 
Pro duc t ion rate of ant ib o dy 6 (molecules /hr) 2 . 5 2Xl0 
VAR . 
D(.N , 4] 
D {
_
N ,  6) 
REF . 
7 8  
1 8  
00 00 
EJ-, ' ' ' 
1 .  IRTLST 
2 .  NGCTL 
S. TNABFCS 
6 .  TNGCS 
B 
... _ _ _ _ _ _  _ 
- - - - - - - - .. 
. -
Figure 11 . Block diagram of the ' se condary immune response s ector ' • 
00 
\D 
. Ta b l e  8 .  The s econdary immune re spon s e  s e c tor. 
ABBREVIATION 
1 .  IRTLS T 
2 .  NGCTL 
3 .  p 
4 .  A 
5 .  TNABFCS 
6 . TNGCS 
7 .  T:�GMS 
8 . . CRG 
9 .  PRG 
10 . c 
11 . M 
12 . NNGCF 
13 . ·  NNGMF 
DES CRIPTION 
Innnune respons e time limit wi th S?ecified 
intervals (hr) 
Numb er o f  generations completed ia this 
t ime limi t 
Numb er o f I gG precursors 
Number of a c t iva ted I gG ABFC precur sors 
Total number of ABFC fo rmed from 1 
p recursor ( s econdary respons e) 
To tal numb er of I gG producing cells 
fo rmed ver sus · t ime ( s econdary respons e) 
To tal numb er of IgG mo lecules forned 
versus time ( s econdary respons e) 
Catabo lic rate of I gG (mo lecule / hr) 
Produc tion rate o f  I gG (mo lecule. /hr) 
Residual number of I gG cells in tt e . 
primary response s e c to r  
Res idual numb er o f  I gG mo le�ule s from 
the p r imary r espons e sec to r · 
Net number of I gG ABFC formed 




A31(D(X,  6] · 
D N , 20 =A2*D[N , 2)  
N =C
-htNt 
2 . s 2x10 6 
D {N,  10) +D fX, 6) 
D(N , 81 =2 . s2x106 
·X (D N , 10 +D X , 6 ) 
VAR . REF . 
T7 , HO 
G9 
W8 41  
A3 
A3*D(X, 6) 42 . 
D (N , 10) 
D (N , 8 ) 
7 8 . 
1 8  
\.0 
0 
Table 8 (Con ' t . ) .  
· ABBREVIATION · DES CRIPTION 
14 . NVC Number of virgin cells 
15 • . NABFCP Numb er o f  ABFC in primary respons e 
16 . FABFCS Fraction of ABFC (pr ecursors) in secondary 
· response 
17 . NABFCS Number o f  ABFC (precursors) in secondary 



















from one precursor i s  derived from the same function used in the pri­
mary re spons e .  The level of I gG  and the re sidual number o f  I gG  form­
ing cel l s . that remained at the time of a second inj e c tion were taken 
into account
. �
o that the ne t anti body level i s  equal to the sum of 
the re sidual I gG and the newly formed I gG .  
The basic assump tions made in thi s model are : · 
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1 .  The contact bet�een antigen and ICC i s  an entirely random and 
independent event .  
2 .  The rate o f  anti body formation . remains cons tant throughout 
the entire course of the inunune re sponse . 
3 . Generation time of proliferating ICC is  assumed to be con� 
s tant . 
4 .  The effective dose of antigen and the elimination ra te of the 
antigen i s  as sumed to vary dire c tly wi th the size of the dose . 
5 .  A t  about day 5 after ini tial challenge , I gG  precursors are 
formed which is part of the proliferating I �  precursors . 
6 .  The ratio between the memory cell and the ABFC remains con­
s tant in the primary re sponse . 
7 .  From a given number of ICC progeny cells ,  the number going to 
the memory pool is proportional to the number of ABFC formed . 
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Experimental Values U sed in the Immune Response Model 
A hi s togram was p lotted from the body weights of a hundred mice 
and the average was found to be around 30 grams . Thi s result  i s  shown 
in Tables  9 apd 10  and in F igure 12 .  The weight o f  a mouse lymphocyte 
1s important in determining the number of lymphocy te s in the lymphatic 
compartment .  Thi s was estimated from the volume and d ensi ty of an 
average small lymphocy te . Volume was evaluated from the average radius  
of the lymphocyt e  using the equation which calcu l ates the volume of 
a perfect  sphere . Results  of the measured radi i  and the calculated 
volumes of  mouse lymphocy tes are shown in Tables 1 1  and 12 and F i gure s 
13 and 14 . 
Densi ty was e s t imated by isopycnic c entrifugation of  mouse periph­
eral blood over F i coll-hypaque gradient of different dens i ti e s . Dif­
ferent elemen t s  of the blood are characterized by differences  in s ize 
and densi ty ;  both of these parame ters can be utilized for selective 
purifica tion p urposes . Rate zonal centrifugation is applied on the 
basi s  of s ize  whi le  isopycnic zonal sedimentation i s  based on densi ty .  
The firs t step i n  determining the density of lymphocyt e s  i s  t o  remove 
the erythrocytes  and other leucocyte s .  Various gradi en t  sys t ems such 
as  I sopaque-Dextran, I sopaque-F icoll , EDTA -F i coll , EDTA -Dextran and 
F ico ll-Hypaq ue could be used ( 9 ) .  F i coll i $  a large molecular weight 
erythrocyte-aggrega ting agent whi le hypaque serves as a layering ma­
terial . F icoll i s  a sucrose polyme� wi th a molecular wei ght o f  about 
400, 000.  I t  is highly soluble in water or aqueous solutions and has 
a rela tively low vi scosity and a spherical shape . Ten and eleven 
Table 9 .  E s tima tion of average mouse weight . 
DATA 
MOUSE WE I GHT 
{gm) 
3 2 ; 3 0 0 0  
3 2 . 0 0 0 0 
3 4 . 0 0 0 0  
2 1 . 0 0 0 0  
3 0 . 0 0 0  
2 5 . 8 0 0 0 . 
3 3 . 6 0 0 0  
3 4 . 3 0 0 0  
3 0 . 7 0 0 0  
2 9 . 3 0 0 0  
3 0 . 6 0 0 0 
2 5  • 1 0 0 0 
2 7 . 4 0 0 0  
2 1 . 2 0 0 0  
3 1  . 6 0 0 0  
2 8 . 4 0 0 0  
3 1 . 6 0 0 0  
2 8 . 2 0 0 0  
. 2 9 . 4 0 0 0  
2 9 . 8 0 0 0  
3 0 . 9 0 0 0  
3 1  � 3 0 0 0  
3 2 . 2 0 0 0  
3 2 . 6 0 0 0  
3 2 . 7 0 0 0  
3 3 . �rn o o  
3 3 . 5 0 0 0  
3 3 . 7 0 0 0  
3 2 . 5 0 0 0  
2 6 . 6 0 0 0  
3 0 . 0 0 0 0  
3 0 . 8 0 0 0  
MOUSE HE IGHT 
(gm) 
3 2  . 1
·
o 0 0 
3 4 . 5 0 0 0  
3 2 . 3 0 0 0 
2 8 . 2 0 0 0  
2 4 . 2 0 0 0  
3 0 . 1 0 0 0  
3 4 . 2 0 0 0  
3 2 . 5 0 0 0  
3 2 . 6 0 0 0  
3 2 . 4 0 0 0  
2.9 . 11 0  0 0 
2 8 . 4 0 0 �  
2 8 . 3 0 0 0  
3 3 . 4 0 0 0  
2 s . 1 0 0 0  
2 8 . 0 0 0 0  
2 1 . 2 0 0 0  
2 9 . 8 0 0 0  
2 9 . 1 0 0 0  
2 8 . 7 0 0 0  
3 3 . 5 0 0 0  
3 2 . s o o o  
2 5 . 4 0 0 0  
2 6 . 0 0 0 0  
2 8 . 8 0 0 0 · 
. 2 7 . 5 0 0 0  
2 1 . 0 0 0 0  
2 7 . 6 0 0 0  
2 6 . 8 0 0 0  
3 0 . 0 0 0 0  
2 9 . 8 0 0 0  
3 1 . 1 0 0 0  
2 6 . 3 0 0 0 -
2 1 . 2 0 0 0 ·  
MOU SE WE IGHT 
( gm) 
2 7 . 3 0 0 0  
2 8  .. 8 0 0 0  
3 3 . 5 0 0 0  
3 4 . 4 0 0 0  
3 2 . 4 0 0 0  
3 3 . 1 0 0 0  
3 3 . 6 0 0 0  
. 2 6 .  0 0 0 0 
3 4 - 2 0 0 0  
3 0 - 6 0 0 0  
� 9 . 5 0 1) (1  
3 D • I! 0 0 0 
2 8 . 6 0 0 0  
2 5 . 8 0 0 0  
2 6 . 2 0 0 0  
2 4 . 2 0 0 0  
2 5 . 5 0 0 0 
3 2 . 3 0 0 0  
3 4 . 2 0 0 0  
3 4 . 3 0 0 0 
3 3 . 9 0 0 0  
3 1 . 0 0 0 0  
3 2 . 5 0 0 0  
2 6 . 6 0 0 0  
3 0 . 8 0 0 0  
3 0 . 0 0 0 0  
2 5 . 5 0 0 0  
3 2 . 3 0 0 0  
3 3 . 9 0 0 0  
3 1 . 0 0 0 0  
. 3 2 . 5 0 0 0 
3 0 . 2 0 0 0  
3 1 . 0 0 0 0  
2 9 . 8 0 0 0  
94 
. 9 5  
Table 1 0 .  Mou s e  weight hi stogram. 
CELL STATISTICS 
C E L L #  L OWE R L I M I T  N O . OF OBS % RE LAT I VE FRE Q 
1 0 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 i . o o o o  0 0 . 0 0 0 0 0  
3 2 . 0 0 0 0  0 0 . 0 0 0 0 0  
4 3 . 0 0 0 0  0 o . o o o n o 
5 4 . 0 0 0 0  0 0 . 0 0 0 0 0  
6 5 . 0 0 0 0  0 0 . 0 0 0 0 0  
7 6 . 0 0 0 0  0 0 . 0 0 0 0 0  
8 1 . 0 0 0 0  0 0 . 0 0 0 0 0  
9 8 . 0 0 0 0  . 0 0 . 0 0 0 0 0 . 
1 0 9 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 1 1 0 . 0 0 0 0  0 0 • 0 (l 0 0 0 
1 2 . 1 1 . u o o o  0 0 . 0 0 0 0 0  
1 3  1 2 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 4  1 3 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 5  1 4 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 6 1 5 . 0 0 0 0  0 0 . 0 0 0 0 0 
1 7 1 6 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 8  1 7 . 0 0 0 0  0 0 . 0 0 0 0 0  
1 9 1 8 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 0  1 9 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 1  2 0 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 2  2 1 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 3  2 2 . 0 0 0 0  0 0 . 0 0 0 0 0 
2 4  2 3 . 0 0 0 0  0 0 . 0 0 0 0 0  
2 5  2 L1 . o o o o  2 2 . 0 0 0 0 0  
2 6  2 5 . 0 0 0 0  
--� -
6 6 . 0 0 0 0 0  
2 7  2 6 . 0 0 0 0  7 1 . 0 0 0 0 0  
2 8  2 1 . 0 0 0 0 9 9 . 0 0 0 0 0  
2 9 2 8 . 0 0 0 0  1 1 1 1  . 0 0 0 0 0  
3 0  2 9 . 0 0 0 0  9 9 . 0 0 0 0 0  
3 1  3 0 . 0 0 0 0  1 3  1 3 . 0 0 0 0 0  
3 2  3 1 . 0 0 0 0  7 1 . 0 0 0 0 0  
3 3  3 2 . 0 0 0 0  1 7  1 1 . 0 0 0 0 0  
3 4  3 3 . 0 0 0 0  1 1 1 1  . 0 0 0 0 0  
3 5  3 4 . 0 0 0 0  8 s . 0 0 0 0 0  
HISTOGM.M WITH PLOT OVERLAY 
H I S T OG R.t\ M  
OFFS E T =  O . S 
C E LL W I DT H  = 1 
EAC H X = 0 � 4 3  PE RC E NT 
N =  1 0 0 
MEA N = 
S T D . D E V = 
S KE W NES S =  
KU RT OS I S = 
X M I N = 
X MA X = 
RA N GE =  
3 0 . 1 7 3 0  
2 . 7 9 5 4  
0 � 0 0 0 0 0 0 0 0 0 � 0 0 
o o 0 o o o o o o o o o o · o 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
• • • • • • • • • • • • • • 
(\) M .:;r ti) \0 t- CO 0\ o (\) M q l{) : 1  
N N ru ru (\) ru � ru M M M M M M 
Figu re 1 2 .  H i s t o gram o f  t
he b o dy weigh t  range o f  mi ce • 
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Table 1 1 .  E stimation of the average radiu� - of mouse  lymphocytes .  
· 97 
Radius (Mi cron)· Radius (Mi cron) Radius (Mi cron) Radius (Mi cron) 
3 . 2 7 3 6  3 . 4 5 9 6  3 . i  2 4 8  3 . 1 6 2 0  
3 . 3 6 6 6  . 3 . 4 1 3 1  3 . 4 6 8 9  3 . 3 0 1 5  
3 .  2 2  7 1  3 . 5 4 3 3  4 . 0 8 7  3 . 1 8 0 6 
3 . 2 7 3 6 3 . 2 7 3 6  4 . 4 8 2 6  3 . 5 7 2  
3 . 4 6 8 9  3 . 2 9 2 2  3 • 2 6 L& 4  3 . 3 9 4 5  
3 . j 9 4 5  4 . 0 1 7 6 3 . 5 8 9 8  3 . 3 4 9 4 
·3 . 5 2 1 1 3 . 9 5 2 5  3 . 6 1 7 7  3 . 4 7 8 2  
3 . 5 4 3 3  J . 4 5 0 3  3 . 3 8 5 2  3 . 3 9 4 5  
3 . 3 8 5 2  3 .  1 6 2 0  3 . 0 7 0 3 3 .  2 2  7 1 
4 . 3 6 8 6  3 . 5 4 3 3  3 .  2 2  7 1  3 . 3 9 4 5  
CELL STAT I ST IC S  
CELL /I L OWE R L I M I T  NO . OF OBS 1' RE LAT I VE FRC: Q 
1 0 . 1 0 0 0  0 0 . 0 0 0 0 0  
2 Q . 3 0 0 0  0 0 . 0 0 0 0 0  
3 Q . 5 0 0 0  0 0 . 0 0 0 0 0  
4 0 . 1 0 0 0  0 0 . 0 0 0 0 0  
5 G . 9 0 0 0  0 0 . 0 0 0 0 0  
6 1 • 1 0 0 0 0 0 . 0 0 0 0 0  
7 1 . 3 0 0 0  0 . 0 . 0 0 0 0 0 
; 8 1 . s o o o  0 0 . 0 0 0 0 0  
9 1 . 1 0 0 0  0 0 . 0 0 0 0 0 
_: 1 0 1 . 9 0 0 0  0 0 . 0 0 0 0 0 
1 1 2 . 0 0 0 0 0 . 0 0 0 0 0  
·, 1 2  2 . 3 0 0 0  0 0 . 0 0 0 0 0  
. 1 3  2 . 5 0 0 0  0 0 . 0 0 0 0 0  
, 1 4 2 . 1 0 0 0  0 o • o o o o o ·  
. 1 5  2 . 9 0 0 0  1 2 . s o o o o  
1 6  3 . 1 0 0 0 1 2  3 0 . 0 0 0 0 0 
. 1 7 3 . 3 0 0 0  1 5  
� 7 � 5 0 0 0 0  
1 8  3 . 5 0 0 0  7 1 . s o o o o  
1 9  3 ._ 7 0 0 0  0 0 . 0 0 0 0 0 
2 0  3 . 9 0 .0 0  3 7 . 5 0 0 0 0  
2 1  4 . 1 0 0 0  0 0 . 0 0 0 0 0 
2 2  4 . 3 0 0 0  2 s . 0 0 0 0 0 
- \ -Table 1 2 . C alculated average volume �f - ffiOU$e - lymp�cy�es=. -
.. .  ,.,; 
Volume
�·� (cub i c  mi c ron) 
1 7 3 . 4 5 0 0  
1 6 6 . 5 5 0 0  
1 8 6 . 3 4 0 0  
1 4 6 . 9 5 0 0 · 
1 4 9 . 4 5 0 0  
2 7 1  • 6 4  0 0 
2 5 8 . 6 5 0 0  
1 7 2 . 0 5 0 0  
1 3 2 . 4 3 0 0  
1 1 8 . 3 4 0 0  
1 4 6 . 9 5 0 0  
1 5 9 . 8 3 0 0  
1 4 0 . 7 8 0 0  
1 4 6 . 9 5 0 0  
1 7 4 . 8 5 0 0  
1 6 3 . 8 4 0 0  
1 8 2 . 8 6 0 0  
1 8 6 . 3 4 0 0  
1 6 2 . 5 0 0 0  
2 8 5 . 9 8 0 0 



















1i By f orroulae . . 
LOWER LIMIT 
-9 . 0000 
1 1 . 0000 
3 1 . 0000 
5 1 . 0000 
71 . 0000 
9 1 . 0000 
1 1 1 . 0000 
1 3 1 . 0000 
15 1 . 0000 -
17 1 . 0000 
19 1 . 0000 
2 1 1 . 0000 
2 31 . 0000 
2 5 1 . 0000 
2 7 1 . 00 00 
2 9 1 . 0 000 
311 . 0 000 
4 / 3  x� x (r ) 3 
; 
�·: 
Volume ( cub i c  mi cron) 
1 2 7 . 8 1 0 0  
1 7 4 . 8 5 0 0  
3 4 9 . 2 3 0 0 
3 7 7 . 2 9 0 0  
1 4 5 . 7 0 0  
1 9 3 . 7 8 0 0  
1 9 8 . 3 3. 0 0  
1 6 2 . 5 0 0 0  
1 2 1 . 2 1i o o  
1 4 0 . 7 8 0 0  
1 3 2 . IJ. J ;,) 0  
I �  � . 7 4 0 0  
1 J 4 . 7 8 0 0 
1 9 0 . 7 8 0 0  
1 6 3 0 8 4 0 0  
1 5 4 . 6 0 0 0  
1 6 3 . 8 4 0 0 
1 4 0 . 7 8 0 0  
1 6 3 . 8 4 0 0  
1 ? 6 . 2 6 0 0  
NO . OF OBS . % RELAT IVE FREQ . 
0 0 . 0 0 0 00 
0 - 0 . 0 0000 
0 0 . 0 0000 
0 0 . 0 00 0 0  
0 0 . 0 0000 
0 0 . 0 00 00 
3 7 . 5 0000 
12 2 2 . 5 0000 
9 2 2 . 5 0000 
9 s . 0 0000 
2 0 . 0 0 000 
0 0 . 0 00 0 0  
0 0 . 0 0 000 
1 2 . 5 0000 
2 s . 0 0000 
0 0 . 0 00 0 0  
0 0 . 0 0 000 
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· Figure 13 . His togram o f  measur
ed radii o f mouse �ymp
h o cy tes •  
9 9 





EAC H x = 0 . 7 5 PERC E NT 
H I S T O G RA M  
OFFS ET = 1 




x N =  4 0  
x MEA N =  1 7 7 . 2 5 3 5  
x 
x S T D . D E V =  5 6 . l! L& 9 6  
x 
x S 1\£ WNC:S S = 2 . 0 4 0 4 
x KU RT OS I S = 6 . 8 6 6 5 x 
x x x X M I N = 1 1 8 . 3 4 0 0  
x x x 
x x � X M A X =  
3 7 7 . � 9 0 0 
x >< >< RA N G S ::- 2 5  8 i. -9 5  D 8 >< x x 
x >< x 
x x x 
x x >< 
x x >< 
>< x x x x .. 
x >< -1 x 
x x x >< 
x >< 
;,c x >< >< x x >< 
x x 
x x x x 
>< >< 
x >< x 
x >< x 
x x x x x x x 
x x x x 
x x x x 
-- Ill ·-· ! d'  t 
. . ,,,,P-:W 
0 C> c:> C> C> C> 
C> C> C) Cl c:> 
0 c:> C> C> C> c:> C) C> 
C) C> C> C> c:> C> 
0 C> C) 0 C> C> 0 
c:> C) c:> C> c::> c:::> 
0 
0 C> C> 0 C> C> C> 
c:> c:> c::> c::> c::> c:> C> 
• 0 C> 
0 • • 
- - -
- -
"""" °' - ("') lO t- (J\ - ("") 
tfl t- °' M 
- - - - - C\) C\) C\) 
(\J C\) M ("') 
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percent solu t i ons have rela tive vi scosity of 5 . 4 and 6 . 4 ,  re spectively . 
Hypaq ue or sod i um dia trizoate i s  a water so l uble rad iopaq ue med ium 
wi th a molecular weight of 63 5 . 92 . It i s  sens i t ive to l i gh t  and should 
be prepared f�� shly be fore uqe . Oral prepara tions con taining carame l 
should b e  avoided . F ol lowing centri fuga tion , the b lood component s 
would be  d i s tri b u ted as fo llows : the top layer i s  a clear zone of 
plasma , fo llowed by a small band of mononuclear cel l s  and p la te le ts . 
B e low thi s i s  a cloudy zone containing mainly granulocy t e s , and the 
erythrocy t e s  were in t he bo t tom zone . Purity of whi t e  bl ood cells  i s  
a func t i on o f  the effi c i ency o f  red blood removal which in  turn i s  a 
func tion of t he c e l l -c l ump ing mixture , of i t s  densi ty and o f  the con­
centra t i on of ce l l -clLm1ping compound , vi scos i ty ,  o smolari ty and i onic  
compos i t ion . I t  is  al so a func tion of the top pha s e , of the hei ght 
of the b lood co lumn , and o f  the degree of di lution . The whole pro­
cedure i s  grea tly infl uenced by temperature change s .  
An increase in whi te  cell  yield is  ob tained by the fol lowing : 
1 .  d i l u ting the b lood 
2 .  increasing the blood volume 
3 .  increasing the osmo lari ty of . t he. lower,. . phas e 
. 4 . ra i s ing t he temperature to 3 7  C .  
The cataboli c ra te o f WEE virus in mice was de t ermined by single 
i . v. in j e c tions of 1 2
51 labe led WEE vi rus into mi ce . The rate of 
removal of the inje cted viru s was reflec ted by the ra te  of d i s appear­
ance of radioactivi ty in the blood of  mi ce . The radioac tivi ty of the 
blood sample was firs t converted by volume ratio into radio
ac t ivi ty 
of the t o t al vol wne o f  blood in each mouse . When t he l o gar i t lliTI ( log)  
of the s e d ata ( i n CPM )  was plo tted agains t t ime , the  c urve appeared 
to be biphas i c .  The f i r s t  l inear portion repre s en t s  the c a tabo l i c  
1 02 
decay of  WEE virus and the s � cond portion i s  t he increased  immunologi-
cal removal pha s e . Data b e tween the f i rs t  l i near por t i on o f  thi s curve 
were used to e s t ima t e  the average cataboli c  rat e  of WEE virus by a 
f irs t order exponential  eq ua tion and the re s ul t s  are s hown in Table s 
13 ,  14 , 1 5 ,  1 6  and in F igure 1 5 .  The half-l i f e  of mous e  I gG in vivo 
wa s e s t imated in a s imi lar fashi on and , again , only the l inear p or t i on 
of t he curve was used . I t  was found tha t  in hyperimrnun i zed mi c e  where 
the I gG leve l  wa s exp e ct ed to be hi gher , the catabo l i c  ra te of the 
. 1 · . 1 2 51 1 b 1 d I G h f t pas s ive y i n J e c t ed a e e mouse g was muc as er . 
are summari z ed i n  Tab l e s  1 7 , 1 8 ,  1 9  and 2 0 and in F igure 1 6 .  
Re sul t s  
� Genera tion t ime o f  mou s e  lymphocy te s wa s e s t imated i n  vi tro by 
ti ssue cul t ure techniq ue . P eripheral blood lymphocy t e s  were f i r s t 
puri f ied by an i s opy cnic centri fugation in a layering solut ion o f  
F i co l l -Hypaq ue wi th a dens i ty o f  1 . 08 and the lymphocy t e s  harves ted 
as inoculum were found to contain abou t  8 0% lymphocy t e s  as reveal ed 
by Wri ght ' s s tain and 9 0% o f  the ce l ls were viable as  d e t ermined by 
trypan b l ue ex clus ive s tain .  
C oncentra tion o f  ce l l s  in  the cul ture was found t o  be  abo u t  one 
mi llion c e l l s  per m l . The i ncrease in c e l l  numbers of thi s cul ture 
was de termi ned by a C oul ter c ounter a t  various time int e rva l s . S ince 
the number o f  ce l l s  we re compared i n  a re la tive bas i s ,  no a t t emp t was 
d b ].. z e  The c e l l  counts  ma e to es tima t e  t he abso l u te ce l l  num er �r s • 
1 03 
Table 13 . E l imi nati on rate of WEE virus in mi ce using the following · data : mouse wei ght , blood vo lume and CPM of sample . 
Mous e Wei ght ( grams ) B lood Volume (ml ) CPM of Sample 
Time 
1 2 1 2 1 2 
5 min 33 . 7  34 . 3  2 . 6180 2 . 6685  9617 5 8 9622 
1 5  min 26 . 0 30 .  7 2 . 0228 2 . 3 885 97 7 3 8  84299 
30 min 3 4 . 2 29 .. 3 2 . 6608 2 . 27 9 5  56422 7 0032  
4 5  min 3 0. 6 29. 7 2 .  3807 2 .  3 1 07 5890Y 53408 
90 min 2 9 . 5 3 0. 6 2 . 2951 2 . 3 807 7 6 088 62894 
2 hr 3 0. 4 25. 1 2 . 3651 1 . 9528 43240 59928 
S . S hr 2 8 . 6 27 . 4  2 . 22s1 2 . 13 17  3 2155  3 2858 
20 hr 2 5 . 8 27 . 2  1 . 9866 2 . 1162  1 07 66 963 9  
24 hr 2 9 . 8 31 . 6  2 . 3184 2ci 4585 117 7 6  11823 
48  hr 26 . 2  3 1 . 6 2 .  03 84 2 . 4585  1 07 4  1200 
53 hr 24 . 0 2 8 . 4 1 . 867 4 2 . 209 5  2 2 0  17 5 
7 2 hr 3 0. 6  28 . 9 2 .  3807 2 . 2484 3 8  3 0  




3 0  min 
4 5  min 
90 min 
2 hr 
5. 5 hr 
20 hr 
24 hr 
4 8  hr 
53 hr 
7 2  hr 
Elimination rate of WEE virus in mi ce . .  usi ng data of 
CPM in a whole mouse.  
Counts Per Minute ( CPM ) 
1 2 Average log 
2517 82 23 9160 24547 1 5 . 3 9  
1 97 7 04 201348 1 9 9 526 5 . 3 0  
150126 15963 8 1 54 882 5 . 1 9  
140243 123409 131 82 6  5 . 12 
174630 1497 3?  162181 5 � 21  
1 02268 117 028 1 09648 5 . 04 
7 1547 7 0043 7 07 95 4 . 85 
213 87 203 99 20893 4 . 3 2 
27 3 01 29067 28184 4 . 45 
2189 2951 2 57 0  3 . 41 
41 0 3 86 3 98 2 . 6 0  
91 67 7 9  1 . 90 
1 04 
Table 1 5 .  Calculation of the el imination rate of WEE virus i n  mice 
using the firs t order exponential decay equa tion : 
Time 
(hr) * D 
0 




) x l/T . 
D + 
t 
0-20 24 54 7 1  20893 20 2 . 3  x log ( 24547 1 /208 93 ) x 1 /20 hr 
= 0. 123 /hr 
0-21� 24 54 7 1  28184 24 2 . 3  x log ( 24 54 7 1 /2 81 84)  x 1/24 hr 
= o. 090/ hr 
0-48 24 557 1  2 5 7 U  48 2 . 3 x log ( 24557 1 /2 57 0) x 1 /48 hr 
= O. 095 /hr 
20-48 20893 2 57 0  28 2 . 3  x log ( 20893 / 2 57 0) x 1 /28  hr 
= 0. 07 1/hr 
24-48 28184 2 57 0  24 2 . 3  x l Og ( 28184 / 257 0) x 1/24 hr 
= 0. 100/hr 
� 
- D -- CPM a t  time zero 0 
+ 
- D = CPM 
t a t  
t ime t 
a - T = t ime between two counts ( hr) 
b 
· - C = elimina tion rate cons tant /hr 
105 
Table 1 6 . Summary of the elimination rate of WEE virus in mice . 
Time 

















ln (D /D ) x l/T .  0 t 
* 
C Value 
0 . 123 
0 . 090 
0. 095 
o. 07 1 
0 . 100 
0. 47 9 
0. 096 
E limination 
Rate ( 0/ 0/hr) 
12. 3 
9. 0 
9 . 5 
7 . 1  
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9 0 min 
2 h r  
5 . 5  h r  
20 h r  
2 4  hr 
48 hr 
5 3  hr 
72 hr 
log CPM 
5 . 39 
5 . 30 
5 . 19 
5 . 12 
5 . 2 1 
5 .  0 1. 
4 . 85 
4 . 32 
4 . 45 
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Figure 1 5 . The elimination curve of pas s ive ly inj ected I lab e le d  WEE viral part i cle in 
the b lood o f  mice • 
� 
0 '-J 
. 1 08 
Table 1 7 . Cataboli c rate of mouse l g  in normal mice . 
Total B lood 
Time Mouse Weight (gm) B lood Sample (ml ) Volumes (ml ),•: 
( hr) 1 2 1 2 1 2 
8 29 . 7  27 . 8 0. 9 1 . 0 2 . 3 1 2 . 16 
24 3 0 . 2 3 0. 5 0 . 6 O. la 2 . 3 5  2 . 3 5  . 
3 2  31 . 9  2 5 .  2 0. 3 0 . 4 2 . 48 1 . 96 
48  26 . 2  27 . 1  0. 2 1 . 0 2 . 04 2 . 10  
58  34 . 1  2 9 . 8 0. 9 0. 6 2 . 6 5  2 . 32 
80 23 . 8  24 . 1  0. 45  0 . 5 1 . 85 1 . 94 
Counts Eer Minute ( CPM ) 
Time Tai l B lood .Total Average Log 
( hr) 1 2 1 2 1 2 
8 27 06 121 94 19024 12441 217 28 14636 217 2 8  4 . 27 94 
24 6 7 4  67 6 117 54 10862 12228 1153 0  1 2 03 1  4 . 0612 
32 1082 293 0  10888 7 134 1197 0 10094 11324 
4 . 0540 
48 3 9 04 2656 6854 6 82 5  1 07 58 9481 1 0240  4 . 0100 
58 2286 990  7 032 8104 93 18 9094 
93 7 7  3 .  97 20 
80 23 50 206 0 5032 53 22 7382 73 82 
7 622 3 . 8820 
* Volume of blood = 7 . 7 8 ml/�g of body weight of mouse . 
Table 1 8 . Catabolic  rate of mouse I gG in WEE hyperimmune mice . 
Total __ B lood 
Time Mouse We ight (gm) B lood S am.J?.!e (ml ) Volume s (ml ) (hr) 1 2 1 2 1 2 
8 26 . 7 28 . 5 1 . 0 0 . 7 2 . 20 2 . 22 
24 27 . 6  0. 5 2 . 1 5  
118 2 9 . 8 28 .  7 0. 6 0. 6 2 . 3 2 . 2 .  23 
Counts  Eer Minute (CPM ) 
Time Tai l  B lood Total A verage Log 
( hr) 1 2 1 2 1 2 
8 1 080  1 1 07 123 04 11340 12283 11347 127 98 . 8 4 . 1 06 8 
24 1 2 96 9742 11038  1 1 03 8  4 . 0429 
48 2663 956 547 4 7 284 8137 8343 833 9 3 . 9211 
1 09 
Table 1 9 .  Ca taboli c rate of mouse I gG .  
Time B e tween Time Laps e  
* 
a 














- k = ln D0/Dt x 1 /T 
- r
1 1 2  




















o. 007 5 7 0 91 . 1 5  3 . 80 
0. 006 7 16 1 02 .  7 4 4 . 28 
0. 007331 94 . 12 3 . 92 
0. 008150 84 . 66 3 . 53 
0� 006289 1 09 . 56 4 .  57 
0. 007 258 94 . 7 2 3 . 95 
0 . 008247 83 . 67 3 . 49 
0. 008087 85. 3 2  3 . 55 
0. 009226 7 4 .  7 9  3 . 12 
o. 009lt15  7 3 . 29  3 . 05 
Average 8 9 . 40  3 . 73 
0. 009250 7 4 . 59  3 . 11 
o. 0133 90 51 . 53 2 . 1 5 
0. 011680 5 9 .  07 2 . 46 
Average 6 1 . 7 3  2 . 57 
b _ WEE hyperimmunized mi ce , all o thers 
are normal mice . 
1 1 0  
Tab le 20 . Calculation of the catab olic rate of mouse I gG .  
'Iime 
( hr) 











* D 0 
1 2031 
12031 
1203 1  
1203 1  
11324 
1 1 3 24 
1 1324 
1 0240 
1 024 0 
937 6 . 6 





9376 . 6  34 
7 622. 3 56 
1C24 0 16 
9376 . 6  2 6  
7622 . 3  4 8  
9376 . 6  10 
7622. 3 32 
7622.'3 2 2  
- D c CPM a t  t ime zi?ro 0 
+ - D = Cl'M at t i me t t • 
a - T IC t ime b·� t 1o1e�n two coun ts ( hr )  
T
1/2 
= 0 . 69 /k 
b c k or 
_
T1 1 2  
k = ln ( 12 03 1 / 1 1 324) x 1 / 8  
= 0�007 57 0 ( hr-1 ) 
T
1/2 
= ( 0. 69/0. 007 57 0) hr 
c 91. 1493 hr 
k = ln ( 1 203 1 / 1 0240) x 1 /24 
= 0. 006 7 1 6  ( hr-1 ) 
T
112 
= ( 0. 69/ 0 . 0067 16 )  hr 
c 1 02 . J397 hr 
k = ln ( 12031/9�76 . 6) x 1 /3 4  
• =  0. 007331 ( hr-1 ) 
T
1/2 
= ( 0. 6 9 /0. 007 33 1 )  hr 
c 94 . 1209 hr 
k = ln ( 1 2 03 1 /7622 . 3 ) x 1 / 56 
c 0. 0081 50 ( hr-1 ) 
T
l /l 
c ( 0. 6 9/0. 0081 50) hr 
c 84 . 66 2 5  hr 
k = 14 ( !1324 / 1 0240) x 1/16  
IC 0. 006289 ( hr-1) 
r
1 12 
.... ( G . v 9/0. Ovu2 &5) hr 
= 109. 5585 �:-
k IC ln ( 1 1324/9376, 6 )  X lf26 
IC Q, 0072 58 ( hr-1) 
r
112 
c ( 0. 6 9/ 0. 007 2 58) = 94 . 7 1 52 hr 
k = ln ( 11324/76 22. 3 )  x 1 /4 8  
= 0. 008247 ( hr- 1) 
1
112 
= ( 0. 69/0. 008247 )  = 83 . 66 7 8  hr 
k. = ln ( 1 024 0/93 76 . 6 ) x 1 / 1 0  
c: o. 008087 ( hr-1) 
T
l/l 
c ( 0. 69/0. 008087 )  hr 
. c 85. 3 2 2 1  hr 
k = ln ( 1 0240/7622 . 3 )  x 1 /3 2  
IC 0. 009226 ( hr-1) 
T
I 
c ( 0. 6 9/0. 009226) hr 
1 2 = 74 . 7 886 hr 
k = ln ( 93 7 6 . 6/7622 . 3 ) x 1 /2 2  
c: 0. 0094 1 5  ( hr-l )  
T = ( 0. 69/0. 00941 5) hr 
l/2 c: 7 3 . 2 87 3  hr 
b -1 . k = decay C'on s tant ( hr ) 
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throughout the experiment were low so no coincidence correc tions were 
necessary . Since mos t  of the peripheral blood lymphocy tes  were the 
small  lymphocy te s ,  only the se cells were taken into consideration .  
The . cel l  growth rate was calculated by a natural growth equation and 
assumed an exponential increase of cells by binary f i s si on .  Only data 
point s  lying between the linear portion of the curve in  a log-plot were 
used . Resul ts  are swnmari zed in Tables 21 , 22 , 23 and 24 and in F i g­
ures 17 , 1 8  and 1 9 .  The Coulter Counter could rapidly de termine bo th 
cell vol ume and cell concentration far more efficiently and a ccurately 
than by o ther techniques ( 1 , 44 ,  45) . A Coul ter C o unter provides  an 
unique advantage for s tudying cell population as  a function of cell 
size and for s tudying synchronize� cell cul tures where both cell counts  
and volume profi le s  are needed for optimal information .  A lthough the 
lymphocy te culture in thi s s tudy was not experimentally designed for 
synchronous growth, i t  i s  safe to assume that  i t  i s  a synchronous cul­
ture .  B a s ically ,  the small lymphocyte s in the cul ture were mos t ly 
memory T cell s  since the source of these cells was from the blood of 
WEE hyperimmunized mi ce . Under normal condi tions these  cells  should 
be in an intermi to tic  s tate until further antigenic challenge was met .  
Thi s further s timulation was provided by the WEE virus i n  the medium ,  
and activation and allogenic interaction of the small lymphocytes 
should be almo s t  simul taneous . 
The propaga tion and ti tration of WEE virus were done in primary 
tissue cult ure s  of chick embryo fibroblast.  The preparation o f  t i ssue 
cultures involve s fairly preci se control of a number o
f biophysi cal 
Tab le 2 1 . - Coulter counter data for the e s t imation of the 
average generation time of mouse lymphocytes 
% 
Time of Threshold Counts Standard S t andard 
S amp l i ng N umber l 2 3 Average Deviat ion : Deviat ion 
3 58 53 48 53 . 00 s. oo 9 . 43 
4 4 5  50 3 5  43 . 33 7 . 64 17 . 63 
5 1 9  1 7  2 1  1 9 . 00 2 . 00 1 0 . 52 
0 hour 6 14 1 2  11 1 2 . 33 1 . 53 1 2 . 4 1  
7 12 1 0 1 0  1 0 . 67 1 . 1 5 1 0 .  7 8  
8 10 8 7 8 . 33 1 .  53 1 8 . 37 
9 11 1 2 1 0 1 1 . 00 1 . 00 9 . 1 0  
lG 8 6 5 6 . 33 1 . 53 24 . 17 
3 3 0  3 2  3 9  3 3 . 67 4 . 7 3 14 . 05 
4 2 9  3 7  3 3  3 3 . 00 4 . 00 1 2 . 1 2  
5 7 11 9 9 . 00 2 . 00 2 2 . 22 
24 hours 6 1 8  1 0 13 1 3 . 67 4 .  04 2 9 . 5 5  
7 8 13 11 1 0. 67 2 . 52 2 3 . 62 
8 6 9 1 0 8 . 33 2 . 08 2 5 . 00 
9 63 67 6 5  6 :>. 00 2 . 00 3 � 08 
10 64 62 60 6 2 . 00 2 . 00 3 . 23 
3 187 202 . 1 86 1 9 1 .  67 8 . 96 4 . 67 
, . . 137 17 6 1 6 7  1 6 0 . 00 2 0 . 4 2  1 . 28 
5 1 02 1 03 1 1 9  1 08 . 00 9 . 54 8 . 83 
4 &  h<>tH:'� 6 1 38 � � f" ,l. .) J  13 9 1 3 7  . '.}'.) 2 . 03 1 .  51 
7 .  1 1 0  11 1; 1 2 5  1 1 6 . 33 7 .  7 7  6 . 67 
8 1 12 90 96 9 9 . 33 1 1 . 3 7  1 1 . 4 5  
9 3 1 5  280 322 2 05 .  67 2 2 . 50 7 . 36 
1 0  258 243 247 24 9 . 33 7 .  7 7  3 . 12 
3 536 524 5 50 53 6 . 67 13 . 01 2 . 42 
4 11 52 461 4 2 0  444 . 33 2 1 . s 5 4 . 8 5  
5 262 266 2 90 27 2 .  67 1 5 . 14 5. 55 
7 0  hours 6 227 207 2 1 5  2 1 6 . 33 1 0 .  07 4 . 6 5  
7 1 99 194 205 1 9 9 . 33 5 . 51 2 . 7 6  
6 1 7 5  199 1 93 1 8 � . oo 1 2 . 4 9· 6 . 60 
9 136 133 1 3 8  1 3 5 .  6 7  2 . 52 1. 86 
1 0 1 4 0  13 5 1 3 5  13 6 . 67 2 . 89 2 . 11 
3 960 959 898 9 3 9 .  00 3 5 .  51 3. 7 8  
4 7 4 8  7 58 7 28 7 44 . 67 1 5 . 2 8  2 . 05 
5 57 5 6 1 0  583 5 8 9 . 33 1 8 . 33 3 . 11 
76 hours 6 53 5 500 511 51 5 . 33 17 . 90 3 . 47 
7 423 438 428 4 2 9 . 67 7 . 64 1 . 7 7  
8 4 14 432 3 89 4 4 5 . 00 3 9 . 1 5  8 .  7 8  
9 4 03 3 7 7  3 7 1  3 83 .  6 7  1 7 . 01 4 . 4 3  
1 0 3 53 347 333 344 . 33 1 0. 26 2 . 98 
Aper t ure 5 1 2  Sample s i ze = 50 ul 
A t tenua t i on = o. 7 07 Dilu tion of . sample = 1/ 5 0  
Ori f i ce = · so ul 
114 
1 1 5  




0 hr 24 hr 48 hr 7 0  hr 7 6  hr 
3* 1 0  1 32 92 194 
4 24 24 . 52 172  155  
5 7 0 0 56 74  
6 2 3 21 17  86 
7 2 2 17 1 0  18  
8 0 0 0 53 28 
To tal · 4 5  122 - 400 555 
Log 1 . 653 2 1 .  47 7 l  2. 0864 2 .  6 026  2 . 7443 
* - Channel 3 are counts between thre shold 3 and 4 .  
Table 24 . Calculation of the growth rate  of mouse lymphocy t e s 
using the following natural growth equa tion : 
g � log 2 x T/ log N
t 





a b Time T g 
(hrs ) t 0 
24-4 8  24 122 3 0  0. 3 01 x 24 hr/( 2 . 0864 - 1 .  47 7 1 )  
= 11 . 856 hr 
24-7 0  46 4 00 3 0  0. 3 01 x 46 hr/( 2 . 6 026 - 1 . 4 97 1 )  
= 12 . 3 02 hr 
24-76 52 555 3 0  0. 3 01 x 52 hr/ ( 2 .  7. 443 .-._ .1 •. 477 1 )  
= 12 . 3 52 hr 
48-7 0 22 400 122 0. 3 01 x 22 hr/( 2 . 6 026 - 2 . 0864 )  
= 12 . 7 86 hr 
48-76 28 555 122 · 0. 3 01 x 28 hr/( 2 . 7 443 - 2 . 0864) 
= 12. 81 hr 
7 0-7 6 6 555 4 00 0. 3 01 x 6 hr/ ( 2 . 7 443 - 2 .  6 026 
= 12 . 7 5  hr 
* 




- N = N umber of cell at time t t 
- N • Number of cell at time o o· 
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Time · Total c ell fl 
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2 4  h r  3 0  
48 hr 12 2 
70 hr 400 
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log 
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and bio chem i c a l  parame ters s uch as the compos i t i on o f  t he growth med ­
i um ,  ce l l  concen tra t ion and vol ume o f  cul ture med i um .  T he med i um  i s  
1 2 1  
us ual ly based o n  a balanced solution o f  p hy s io lo gi ca l  organi c  sal t s  
b uf fered wi th phospha t e  or bi carbona t e . I n  add i t i on ,  a pro t e in s o urce 
is provided as amino acids or as aci d  hydrolysat e  of a s ui table pro -
tein , us ua l ly l a c toa lbwnin . A further source of pro te in i s  s erum , 
common ly u s ed to s upp l ement the o ther nu tri ent s . The s ame component 
also s upp lies  e s s en t i a l  vi t�ins and addi t i onal b uffering capaci ty . 
A contro l led gas p ha s e  of approximately 5% co 2 in a i r  i s  emp l oyed to 
preven t exces s ive a lka l i ni ty deve loping in t he cul ture med i um .  P henol 
red i s  incorpora ted i n to mo s t  s tandard med i a  as an inert pH i nd i ca tor . 
To prevent contamina t i on of hi ghly nu tri t i onal medium , spe c i f i c  an ti-
bio t i c s  are usua l l y  added . P eni ci l l i n  and s trep tomy c i n  are a c t ive 
again s t bacteri a ; myco s ta t in and aJnphi s teri c i n  B are speci f i ca l ly a c t ive 
again s t  yeas t s  and mo l ds whi le a ureomycin and kanamy c i n  are used to 
prevent t h e  contamina t ion by mycop lasmas . A parame ter c losely re lated 
to b uf fering capaci ty in de termining the readine s s  wi th whi c h  a c t ive 
cell  growth i s  ini t ia t e d  i s  the concentra t i on a t  the beginnin g .  The 
s i ze of inoculum d i re c t ly i n f l uence s the pH of the medi wn immedi a t e ly 
fol l owing incuba tion . Too low a concentra t i on wo uld prolong the ini-
tia l a lkaline period whi le a high concentra tion wo uld cause an abrup t 
· 
1 1  · b ly F or s e t t ing mos t rap id drop in pH ; bo th can damage ce s irrevoca • 
mono laye r  cul tures a concentrati on of 1-1 0 x 1 0 5  c e l l s /m l  i s  u s ua l ly 
s a t i s fac tory ( 3 6 ) . The volume of cul t ure mediwn affe c t s  the oxy
ge n  
grad i ent a cros s t h e  med i um ,  the to tal supp ly o f  nutrien t s , and the 
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adequa te control of pH . For optimwu growth of cell  monolayer, the 
fluid phase  should be about 1 cm in depth and represent 1 0-3 0% of the 
total  vol ume of the culture vessel ( 3 6 ) . C e l l s  usually s tart to set­
tle  immediat�ly after they are £uspended in growth med i um,  and irre­
versible a ttachment to the cul ture vessel wal l  usually occurs within 
the firs t hour . To ensure uniform settling of ce l l s , cultures should 
always be placed in a level pos i tion .  In primary cul t ures the ini tial 
single  cells tend to die whi le mos t  active prolifera tion is ini tiated 
by the cel l  clump s .  I n  fac t ,  most  primary cul tures se t wi th a high 
proportion of single-cells usually grow poorly . 
Chi ck embryo fibroblas t s · (CEF ) are a fas t  growing s train and 
monolayers shoula be formed 48-56 hours after incuba tion . F or op timwn 
growth i t  i s  advi sable to add 5% chicken serum and 5% chick embryo 
extract .  The serum should be heat inactivated to e l iminate any infec­
tious avian leukosi s virus before use . CEF tend s to degenerate in 
a short  time so a fresh primary culture should be prep�red for each 
experimen t .  CEF i s  very sensi tive and is  thus used mos t  often for 
the propagation and ti tration of arboviruses . Res ul t s  of the WEE 
ti tra tion are shown in Table 25.  
WEE virus belongs to the group A arboviruse s  which by defini tion 
are those virus e s  which harbor in certain arthropods and are transmi t­
ted to man and o ther vertebrates . This definition specifica lly ex­
cludes those a gents which are transmi tted mechanically by anthropods 
and do not mul tiply in the tis sue of the lat ter . WE
E virus mul tiplies 
readily in both
.
chick and duck embryo fibroblasts  bu
t cellular 
Table 2 5 .  Ti tration o f  WEE virus by plaque assay . 
Data : 
P lague Count (Efu) 
Di lution 1 2 Average 
1 0
-4 




1 0-6 69  
10-7 9 
1 0-8 2 
·:: Not  countable . 
Calculation s 
0. 2 ml of 
0 . 02 ml of 
0. 002 ml of 
0. 0002 ml of 
-5 









N . c .�·, 
169 
7 5  
3 
0 
solution contained 1 58 pf u 
solution contained 72 pfu 
solution contained 6 pf u 
solution contained 1 pf u 
7herefore 0 . 2222 ml of viral solution contained 227 pfu . 
Therefore the virus ti ter ( pfu/ml )  is : 






( pf u) 
des truc tion i s  freq uently incomple te and cytopathic effe c t s  may be 
poorly i f  at  all  vi sible ; thus , the plaque technique is more useful 
than the insula tion of conventional tube cultures . Hemagglutinins 
are produced . �y most but not all arboviruses . 
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No s ingle complement-fixing or ·other antigen i s  common to the 
entire arbovirus group . Primary grouping of the agen t s  i s  based upon 
the hemagglutinat ion-inhibi tion (HAI ) tes t ;  four ma j or groups are 
recognized : A, B ,  C ,  and B unyamwera . Further subdivi s i on of t he s e  main 
groups is pos s ible by means of complement-fixation { CF ) and neutraliza­
tion tes ts . A t  least nine other minor groups are recognizable , each 
group con s i s ting of 2 to 4 members . I n  addi tion ,  a large number of 
arbovi �uses exi s t  whose rela tions�ips are uncertain at  the  pre sent 
time . 
I n  s tandard HAI and CF te s t s ,  cross reactions between groups limi t 
the usefulne s s  of s tandard test  procedure s .  Cross rea c tions are also 
evident  in neutral ization te s ts but to a much lesser extent . The 
'identifi ca t ion of a single agent is faciliated by us ing the p laq ue­
inhibi tati on t e s t . The determination of serum ant ibodi e s agains t the 
arboviruse s i s  s imi lari ly ted ious . Tests are often unre liabl e due 
to cros s  reac tions be tween serotypes . Recently a me thod was deve loped 
to de termine arboviruses  or their  antibodies . Thi s  is the radioimmuno­
Precipi ta tion t e s t  { 1 1 , 23 ) whi ch has the sensi tivi ty of �he . p laq ue­
inhibi tion te s t  but offers - much more rapid re sul ts . Like all immuno­
Precipi ta t ion sys tems ,  the sens i t ivi ty and specifi ci ty of thi s te s t  
depend s  upon the puri�y ,  specifici ty and concentra tion o f  labeled 
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antigens . The RIP tes t  i s  based on the precipi tation tes t ;  only the 
t d d WEE . . d .  
. 
1 1 b 
. 
12 51 s an ar v1 r1ons are ra ioact1ve y a elect wi th and . anti-mouse 
Ig s erum is added to enhance the precipi tation of the antigen-antibody 
complex. Ad��uate control s are nece ssary to ensure the succ e s s  of 
this tes t .  A l though thi s te st  doe s . not allow the s t udy of the forma-
tion rate of ant ibodies , i t  provides a rapid , specific and s ensi tive 
te s t  to d e te c t  the overall antibody produc tion from the serum of an 
animal . Thi s te s t  was used to s tudy the kinetics  of ant i -WEE antibody 
formation in mice and the re sul t s  are shown in T able 26 and F igure 20. 
Tab l e  2 6 . De te c t ion o f  WEE -an t i body forma t ion by RIP . 
Time 









1 0  
1 6  
Con tro ls 
a .  WEE;'• virus + Tri s 
buff er 
b . WEE ;'.- vi rus + an. t i -mouse 
l g serwn 
c .  WEE 7• vi rus + an t i -mouse 
I g serum + norma 1 
mous e  serlUn 
•k 125 - I lab e l ed 
Counts P er M i nute 
Preci p i tate S uperna tant 
24 57 2 56 1  
2 53 6  27 13 
2497 2 5 8 5  
2 564 1 9 7 6  
3 7 6 4  1 7 51 
3 7 8 5  127 0 
3 2 7 4  9 94 
3 6 6 2  97 6 
2642 803 
3 81 9  2400 
23 7 1 2643 
253 0 27 1 5  
24 58 2441 
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Ra tio of 




1 . 22 
2 . 1 2 
2 . 92 
3 . 3 1 
3 . 7 5 
3 .  52 
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DAY . CPM RATIO 
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2 · 1 
3 1 
4 1 . 2 2 
5 2 . 12 
6 2 . 9 2  
7 3 . 31 
8 3 . 75 
10 3 . 5 2 
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Figure 20 . Dete ct ion of ant i-WEE ant ib ody formation by RIP t es t .  Radioact ivity (CPM) in 
supernat ant represents I-125 lab e led T.fEE viral p articles and CPM in the p re c­
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S imu l a t i on Data 
The  above experimen tal val ue s  and some o ther t heore t i ca l  and 
l i terary val u e s  are u s ed as inpu t data to te s t  the mod e l . The s tandard 
cond i t ions s e t  to s imula t e  t�e immune re sponse c urve in F i gure 2 0  are 
shown in Table 2 7 . Re sul t s  ind i cate  that the number of I gM  ABFC i n  
the primary re sponse i s  ih go6d agreement wi th the find i ng s  o f  H eg e  
and C o le ( 3 2 ) , .  and the kine tics  of I gG  an t i body forma t i on in bo th 
primary and s e cond ary rcspon 9 e s  are very s imi lar t o  the find i ng of 
Ad ler ( 2 ) working wi th Venezue lan eq uine encepha l i t i s  (VEE ) viru s . 
The ra t e  o f  prod uc t i on of an an t i body mo lecule of  e i ther I gM  or I gG 
i s  mo s t  controve rs i al ; i t  ranges from 0. 5 to 2 0 , 000 mo l e c u l e s  per c e l l  
per s e c  ( 1 8 ,  3 5,) .  S ince i t  may be true tha t  the antibody produc t i on 
rate vari e s  wi th fac t ors such as t ime , speci es  of animal hos t s , anct 
other mi cro environmen tal cond i tions s uch as the phy s i o lo g i ca l  cond i t ion 
of the animal , the i1nmunogen i c  characteri s ti c s of t he an t i gen and t he 
6 previo us immunol o g i ca l. f!Xp 2ri ence of the ho s t ,  a val ue of  2 .  52 x 1 0  
molecu l e s  per c e l l  per hou r  wq s cho s en arbi trari ly . 
I t  i s  obvious t ha t  the kin� t i cs of  anti body forma t ion are d iffer­
ent wi th each ho s t -an t igen sys tem ( 8 , 7 6 ,  7 7 ,  7 8) b u t  c e r ta in para­
me ters and the s tep s of  component interac t ion should no t be too far 
vff from each sy s t em .  I t  s hould be empha s i zed tha t  thi s mod e l  . in i t s 
Present cond i t ion i s  only va l id for the mouse-WEE sys t em .  I f  o t her 
sys tems are used to t e s t  thi s mode l ,  the s tandard cond i t i ons  have to 
be changed .  The i nf l uenc e s  o f  mouse we i g h t  a nd the do s e  o f  an t igen 
to o ther parame ters of  thi s  mod e l  are shown in Table  2 H .  T he s imula ted 
Tab l e  2 7 . S t an dard cond i t i ons of the immune respons e mode l 
De s crip tion 
Mouse He i gh t  (gm) 
Average r a d i u s  of lympho cyte (u ) 
Average d en s i ty o f  lympho cy t e  (gm/ml) 
Primary dos e o f  ant i gen (p fu /ml ) 
Se condary d o s e  o f  ant i gen (pfu /ml) 
El imin a t i on rate o f  HE E  v i ru s  ( %/hr ) 
Elimi n a t ion ra t e o f  t h e  e f fe ct ive 
port i on o f  WEE virus (%/hr) 
Laten t pe riod for ICC to be come !AC (hr )  
Laten t pe riod for IA C  to become ABFC 
Cel l  gen erat i on t ime (h r) 
Li fe s p an o f  ABFC (h r)  
Maximum numb e r  of  s u c ce s s ive divi s ions 
an ABFC pre curs or cou ld und ergo 
(numh er o f  g �'. n e ra t ion s )  
Value 
30 . 
3 . 5 
1 . 0 8  
7 
1 . 2 x 10 
1 . 0  x 10 7 
10 
1 . 2 
2 0  
2 0  
12 . s  
4 8  
9 
Simula t e d  va lue s of  the n umb e r  o f  lympho cy tes p res ent in the two 
comp ar t men t s  o f  a 30 gm mouse 
Description 
Weigh t  (gm) 
Volume (ml ) 
Lympho cyte (n o . )  
T ce l l  · (no . ) 
B ce ll (no . ) 
· WEE spe c i f i c  T c e l l  
WEE 
I 
s p e ci fi c  B ce ll 
WEE s p eci f i c  ICC 
I.:ymphoj d tissues lilruld 
0 . 6 
· - · 
- - 7 
6 . 19 x 10 7 3 . 74 x 10 7 2 . 4 4 x 10
3 3 . 74 x 10
3 2 . 44 x 10 3 6 . 18 x 10 
2 . 4 
1. 2 8 x 10
8 
1 � 0 3 x 10� 
2 .. 5 7  x 103 1 . 0 3 x 103 2 . 5 7 x 10
3 3 . 60 x 10 
l'otal 
1 . � x 10 8 
1 . 4 x 10 � 
s . o  x 10 Li 
1 . 4 x 10� 
s . o  x 10
4 1 . 9 x 10 
. . 129 
Tab le 2 8 . Th e e f  fe e t  o f  mous e  wei gh t s  on the n umb e r  o f  lymp h o c y t e s  
Va l u e s  n r c  � d 1r11 1 l a t e d  un d e r  s t an d ard c o n  i t j on s  
Numb e r  ---WEE spe c i f i c Mous e we i gh t T ce ll B ce ll T o t a l  I CC B ce l l ABFC 
(,gm) . .  x10 8 x 10 7  x 10 8 x10 4 ·- --
2 4 . 5 l o l l1 4 . 1 0 1 . 5 5  1 . 5 5  40 9 2  7 39 
2 6 . 5  1 . 2 l1 4 . 4 3 1 . 6 8 1 . 6 8  4 4 2 6  75 9 
2 8 .  5 1. 3 3 4 . 7 6 1 . 80 1 . 8 0  4 76 0  7 7 2  
30 . 5  l . l:. 2 5 . 10 1 .  9 3  1 . 9 3 5 0 9 4 7 85 
32 . 5  1 . 5 2  5 . 4 3 2 . 0 6 2 . 06 5 4 2 8 79 6 
3 4 . 5  1 . 6 0 5 . 7 6 2 . 19 2 . 19 5 7 6 2  80 7 
3 6 . 5  1 .  7 0  6 . 10 2 . 31 2 . 31 6 0 9 6  8 1 7  
I 
E f fe c t  o f  rimary d os e  o f  ant i. gen on t h e  n umb e r  o f  ABFC p re cu rs ors 
Va 1 u s · a re rd mu 1 a t e <l un d e r  :;..s..!:.t�an:!.:d::..::a�r::.· d ::.._::c;.;::.o.:..:.n.::;.d i::::..:· t:;..:i;;.;.o_n-:-s�-:-- �---:�::-::-::::----:-::--
Vi rgin LZT c e l l  A BFC HZT c e l l  
Dose 
(p fu /ml ) 
1 . 2  x 10 5 
1 .. 2 x 1 0 6 
1 . 2 x 1 0 7 
1 . 2 x 10 8 
1 . 2 x 1 0 9  
1 .  2 x 105  
1 . 2 x 1 06 
1 . 2 x 10 7 . 8 1 .  2 x ,1 0
9 1 . 2  x 10 
c e l l  
0 . 5 3 ?.  
0 . 3 8 8  
0 ., 2 8 3 
0 . 2 0 7  
0 . 0 0 1 4  
5 1 1  
39 6 
309 
2 1� 4 
2 
F r a c f- j Q D 
0 . 8 0 8  0 . 4 6 8  5 x l o- 5 
0 . 7 5 5  0 . 6 1 2  4 . 4 x io- 4  
0 . 6 4 0  0 . 7 16 1 . 8 x 10-4 
o . 5 3 2 0 . 7 9 2  5 . 4  x io- 3 
0 . 0 2 4  0 . 4 6 6  0 . 9 8  
N 11 lll b e i: 0 f c e l ] 
7 75 4 4 9 
7 70 6 12 
6 9 9  7 82 6. -9 2 4  6 2 1  
30 5 7 4  1 2 0 9  
. 13 0 
da ta of the s tandard inunune re sponse curve in the primary I gM  re­
sponse are s hown in Table 29 and Figures 21 and 22 ; the I gG response  
in bo th primary and secondary responses is  shown in Table 30  and F ig­
ures 23 and 24 . 
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I t  i s  worthwhile mentioning that the kinetics  of an immunological 
respons e  to various viral antigens are somewhat peculiar .  The inunune 
response of guinea pigs to phage � X 1 7 4  i s  detectable as early as  
one day af ter an tigenic challenge ( 7 7 ) . Another peculiar example is  
tha t  the immune response of  humans to ye llow fever viral  vaccine i s  
predominately an I gM  anti body response whi ch persi s ts for months wi th 
a high ti ter of circulating antibody . Only af ter repeated vac cina• 
tions over a long period of timt! wilJ. a dominant IgG response  occur , 
and even then the ti ter of I gG antibody does no t go beyond the previous
· 
I gM level ( 55) . 
Tab l e  2 9 .  C ompu t er o u tp u t  on t h e  number of ABFC formed and the num­
ber and monogram s of I gM  ant i body mol e cu l e s  formed in a 
primary re spon se . 
13 2 
T ime ( hr) ABFC (No. ) I gM  (mole cules ) I f!J1 (n an o g ram) 
0 o .  0 0 
4 8  0 . 57 1 .  90 x 1 07 0 . 02 84 
96 1 1 . 1 . 3 5  x 1 09 2 . 02 
144 1 94 .  1., 0 8  x 1 01 0 3 .  63 
1 92 3 1 1 2 7 . 3 . 7 6 x 1 01 2  5 6 9 . 0 
240 1 7 1 52 .  4 .  2 0  x 1 01 1 6 2 7 . 8  
2 8 8  9 53 4 .  9 . 68 x 1 01 1 333 . 45 
33 6 53 2 6 .  2 Q 81 x 1 01
1 133 . 2 6  
3 84 2 9 83 .  2 . 6 5  x 1 0
1 1 113 . 9 6 
43 2 1 6 7 2 .  8 . 59 x 1 01
0 
1 28 . 4 
4 8 0  940.  7 .  59 x 1 0
1 0 
13 4 & 0 
52 8 52 8 .  3 . 05 x 1 01
0 
4 5 . 5 
I 
1 0
1 0  
33 . 6  57 6 2 97 . 2 .  2 5  x 
624 o.  0 0 
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Figure 21 . S t andard curve s of IgM an
d I gG ant ib o dy forming 
ce ils . fo rme d in WEE hyp e rirom
un i z e d in a p rimary 





COMPUTER S I11ULATED DATA 
. . . . . • • . . . . . 
C) 
C) 




co ·  




o <=> o c::> o o o o o o o o o o o o '  
c;:> C> c.:> C> 0 C) C> c:> C> 0 0 C> C> C> C> 0 
c::> co \.Q '1 (\] C> D'.) \() '1' (\} C) i:f) \() '1' (\} C> 
'1 °' '1 °' � ro n co (") ro C\J c-- N c-- C\J 
- (\] (\] ("') (") 'J' 'f' lf) I () \() \() C"-
B • • • • • •  Leve l o f  I gM mol e c­
ules 
D Level o f  I gG mo le c­
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Figure 22 . S t andard· · cµrve s o f  I gM and I gG ant ib ody format ion 
in hype rimmun i z e d  ( agains t HEE) mi ce in a p rimary 
inlPmne resp ons e. 
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13 5 
Tab le 3 0 . C omputer ou tpu t on t he number of ABFC formed and the nwnber 
and mono grams of I gG  anti body mol ecul e s  . formed i n  bo th pri ­
mary and s econdary immune re spon s e . 
T ime ( hr) A BF C  ( No . ) I gG  ( mole c ul e s )  I gG  (_ n ano gram) 
0 o .  0 o . o  
4 8  o.  0 o. o 
96 o. 0 0 . 02 6 
144 o . s 9 . 6 x 1 07 0 . 2 89 
192  3 5. 5 4 . 3  x 1 0
9 
1 . 42 
240 1298 .  3 . 6  x 1 0
1 0 
9 . 64 
288 98666 . 7 . 1  x 1 0
1 2  
7 3 1 1 . 
3 3 6  3 54 6 8 .  4 .  0 x 1 01
2 
3 87 4 .  
3 84 33 023 . 2 . 2 x 1 0
1 2  
3 1 04 .  
4 3 2  1 6 882 . 1 . 2 x 1 0
1 2  
5 84 .  
4 8 0  94 56 . 6 ., 9 x 1 01 1  3 2 7 . 
528  53 06 . 3 .  9 x 1 0
1 1 
1 86 .  
57 6 297 9 .  2 . 2 x i o
1 1 
1 01 .  
624 1 1 6 8 .  1 . 23 x 1 0
11 
57 . 9 
6 7 2  9 4 0 .  1 . 2  x 1 01
1 
3 2 . 5 
7 20 7 0414 . 1 ; 2s x 1 0
13 
2 6 0 .  
7 68 804 1 5 .  1 . 267 x 1 0
1 3 
1 13 6 5 .  
816 1 00 592 . 1 . 2 6 9  x 1 0
1 3  
1 1 7 00.  
864  1 005 92 . 1 . 269  x 1 0
13 
1 1 7 00.  
91 2 1 00592 . 1 . 26 9  x 1 0
1 3 
1 1 7 00 .  
1 00592 . 1 •. 26 9 x 1 0
13 
1 1 7 00 .  960 
COHPUT� R S IMULATION DATA 
A ____ �Number of  I g.11 forming ce lls 
C .  • • • • • . • . Numb e r  of .IgG forming cells 
co • • • .. 
Each • = 4 8  hr 
f = Time of :second inj e c tion 
• 
µ �.,o ·ey o c:'.) 
... · � , ' ' • . I . . u. 
. • 







I '• ' 
b.. ! 





9 6 0  HOURS 
Fi gure 23 . S tandard curves o f  IgM and I gG antibody 
forming ce lls  in b o th primary and secondary 
immune responses 
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COMPUTER S I�LATION DATA 
B --��- Level of IgM mole cules 
D • • • • • , .  Leve l of I gG mole cules 
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9 60 HOURS 
Figure 24 .  S t andard curves o f  I gM and I gG ant ib ody form­





that the resul t repre s en t s  a typ i cal primary I gM  re spon s e  c urve . 
S tudy o f  thi s model t hrough compu ter simulat i on l ead s t o  the 
conc l u s i on tha t the s imula ted and experimental d a t a  are clo s e ly para l ­
l e d  t o  e a c h  o t her in both primary and secondary re spon s e s  unde r  the 
following defined cond i t ions : 
1 .  T he la tent period for ICC to become IAC i s  2 0  hr . 
2 .  The l a te n t  period for IAC to become ABFC i s  2 0  hr . 
3 .  The l i f e  span of ABFC i s  48 hr . 
4 .  The maximwn nwnber o f  genera tions tha t a prec ursor c e l l  would 
und ergo is 9 genera t i ons . 
S .  The e ffe c t ive por t i on o f  a given do se o f  ant igen vari e s  wi th 
the con centra tion of  the ant i gen but is a lways l e s s  than 1 % .  
6 .  T he e l imina t i on ra t e  o f  thi s effect ive por t i on o f  a gi ven 
d o s e  o f  an t i gen i s  very slow and i s  found t o  be  a bo u t  
1 .  2 % /hr . 
7 .  O p t i mal d o s age for immuni zation i s  found t o  be i n  the range 
7 8 of 1 . 0 x 1 0  to 1 . 0 x 1 0  pfu of virus . 
8 .  The nurr.be r o f  I gG prec ursors i n  a primary re spons e  i s  1 /3 0  
of the nurr.ber o f  I gM  ABFC a t  the peak of  ant i body prod u c t i on .  
The uniq uene s s  o f  thi s mod e l  i s  that i t  embod i e s  a lo t o f  informa-
tion concerning an immuno logi cal re spons e .  T hi s  mod e l  s imul a t e s  a 
whole seri e s  o f  even t s  s tart i ng from the anima l ho s t  i t s i::! l f  and d e -
scri be � in ful l  d e ta i l  t he various componen t s  and s te p s  involved i n  
an immune re spon s e . A s  in any s imu l a t i on mode l s , the cond i t i ons pre-
d i e ted may and may no t be true b u t  it provid e s  a way to a cquire 
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information that could no t be obtained o therwi s e .  No model i s  perfect 
in i tself and both the numbers and the value of  the standard condi tions 
should be changed if  new evidence arises and new value s  are available 
in the future . 
APPENDIX 
Table 1 .  COULTER COUNTER PROGRAM 
1 0  C O M A , z , s , o � C 3 2 J , DS C 3 , 5 0 J 
2 0  R E M :  C OU LT E R  C OU NT E R  PR O G RA M 
3 0  D I M  T S C 9 , S O J , C S C 3 , S O J , MS C 3 J , S S C 3 J  
4 0  D I M A $ C ? J , C $ C S J , Q .£ C l l O J , p :£ ( 1 1 0 J 
5 0  D I M  T $ ( 1 6 0 J , H i C l O O J , 8 $ C 3 l  
6 0  RE M :  RUN S E C T I ON 
7 0  RE M 
8 0  X = O 
9 0  C $ = " 1 2 3 4 5 .. 
1 0 0 F OR I = 1 T 0 1 1 0 
1 1  0 Q $  ( I , I J = "  .. 
1 2 0 NE XT I 
1 3 0 Q $  ( ' 1 ) :-: " + .. 
---
1 4 0 D I S P  .. E NT E R T I T LE : 5 L I NE S < = 3 2  S PA C E S  .. ; 
1 5  0 F QR I =  1 T 0 5 
1 6 0 I N PUT T $ C I * 3 2 - 3 1 , I * 3 2 l 
1 7 0 N � XT I 
1 8 0 D I S P  " E NT E R # OF DAT A S ET S : < =5 • ;  
9 0  I N PUT N 
2 0 0 D I S P  " D O Y OU WA NT C HA N�E L D I F FE RE NC E S " ;  
2 0  I N PU T 8 :£  
2 2 0 D I S P  " E NT E R  H E A D I NG S : < = 2 0  S PAC E S  " ;  
23 0 F OR I =  1 T 0 N 
2 4 0 I N PUT H 5 C I * 2 0 - 1 9 , I * 2 0 J 
2 5  0 NE XT I 
2 6 0 D I S P  " E NTE R F I RS T  A ND LAS T T H RE S H OLD # 
2 7 0 I N PUT A 0 , Z 0 
2 8 0 D I S P  " E N T E R  A PE RT U RE S ET T I N G · ; 
2 9 0 I N PUT A 8  
3 0 0 D I S P  " E NT E R  A T T E NUAT I ON S E T T I N G • ;  
3 1  0 I NPUT A 9  
3 2 0
.
C 4 = 0  
3 3 0 . D I S P  " D O Y OU W I S H r o· S ET THE S C A LE · ;  
3 4 0 I NP U T  A $  
3 5 0 I F  A $ = " NO "  T H E N  4 2 0 
3 6 0 C 4 = 1  
3 7 0  D I S P " E NT E R  YMA X F OR C HANNE L PL OT " ;  
3 8 0 I N PUT Y 
3 9 0 I F  B $ = " N O "  T H E N 4 2 0 
4 0 0 D I S P " E NT E R  YM I N , YMA X F OR D I F F .  P L OT
 " ;  
4 1  0 I N P u T  Y O  , Y9 
42 0 F 0!1 I =  T 0 N 
4 3 0 D I S P " E NT E R  F I L  H F OR DATA S E T  H N ; I ;  
44 0 I N PUT S C I  l 
4 5  0 NE XT I 
4 6 0 F OR I = T 0 N 
4 7 0  L OA D  D A T A  S C I J  
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.. .  
J 
4 8 0  
4 9 0 
5 0 0 
5 1 0 
5 2 0  
5 3 0 
5 4 0 
5 5 0 
5 6 0  
5 7 0 
. 5 8 0  
5 9 0 
6 0 0 
6 1 0 
6 2 0 
. 63 0 
6 4 0 
6 5 0 
6 6 0  
6 7 0 
6 8 0 
69 0 
7 0 0 
7 1 0 
7 2 0 
7 3 0 
7 4 0 
7 5 0 
7 6 0 
7 7 0  
7 8 0  
7 9 0 
8 0 0  
8 1 0 
8 2 0 
8 3 0 
8 4 0 
8 5 0 
8 6 0  
8 7 0 
8 8 0 
8 9 0 
9 0 0  
9 1  0 
9 2 0 
9 3  0 
9 4 0 
COULTER COUNTER P ROGRAM . (Cont ' )  
J = O  
J 9 = < A O -A > IS 
F OR J O �A O  T O  Z O  S T E P  S 
J =J + l 
J 9 = J 9 + l 
F OR K = l T O  3 
T ( 3 * I - + K , J J = D ( K , J9 l  
NE XT K 
NEXT J O  
NEXT I 
REM 
. - · 
RE M C OM PUT E C HANNE L C OU NT S  
RE M 
A =A O  
Z = Z O  
X = O  
F OR I =  T O  N 
T = O 
F OR T O =.l\ T O  Z - 1 S T E P S 
1 =T + 1 
M 1 = < T [ 3 �- 1 - 2 , T J + T C 3 * I - 1 , T J +T C 3 * I , T l > 13 
M2 :: < T ( 3 * I  - 2 , T + 1 J +T ( 3 * I  - 1  , T + 1 J +T ( 3 * I  , T + J > 13 
C ( I ; T J = M 1 - M2 
I F  X > =  C C I , T J  T H E N  73 0 
X = C ( I , T J  
NXT T O  
N E XT I 
R E M 
R M  PR I NT DATA 
C = O 
F OR C O =A T O Z S T E P  S 
C =C + l  
I F  < C - ) / 1 2 = 1 NT < < C - ) /2 )  T HE N  8 2 0 
G OT O  8 4 0 
G OS U B  2 3 6 0  
PR I NT H $ , L I N 1 
K =  
F O R I =  T O  N 
C 1 = T C J( , C J 
C 2 = T C X + l , C J 
C 3 = T ( !( + 2 , C J 
M C I J = C C l + C 2 + C 3 ) /3 . 
. 
A A � 
S C I J � < C C C l - M C l ] ) A 2 + ( C 2 - M
C I J ) 2 + < C - M E I J > 2 ) /2 ) O . S 
K = K + 3  
NE XT I 
F O R  I = l T O  N 
W R I T E < I S , 9 5 0 > C O , T C 3 *
I - 2 , C J , M C I 1 ; 
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COULTER COUNTER PROGRAM (C on t• )  
9 5 0 F O� MAT F 4 . 0 , X , 2 F6 . 0 , 3 X  
9 6 0 N E X T  I 
9 7 0 PR I NT 
9 8  0 F OR I =  l T 0 N 
9 9 0 WR I T  E C l 5 , 1 0 0 0 ) T C * I - 1 , C J , S C I J ; 
1 0 0 0  F O RMAT S X , F 6 . 0 , F 6 . , 3 X  
1 0 1 0 NE XT I 
1 0 2 0  PR I NT 
1 0 3 0  F OR I = l T O  N 
1 0 4 0  I F  M C I J = O  T H E N 1 0 7 0  
1 0 5 0  S l = O O * S C I J / M C I J  
1 0 6 0 G OT 0 1 0 8 0 
1 0 7 0  S l = O 
- - ·  
1 0 8 0  WR I TE C l 5 , 1 0 9 0 > T C 3 * ! , C J , S ;  
1 0 9 0  F OR MA T  5 X , F 6 . 0 , FS . 1 , " � " , X  
1 1 0 0 NE XT I 
1 1 1  0 PR I NT 
1 1 2 0  I F  C O = Z T H E N  1 2 3 0  
1 1  3 0 F OR I =  1 T 0 N 
1 1 4 0  I F  1 �  T H E. N  1 1 9 0  
1 l � U i. F' D $ = . .  NU " T H E N  1 9 0 
1 1 6 0 WR I T E C l 5 , 1 1 7 0 > C C I , C l , C C I , G l - C C , C J ; 
1 1 7 0 F O R MAT 2 X , 2 F 6 . 0 , 6 X 
1 8 0 G OT 0 1 2 l 0 
1 9 0 WR I T E C 1 5 , 1 2 0 0 ) C C I , G J ; 
1 2 0 0  F O /'.t MA T 2 X , F 6 . 0 , 1 2 X 
1 2 1 0 NE XT I 
1 2 2 0  PR I NT 
1 2 3 0 NE XT G 0 
1 2 4 0  R E M  
1 2 5 0  RE M P L ITT C HA NNE L C OU NT S  
1 2 6 0  RE M 
2 7 0  G OS U B 2 3 6 0  
1 2 8 0 PR I NT L I N3 
1 2 9 0  I F  C 4 = 1  T H E N  1 3 1 0 
1 3 0 0  Y = X  
1 3 1 0 Y= Y/ 1 0 0  _ 
1 3 2 0  PR I NT T A B I S , " O · ; 
1 3 3 0  F OR J = l  T O  1 0 
1 3 4 0  WR I T E C l 5 , 1 3 5 0 ) J * Y * l O ;  
1 3 5 0  F OR �mT 2 X , F 8 . 0 
1 3 6 0  N E XT J 
1 3 7 0 PR I NT 
1 3 8 0  WA I T  3 3 3 
1 3 9 0  PR I NT T A 8 1 5 , • + " ; 
l 1-t 0 0 F OR I = T 0 1 0 .. 
1 4 1 0 WR I T E C l S , 1 4 2 0 ) " - - -
- - - - - - +  ; 
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COULTER COUNTER PROGRAM (Cont ' )  
1 4 2 0  F OR MA T  F l  . O  
N E XT I 
P R I NT 
C = O  
1 1� 3 0 
1 4 4 0  
1 4 5 0 
1 4 6 0  
1 4 7 0  
1 4 8 0  
F OR C O =A T O  C Z - 1 > S T E P S 
C = C +  
P $ = Q$ 
1 4 9 0 M = O 
1 5 0 0  F OR I =  T O  N 
1 5 1 0 P =C U , C  J / Y+ 
. 1 5 2 0  I F  P > =  1 T H E N  1 5 4 0  
1 5 3 0  P = l 
1 5 4 0  P $ C P , P J = C $ [ 1 , I l  
1 5 5 0  I F  M > P T H E N 1 5 7 0  
1 5 6 0  M= P 
1 5 7 0  NE XT I 
1 5 8 0  V = C O * A 6 * A 9 * 0 . 0 9 
1 5 9 0  D = < < 6 * V ) / P l ) � ( l /3 >  
1 6 0 0 WR I T  E < 1 5 , 1 6 1 0 > D , V 
---
· 1 6 1  0 F 0Ri1� T F 7 • 2 ,  F 7 .  l , l X ,  .. + .. 
l 6 2 Q ·;11 R 1 T i:.  < 1 5 , l 6 .j u ) C u  , P 4> C l ·, M l  
1 6 3 0  F ORMAT 6 X , F 3 . 0 , 6 X , F l . O  
1 6 4 0 NE XT C 0 
1 6 5 0  V = C O * A S * A 9 * 0 . 0 9 
1 6 6 0  0 = ( ( 6 * V > I P I > � C /3 )  
1 6 7 0  W R I T E  C l 5 , 1 6 1 0 > D , V  
1 6 8 0  I F  8 $ = · N o ·  T H E N 23 5 0  
1 6 9 0  RE M 
1 7 0 0  R E M  F I N D D I FFE RE NC S  FR OM C ONT R OL 
1 7 1 0 X = Y= O 
1 7 2 0  F OR 1 = 2 T O N 
1 73 0 c = 0 
. 1 7 4 0 . F OR C O =A T O  C Z - 1 > S T E P S 
1 1 5 0  C = C + l  
1 7 6 0 C C I , C J = C U , C J - C C I , C l  
1 7 7 0  N E XT C 0 
. 1 7 8 0 NE XT . I 
1 7 9 0  F OR I = T O  < N- 1 > 
1 8 0 0 C = O  
1 8 1 0 F OR C O  =A T 0 C Z - 1 ) S T E P  S 
1 8 2 0 C =C + 1 
1 8 3  0 C [ I ,  C J = C  ( I +  1 , C l · 
1 8 4 0  I F  X > = C C I , C l  T H E N  1 8 6 0  
1 8 5 0  X = C C I , C J  
1 8 6 0 I F  y < =  C C I , C l  T H E N 1 8 8 0  
l 8 7 0 Y = C  ( I  , C J 
1 8 8 0 NE XT C 0 
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COULTER COUNTER PROGRAM (Cont ' )  
1 8 9 0  NE XT I 
1 9 0 0  I F  C 4 = 1  T HE N  1 9 3 0  
1 9 0 Y O = Y  
1 9 2 0  Y9 = X  
1 9 3 0 S 1 = < Y9 -
·
Y 0 ) / l 0 0 
1 9 4 0  R E M 
1 9 5 0  RE M PL OT DATA 
1 9 6 0  R E M  
1 9 7 0  G OS U B 2 3 6 0  
9 8 0 PR I NT L I N 3 
· 1 9 9 0  Q =A B S < Y O /S l  ) + 1 
2 0 0 0  Q $ ( 1  , 1  J = " -c· · 
2 0 1 0 Q $ ( Q , Q J = " + ·  
2 0 2 0  PR I NT T A 8 6 ; 
--· 
2 0 3 0 F OR J = O  T O  1 0 0 S T E P 1 0  
2 0 4 0 WR I T E < 1 5 , 2 0 5 0 > Y O + J *S ; 
2 0 5 0 F OR MA T  2 X , F 8 . 0  
2 0 6 0  NE XT J 
2 0  7 0  PR ! NT 
2 0 8 0  PR I NT T A B 1 4 , " + • ;  
2 0 9 0 F OR I = l T O  1 0  
2 1 0 0  WR I T E c s , 2 1 1 0 > · - - - - - - - - - + · ; 
2 1  1 0 F OR MA T  F 1 • 0 
2 1 2 0  NE XT I 
2 1 3 0 PR I NT 
2 4 0 C = O  
2 1 5 0  F OR G O =A T O  < Z - 1 > S T E P S 
2 1 6 0  C = C + l 
2 1 7 0 P $  = QS 
2 1 8 0  M = Q  
2 1 9 0 F OR I = T 0 < N - I > 
2 2 0 0  P = < C C I , C J /S l ) + Q 
2 2 1 0 P$ C P , P J =C $ ( ! , I l  
2 2 2 0 I F  M > P T H E N  2 2 4 0  
2 2 3  0 M = P . 
2 2 4 0 NE XT I 
2 2 5 0 V = C O * A 8 * A 9 * 0 . 0 9 
2 2 6 0 D = < C 6 * V > I P I > � < l l3 > 
2 2 7 0 WR I T E ( 1 5 , 2 2 8 0 ) 0 , V  
2 2 8 0  F O RMAT F 7 . 2 , F 7 . l , 1 X ,  .. + · 
2 2 9 0 WR I T E  ( 1 5 , 2 3 0 0 ) G 0 , P £ C , M l 
2 3 0 0 F OR MAT 6 X , F 3 . 0 , 6 X , F l · O  
23 1 0 NE XT C 0 
2 3 2 0  V ; C 0 * A 5* A 9 * 0 . 0 9 
2 3 3 0 D = < C 6 * V ) I P I > � < 1 /3 )  
2 3 4 0 WR I T E < I S , 2 2 3 0 ) 0 , V  
2 3 5 0 E N D 
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COULTER COUNTER PROGRAM (Cont ' )  
2 3 6 0  PR I NT WB YT E 1 2  
2 7 0  WA I T  3 3 3 3  
2 3 8 0 PR I NT L I N3 
2 3 9 0 F OR I = ! T O  5 
2 4 0 0  PR I NT S PA 5 , T $ C l * 3 2 - 3 1 , I * 3 2 J 
2 t.t l 0 NE XT I 
2 4 2 0  PR I NT 
2 1l 3  0 RE T U R N  
.--
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COULTER COUNTER PROGRAM (Con t ' )  
DATA STORAGE 
1 0  C O M A , Z , S , D $ C 2 J , DS ( 3 , S O J 
2 0  D I M  A $ C S J 
3 0  D I S P  M E NT E R OR L I S T 
4 0  I NPU T A �  
5 0  I F  A $ = - E NT E R "  T H E N  8 0  
6 0  I F  A $ = - L I S T " T HE N  3 4 0 
7 0  G OT O  3 0 
8 0  M.l\ T D = Z E R  
.. .  , 
9 0  D I S P  " E NT E R  F I LE F OR DAT A  S T ORA G E  " ;  
1 0  0 I N PUT F 
1 1 0  D I S P  M E NT E R  DATA DE S C R I PT I O N < =  3 2 C HA R " ; 
1 2 0 I N PLJT D $  
1 3 0  D I S P  � E N T E R  F I RS T  A ND LAS T T H R E S H OL D  " ;  
1 4  0 I NPUT A ,  Z . 
1 5 0 D I S P  .. E NT E R  T H RES H OLD S T E P " ;  
6 0  I N PU T S 
1 7 0 T O = l  
1 8 0 F OR T =A T O  Z S T E P  S 
1 9 0 D I S P  " E NTE R 3 C OU NT S F OR T #  .. ; T ;  
2 0 0 I N PUT D [ 1 , T 0 J , D ( 2 , T 0 J , D [ , T 0 J 
2 0  T 0 =T 0 + 1  
2 2 0 NE XT T 
2 3 0 D I S P " E NT E R  I OF C ORRE C T I ONS · ; 
24 0 I N PLJT C 
2 5  0 F OR I =  1 T 0 C 
2 6 0  D I S P  " I N PU T T # , REA D I N G # , & C OU NT " ;  
2 7 0 I N PU T T , C , D [ C , T /S J  
2 8 0 NE XT I 
2 9 0 S T O R E  DAT A F 
3 0 0 E ND 
3 1 0 R E M  
- .-- _,. 
--·- · 
3 2 0  R E M :  L I S T I N G S E C T I ON 
3 3 0 R E M  
3 4 0 D I S P " L I S T DATA A LS O " ;  
3 5 0 I N PUT A l  
3 6 0  C l = O 
3 7 0  I F  A i = " N O" T P. E N  3 9 0  
3 8 0  C l = l 
3 9 O D I S p .. NT E R  F I  RS T & LAS T F I  LE F OR I... I S  T 
. .. ; 
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COULTER COUNTER P ROGRAM (Cont ' ) 
4 0 0 I N PUT i-- o , F 9 
4 1 0 L = 6 0 
4 2 0 F OR I = F O  T O  F 9  
4 3 0 L OA D  D ATA I 
4 4 0 L O = S + C l * C l + 4 * C I NT C C Z - A - l > I O > + l > >  
4 5  0 L = L +  L O  
- -·· 
4 6 0  I F  L < 6 0 T HE N  5 1 0 
4 7 0  L = L O  
4 8 0  PR I NT WB YT E 1 2  
4 9 0 WA I T  1 2 3 4  
5 0 0  P R I NT L I N2 
5 0  PR I NT L I N2 , S PA 5 , " F I LE 1 • ; 1  
5 2 0 P R I NT S PA S , 0 $ 
5 3 0 WR I T E C 1 5 , 5 4 0 > A , Z  
5 4 0 F O R MAT 5 X , M T H RE S H OLD " , F3 . 0 , ·  T O " , F 3 . Q  
5 5 0 I F  C l = O T H E N 7 6 0 � 
5 6 0  P R I NT 
5 7 0  T =A. 
5 3 0 PR UJT T .�1 8 7 ; 
5 9 0  F OR K = T T O  T + l O  
6 0 0 WR I T E C l 5 , 6 1 0 > K ;  
6 I 0 F OR MAT F' 6 • 0 
6 2 0 I F  K = Z  T H E N  6 4 0 
63 0 N E XT K 
6 4 0 P R I NT 
6 5 0 F OR J = T 0 3 
6 6 0 P R I NT T A B 7 ; 
6 7 0  F OR K =T T O  T +  l 0 
6 8 0 WR I T E C 1 5 , 6 9 0 ) D [ J , K J ; 
· 6 9 0 F OR MAT F 6 • 0 
7 0 0 I F  K= Z T HE N  7 2 0 
7 1  0 NE XT K 
7 2 0 P R I NT 
73 0 NE XT J 
7 4  0 T =T + 1 1  
7 5 0 I F  T < =  Z T HE N  5 8 0  
7 6 0  N E XT I 
7 7 0  E N D 
Table 2 .  
START KEY I! 0 
1 0  D I M  A I C 5 0 J  
2 0 F OR I =  1 T 0 5 0 
3 0  A C I J = O 
4 0  NE XT I 
HISTOGRAM PROGRAM 
4 5  PR I NT " H I S T O G R A M •  
5 0  S l =S 2 =S 3 =S 4 = N = R3 = R4 =R5 =T l = O  
6 0  R 1 = 1 E + 9 9  
7 0  R2 = - R l  
s o ·  D I S P  " E NT 1 F OR H I S T O GRA M " ; 
9 0  I N PUT S S  
J O O I F  S S # l T H E N  1 6 5 · 
1 1 0  D I S P  " OF FS E T = · ; 
1 2 0  I N PUT 0 
1 2 1  PR I NT " OF FS E T = · o  
1 3 0  D I S P " C E L L  W I DT H " ; 
1 4  0 I N PUT C 
1 4 5 P R I NT " C E L L  W I DT H  = " C  . 
1 6 0 B =5 0 
1 6 5 D ! S P " E NT 1 T O  PR I NT DAT A " ; 
1 7 0  ! !'J PUT D 
1 8 0 I F  D � O  T H E N  2 0 0  
1 9 0 PR I NT " DAT A " 
2 0 0 D I S P  " PRE S S  DAT A E NT RY KE Y " ; 
2 1 0 E ND 
DATA. ENTRY KEY fl 1 
1 0  D I S P  " X C " N + l " > = " ; 
2 0  I N PU T X 
5 0  Z = F N X C l )  
6 0  G OT 0 1 0 
7 0  E ND 
DELETE KEY I! 2 
1 0  D I S P  " D E LE T E  X = " ; 
2 0  I N PU T  X 
3 0  P R I NT " DE LE T E : " ;  
4 1  T l = l  
5 0 Y = F N X C · d  ) 
6 0 E ND 
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HI STOGRAM PROGRAM (Cont ' )  
BASIC STATISTICS KEY # 5 
1 0  M = S l / N 
2 0  S ;S Q R C C S 2 - M * M* N ) / C N - l ) )  
3 0  M3 = S 3 /N - 3 *M* S 2 /N + 2 * M "" 3 
4 0  M4 = S 4 / N - 4 * M * S 3 /N + 6 * C M "" 2 > * S 2 / N 
5 0  M4 = M 4 - 3 �*' M "" L1  
6 0  F OR MA T  F 1 2 . 4 , l , F 1 2 . 4 , / , F 1 2 . 4 , / , F l 2 . 4  
65 PR ! NT 
7 0  PB I NT " N = .. N 
a o · WR I T E  C 1 5 , 6 0 > " MEA N =  .. M , " S T D . DE V = " S , " S KE WNE S S = " M3 /S h 3 
1 1 l I F  T 1 = 0 T H E N  1 2 0 
1 1 2  PR I NT · .. M I N , MA X , RA N GE MAY BE I NC ORRE C T  .. 
1 2 0 WR I T E C l 5 , 6 0 > " X M I N = " R l , " XMA X = '" R 2 , " RA N GE = " R 2 - R l 
1 5 0  I F  R3 = 0  T H E N  1 7 0 
1 6 0  Pfl I NT " NO .  T O O  S MA L L = " RJ 
1 7 0 I F  R 4 = 0  T H E N 1 9 0 
1 8 0 PR I NT " N O .  T O O LAR G E = " R4 
1 9 0  F OR J = l  T O  1 0  
2 0 0 PR I NT 
2 1 0 N E X T  J 
2 2 0 E N D 
HISTOGRAM KEY II 6 
10 P=l 
20 W=FNY . ( 1) 
30 END 
HISTOGRAM/PLOT KEY _ _II 7 
1 0 P = J 
2 0  W = F N Y C l )  
3 0  E ND 
·1 s1 
HISTOGRAM PROGRAM (Cont ' ) 
CELL STAT I STICS KEY D 8 
1 0  PR I NT 
I 1 F 0 R M.1'.\ T F 5 ; 0 , F 1 2 • 4 , F 1 1 • 0 , F I 7 • 5 
1 2  PR I NT " C E L L # " ; " L O wE R  L I M I T • ; 
1 3  PR I NT TA B I  8 ; .. . N O . OF gas .. ; ..  % RE LAT I VE FRE Q -
3 0  Y = F NC < l >  
4 0 F OR I = 1 T 0 B 
4 5 · W R I T E  C l S , I l > I , O + C I - 1  . S > * C , A C I J , l O O * A C I J / N 
5 0  NE XT I 
6 0  F OR J = l  T O  1 0 
7 0  PR I NT 
8 0  NE XT J 
9 0  E N D  
(FNX) KE Y  II 13 
1 8 0 D� F F �!� ( Z )  
1 8 2 I F  D#. 1 T H E N  1 9 0 
1 8 3 WR I T E C l 5 , 1 8 4 > X 
1 8 4 F OR MAT F 1 2 . 4 
1 9 0 I F  X > R l T H E N  2 1 0 
2 0 0 R l = X  
2 1 0 I F  X < R2 T H E N  2 3 0 
2 2 0 R2 ::: X 
2 3 0 N = N + Z  
2 4 0 S l = S l + X * Z 
2 5 0 Y = X * X  
2 6 0  S 2 = S 2 + Y* Z 
2 7 0  Y. = Y * X 
2 8 0  S 3 = S 3 + Y * Z 
2 9 0 Y = Y * X 
3 0 0  S 4 = S 4 + Y* Z  
3 1 0 I F  S S # l T HE N  4 0 0 
3 2 0 Y = I NT < C X - O > IC + t . 5 > 
3 3 0 I F  Y < l T H E N  3 7 0  
3 4 0 I F  Y > B  T H E N  3 9 0  
3 5 0  A ( Y J =A C Y l + Z 
3 6 0  G ar o  4 0 0  
3 7 0  R3 = R 3 + Z  
3 8  0 G OT 0 4 0 0 
3 9 0  R 4 = R4 + Z  
4 0 0  RET U R N 0 
· 1s2 
HISTOGRAM PROGRAM (Cont ' )  
(FNY) KEY II 15 
1 0  DE F FNY < )\ >  
1 1 F OR I = 1 T 0 5 0 
1 2  I F  R S >A C I J  T HE N  1 4  
1 3  R S  =A [ I  J 
1 4  N E XT I 
2 0  W = 2 . 5 * R5 / N  
3 0  U = < N * C / C 2 . 5 0 6 6 * S } J * C 4 0 /R S > 
4 0  F OR MAT 2 F5 . 2 
4 5 PR I N T · 
4 6  PR I NT 
5 0  WR I T E  C l S , 4 0 >  .. EA C H  X = " W ; " 
6 0  PR I NT 
7 0  PR I NT ' 
75 Y = FNC C 1 )  
8 0  F OR I = l T O  B + l 
9 0 Y =  O +  < I - 1  • 5 )  ·;!- c 
1 0 0 F OR MAT 2 F 1 2 . 4 
1 1 0  W R I T E  C l 5 , 1 0 0 > Y H . " ;  
1 2 0 I F  P = O T H E N  1 4 0  
1 3 0 . Z = F N Z C Y > 
1 4 0  PR I NT 
1 4 5 I F  l = B + l T H E N  1 9 0 
1 5 0  Y = Y+ O . s �· c  
1 6 0 PR I NT T A B 1 3 ; " . " ;  
1 7 0 Z = F' N P < Y > 
1 8 0 NEXT I 
1 9 0 F OR J = l  T O " ! O  
1 9 1  PR I NT 
1 9 2 N E XT J 
1 9 3 E ND 
(FNC )  KEY If 15 
1 0 DE F FNC C Y > 
2 0 J = 5 0 
3 0  I F  A C J J # O T H E N 
4 0  J = J - 1 
5 0  G OT O  3 0 
7 0  B = J -t<- ( J < B > + B * C J 
8 0  RE T U RN 0 
7 0  
> = B >  
.. -... - - · 
PE R C ENT " 
153 
1 54 
Table 3 .  IMMUNE . RESPONSE MODEL PROGRAM 
1 0  R M.C\R K :  I MMJ NE rtES P Of'J S E  M OD E L : DAT A  I N P U T  & C l\ L C , " F I LE # O 
2 0 D I M  D S C 1 5 0 , 1 2 J , P I  C 6 J , P £ [ 6 J , G .b [ 1 1 J , Oli ( 0 2 J , Q J> [ 0 2 J , H .S  [ 0 7 J , X I  C 6 J 
3 0  D I M  A I C 3 , 2 J  
4 0  M.C\ T D = Z E R  
5 0  .C\ [ l , 1 J = O  . 
6 0  A [ l , 2 J =.C\ [ 2 , J = l  
7 0 A [ 2 ,  2 J =A [ 3 ,  1 J = 6 
8 0  A C 3 , 2 J = 7  
9 0  G OT O  8 4  0 
. 1 0 0 RE M :  ME A N  A 3FC 
1 1 0  D E F  F N Z < T >  
· 1 2 0  G J = < G - 1  > ·�· r s  
1 3 0 G 4 = G * T 8  
· 1 4 0  I F  T > =  T 3 + G  T H E N  1 6 0 
1 5 0 R E T U R N  0 
l 6 0 G 1 = X P  C L ':· G3 ) 
1 7 0 G 2 =E X P  < L .;:- G 4 ) 
1 8 0 Q 1 = - 1 IE 1 -::· < 1 - 1 I G r ) 
1 9 0 Q 2 = - l / * C l - / G 2 ) 
2 0 0 l! 1 = + G l -i!- 3 
2 l D t.J 2 =- 1 + G 2 :� C: :J 
2 2 0 Z 0 = 2 - C G - ) � � X P C - A > 
2 3 0 I F  G = G 9  T H E N  2 8 0  
2 4 0 I F T 3 + G3 < = T .l\ ND T < T 3 + G 4 T HE i-J 3 1 0 
2 5 0 I F  T 3 + G4 < =  T A ND T < T 3 +T 9 + G  T H E N  7 0 
2 6 0 I F  T 3 + T 9 + G 3 
·
< =  T A ND T < T 3 + T 9 + G 4 T HE N  4 4 0 
2 7  0 G OT 0 5 0 
2 8 0 I F  T 3 + G3 < =  T A N D  T < T 3 +T 9 + G 3 T H E N  3 0  
2 9 0 G OT O  6 2 0 
3 0 0  R M :  PA RT 1 & 5 
3 1 0 Z l = X P C A I * Q ) / Q l  
3 2 0 Z 2 = E XP C A I * U l * E 0 ) /U l  
3 3 0 Z 3 = E X P C A l * C E 2 +E 0 ) )  
3 4 0 Z = Z O * C Z 1 + /E 2 * C Z 2 - Z J ) )  _ 
3 5 0 R E T U rt N  Z 
3 6 0  R M :  PART 2 
3 7 0 Z 1 = E X P  U \ l  -:� 2 1 ) I �  
3 8 0  Z 2 = E X P C A l * Q 2 ) / � 2 
3 9 0  Z 3 = E X P C A l * U � E O > IU l . 
4 0 0 Z 4 = 2 X P C A l * U 2 * E 0 ) / U 2  
4 1 0 Z = Z O * < Z I - Z 2 + /2 2 * < Z 3 - Z 4 ) )  
4 2  0 it E T U R iJ Z 
4 3  0 RE M :  P.C\ �T 3 
'' 4 0 Z 1 = I U  I 
4 5 0 Z 2 = E X P C A l * U l * E O l 
4 6 0  Z 3 = E X P C A l * U l * E 4 > 
4 7 0 Z 4 =£ X P C A l * C E 2 + 2 4 ) )  
IMMUNE RESPONSE MODEL PROGRAM (Can ' t )  
4 8 0 Z 5 = X P < A l * U 2 * E O > IU 2  
4 9 0 Z 6 = X ? < A l * Q 2 ) / �2 
5 0 0 Z = Z 0 * ( 1 /E 2 * < Z l * < Z 2 - ZJ ) + Z4 - Z 5 ) - Z 6 > 
5 1 0 R ET U q N  Z 
5 2 0 R E M :  PA RT · 4 
5 3  0 Z 1 :::: 1 / U  1 
5 4 0 Z 2 = E X P < A l * U l * 0 )  
5 5 0 Z = E X P < A l �U l * E4 ) 
5 6 0  Z 4 = 1 / U 2 
5 7 0  Z 5 = X P < A l * U 2 * E O > 
5 8 0  Z 6 =E X P C A l * U 2 * E 4 ) 
· 5 9 0 Z = Z O / E 2 * C Z l * C Z2 - Z 3 > - Z 4 * C Z 5 - Z 6 ) ) 
6 0 0 :q E T U R N  Z 
6 0  RE M :  PA RT 5 
6 2 0 Z l =E X P C A 1 * £ 2 ) /£ 2  
6 3 0 Z 2 = E X P C A l * E 4 ) - E X P C A 1 * 0 ) 
6 4 0 Z 3 == / C E 2 -�·u 1 )  
6 5 0 Z 4 = E X P C A * C l + G * E 3 * E 0 > )  
6 6 0 Z 5 = E X P C A * C l + G l * E 3 * E 4 ) ) 
6 7 0 Z = Z O * < Z l * Z 2 + Z 3 * C Z 5 - Z 4 ) )  
6 8 0 H.t:: 1' U H N  2. 
6 9 0 R M : FRA C T I ON 
7 0 0 D E F  F N F < I )  
7 0  Y = O 
7 2  0 F OR D =A [ I  , 1 J T 0 A [ I  , 2 J 
7 3 0 Y = Y + E X P C - R ) * R � D / F N V C D >  
74 0 NE XT D 
7 5 0 R ET U R N Y 
7 6 0 RE M :  FA C T OR I A L 
7 7 0 D F  F N V C X > 
7 8 0 F = l  
7 9 0 F OR I = l T O  X 
8 0 0 F = I ·* F  
8 0  NE XT I 
8 2 0 R E T U RN F 
8 3 0 R E M :  E NT � Y  
8 4 0 D I S P  ·• �vE I G H T  OF M OU S E:  I N  G �A M
S .. ; 
85 0 I N PU T vi 
8 6 0 D I S P  .. L Y �'l PH . ::l� D I US C U ) , D E N S I T Y <
G I M L > " ;  
8 7 0 I N P U T  R l  , 0 6 
8 8 0 D I S P  . .. l S T A NT I G E N  D OS E  C P FU > .. ; 
8 9 0 I N PU T D O  
9 0 0 D I S p .• 2 ND A NT I G E N D CS E C PFU ) " ; 
9 1 0 I N ?UT D 9  
9 2 0 D I S P .. . � NT I GC: N  E L I M·I NAT I ON
 RAT E C /H OLJ ? U .. ; 
93 0 I N P U T  L 
9 4 0 L = 0 • 0 0 1 2 -:i- L 
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IMMUNE RE SPONSE MODEL PROGRAM (Can ' t) 
9 5 0 D I S ?  " LAT E NT .  PH A S E  C f1 0U RS ) F O� I C C  T O  B E C O ME I A C .. ; 
9 6 0  I N PJ T T S  
9 7 0  D I S P  " LA T E NT PE S I OD C H OU RS > F OR ! A C  T O  B E C O M E  A B FC " ; 
9 8 0  I N ? U T  T 2  
9 9 0 D I S P  " C E L L  GE N E RA T I ON T I ME C H OU RS > " ; 
1 0 0 0  I N.Pu T T 8  
. 
1 0 0 D I S P " A B FC A B - P R O D U C T I ON < H OU R S > " ; 
0 2 0 I N PU T  T 9 . 
1 0 3 0  D I S P " MA X .  N O . C E LL D I V I S I O NS " ; 
1 0 4 0  I N PU T G S  
1 0 5 0  D I S P  " I N PU T T I ME . O F  S E C O N D  I NJ E C T I ON " ; 
1 0 6 0 I N PU T X 1 
l 0 7 0 D I  5 P .. S T E ?  T I M C H  UJ RS > " ; 
1 0 8 0 1 N PU T  H 0 
0 9 0 D I S P .. LE N GT H  OF RU N C H  OU RS > � ; 
l 1 0 0 I NP'.J T T 7 
1 1 1 0  I F  T 7 > =  6 2 4  T H E N  1 5 0 
1 1 2 0  D I S ?  " RE - E NT E � � M I N .  L N GT H  6 2 4 H OJ RS 
1 3  0 G OT 0 1 0 0 
1 1 4 0 . RC: M :  I C C C A LC 
1 5 0  L l = 0 . 0 2 �� .JJ 
l 1 6 0 L 2 = 0 • 0 2 1'" L 1 
1 7 0 L 3 = L 2 / ( 4 . 1 8 8 8 * R l  � * D 6 > * E + 2 
1 1 8 0 L4 = 0 • 0 7 7 8 .;-.. W 
1 1 9 0 L5 = 5 . 5 E + 0 7 '.r L 4  
l 2 0 0 V Lj = 0 • 8 -::- L 5 
1 2 0 B 4 = 0 . 2 * L5 
2 2  0 C l = 0 • 7 �r L3 
1 2 3 0  C 2 � C 3 = 0 . S * L3 
2 4 0 V l = B l = 0 . 5 * C l  
1 2 s o  v 2 = 0 . s -::- c 2  
l 2 6 0 9 2  = 0 • 2 �(- c 2 
1 2 7 0  V3 = 0  . 9 -:< c 3  
1 2 8 0  B 3 = 0 . * C 3  
1 2 9 0  V = V + V 2 + V 3 
1 0 0 V S = V + V 4 
1 3 0  B = B l + B 2 + 3 3 
. l  3 2  0 BS = 3 + 84 
1 3 3 0  S l = - 0 4 * V  
1 3 4 0 5 2 = E - 0 ·� � V 4 
1 3 5 0  S 3 = 1 C: - 0 4 * B 
1 3 6 0  5 4 = 1 E - 0 4 �.:- 3 4 
1 3 7 0  5 = 5 1 + 5 2 + 5 3 + 5 4  
1 3 8 0 � - M ·  F- R AC T  S T I M A B F C  . c 1 • • • 
- E + O 8 T H E N  1 4 9 0 
1 3 9 0 I F  D O < =  5 E + 0 9  .C\ ND D O  > . - I 
1 O a A ND D O  > =  1 £ + 0 7 .
T rl � N  1 � 7 0  
l 4 0 0 I F D 0 < = + u . I ,- • -;- • 
1 4 1 0  I F  D O  < =  1 E + 0 7  A N D  D O  > =  1 � + 0 b 
T H E �  1 4 5 0 
1 56 
IMMUNE RESPON SE MODEL P RO GRAM (Con ' t )  
f 4 2 0 I F  D O  < =  1 E + 0 6  A N D  D O  > =  1 E + 0 5 T HE N  4 3 0 
1 4 3 0 F 7 = 0 . 1 ��- o o  
l 4 4 0 G OT 0 .5 0 0 
1 4 5 0  F 7 = 0 . G l 5 * D O 
· l 4 6 0 3 OT 0 1 5 0 0 
1 4 7- 0 F 7 = 0  . 0 0 2 -if- D Q  
. 1 4 8 0 G OT 0 l 5 0 0 
4 9 0  F 7 = 0 . 0 0 0 2 5 * D O  
1 5 0 0  R = F 7 /S 
1 5 0 F 0 = XP ( - � O  
1 5 2 0 F 1 = F N F  1 
1 5 3 0 F 2  = F N F 2  
1 5 4 0 F 3  = F N F3 
1 5 5 0 F 4 = F O + F l + F2 + F3 
1 5 6 0  M8 = < F O /F4 ) * S 
1 5 7 0  S 5 = < S 3 + 5 4 ) * C C S 3 + S 4 > / C S 1 + 5 2 l >  
1 5 8 0  A O = I NT C C F 2 / F4 > * S 5 + 0 . 5 > 
1 5 9 0  R E M :  I G - M  VS t 
1 6  0 0 T 1 =T S 
1 6 1 0 G 9 = G 5  
: 6 2 J E3 � 0 • 3 -::- :--t 0 
l 6 3 lJ  A = U .(J Ll � S  
1 6 4 0 A l =A / L  
1 6 5 0  I = X P C L * T ) 
1 6 6 0  .c.. 2 = 1 - /E l  
1 6 7 0  3 = S l -
1 6 8 0 T 3 =T 1 + T 2 
1 6 9 0  M O = N = O 
1 7 0 0  F OR T = O T O  5 7 6 S T E P  H O  
1 7 1 0  E O =E X P C - L * C T - T 2 ) )  
1 7 2 0  E 4 = E XP < - L * ( T - T 2 -T 9 ) )  
1 7 3  0 N = N +  1 
1 7 4 0 Y = O 
1 7 5 0  F OR G = l  T O  G9 
1 7 6 0  Y = Y + F N Z C T ) * Q . 9 9  
1 7 7 0 N .S XT G 
7 8 0 D ( N , 1 J = T  . 
... --
1 7 9 0  D [ N , 2 J = Y * A O 
. 
1 8 0 0 I F  D [ N , 2 J < = 1 T H£ N I 8 2 0 
1 8 0 D C N , 3 J = L GT C D [ N , 2 J > . 
1 8 2 0  D [ N , 4 J = M O =M O + H O * C 2 . 5 2 E
+ 0 6 * 0 [ N , 2 J - M 0 * 0 . 0 3 > 
1 8 3 0 I F  D [ N 1 4 J  < =  1 T H S N  1 8 5 0  
1 8 4 0  D C N , 5 J = L G T C D [ N , 4 J ) 
1 8 5 0 NE.: XT T 
1 8 6 0 A 2 =A O {� D [ 1 9 2 I H 0 , 2 }* 1 I 0 
1 8 7 0  � E M 
1 8 8 0  RE M :  I G - G  V S  T 
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' 
1 8 9 0 T 1 =T S 
1 9 0 0  G 9 = G 5  
IMMUNE RE SPONSE MODEL PROGRAi'1 (Con ' t )  
1 9 0 E = E X P ( L * T l ) 
1 9 2 0  2 = - / E l  
1 9 3 0  E 3 =E l  -
. 1 9 4 0 T 3 =T 1 + T 2 
1 9 5 0  N = I NT C 9 6 /H O > 
1 9 6 0  F OR T = O  T O  7 2 0 S T P  H O  
1 9 7 0  E O =c X P < - L * < T - T 2 ) )  
1 9 8 0  E 4 =E X P C - L * C T - T 2 - T 9 ) )  
1 9 9 0  N = N + l 
2 0 0 0  Y = O 
2 0 0 F O R G = l  T O  G 9  
2 0 2 0  Y = Y+ F N Z C T ) 
2 0 3  0 NZ XT G 
2 0 4 0  D [ N , 6 J = A 2 * Y  
2 0 5 0  I F  D C N , 6 J  < =  . T H E N  2 0 7 0 
2 0 6 0  D ( N , 7 J = L GT C D C N , 6 J )  
2 0 7 0  D C N , 8 J = M O = M O + H O * C 2 . 5 2 E + 0 6 * D ( N , 6 J - M 0 * 0 . 0 2 >  
2 0 8 0  I F  D C N , 3 J  < =  T HS N  2 1 0 0  
2 0 9 0  0 [ N , 9 J = L GT C D C N , 8 J ) 
2 1 0 0  NE XT T 
2 1 1 0  RE M 
2 2 0 R E M :  S EC ON D A R Y  RE S P ONS E 
2 1 0 M 7 = D C 1 8 0 /H 0 , 2 J 
2 1 4 0  M 8 = M 8 + M 7 
2 1 5 0  W 8 = C A O + M 7 > * 5 
2 1 6 0  I F  D 9  < =  1 E + 0 7 A N D  D 9  > =  E + 0 6 T H E N 2 1 9 0 • 
2 1 7 0  I F  0 9  < =  1 E + 0 6  A N D  D 9  > =  l E + O S T H E N  2 2 1 0  
2 1 8 0  I F  D 9  < =  1 E + 0 5 A ND D 9  > =  1 £ + 0 4 T HE N  2 2 3 0 
2 1 9 0  F 8 = D 9 ·:!· 0 . 0 0 4 
2 2 0 0 G OT 0 2 2 4 0 
2 2 0 F 8 = D 9 �'" 0 . 0 3  
2 2  2 0 G OT 0 2 2 4 0 
2 2 3 0 F 8 = D 9 ·:i- 0 • 1 
2 2 4  0 R = F 8  / M8 
2 2 5 0 K O =E X P C - R >  
2 2 6 0 K l = F N F l 
2 2  7 0 K2 = F N F 2  
2 2  8 0 K3 =F N F 3  
2 2 9 0 K4 = � 0 + K l + X 2 + K3 
2 3 0 0  A 3 = C X2 / K4 ) * �o 
2 0 T 1 =T S 
2 3 0 2  G 9 = G 5  
2 3 0 3  S l =E X P < L* T l > 
2 3 0 4  E 2 = - l /.S l 
2 3  0 5  E 3 =E 1  -
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IMMUNE RE SPON SE HODEL PROGRAM (Con ' t ) 
2 3 0 6 T 3 =T + T 2 
2 3  0 N =  I NT < X l  /H 0 )  
2 3 2'0 F O R T = X l . T O  T 7  S T E P  H O . 
2 3 3  0 N = N + ·1 
.2 3 3 1 Y = O 
2 3 3 2  F OR G =  T O  G 9  
2 3 3 3  Y = Y + F N Z C T > * 0 . 9 9  
2 3 3 4  NZ XT G 
2 3 4 0 D C N , 6 J = C A 3 + A 2 > * Y 
2 3 6 0  I F  D C N , 6 J  < =  1 T H E N  2 3 8 0 
2 3 7 0  D C N , 7 J � L GT < D C N , 6 J )  
2 3 8 0  D C N , 8 J = M O =M O + l  . 2 E + O + H 0 * < 2 . 5 2 E + 0 6 * D [ N , 6 J - M O -:-:- o  . 0 2 >  
2 3 9 0  I F  D C N , B J  < =  1 T H E N  2 4 0 
2 4 0 0  D C N , 9 J = L GT < D C N , 8 J )  
2 4 1 0 NE XT T 
2 4 2 0 L I N K 1 
2 4 3 0 E N D 
. \ 
---' " - -
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IMMUNE RESPONSE MODEL PROGRAM -RESULT SECTION 
1 0  RE MA R K : I MMU NE R E S P ONS E  M O DE L :  R E S U LT S , F I LE # I  
2 0  H i = - I MMU NE RS P ON S E M ODE L  • . 
3 0  D I S P  • E NT E R  D E S C R I PT I VE H E A D I N G .  
4 0  I N P :J T  H .£ ( 2 7 J 
5 0  D I S P S PA S " RE A DY PR I NT E R ,  RE P LY Q .  
'6 0 I N P� T K 
7 0 RE M * * * * * * * * * * * * * * � � * * * * * * * * * *  
8 0  RE M * * *  WR I T E  I NP U T  DAT A  * * *  � O  RE M * * * * * * * � * * * * * * * * � * * * * * * * * *  
1 0 0 I F K T HE N  1 3 0 
1 1 0  P R I NT L I N l , UB YT E 1 · 2 
1 2 0 WA I T  1 0 0 0  
1 3 0  W R I T E C 1 5 , 7 3 0 ) H $  




1 5 0 P R I NT • LYMPH OC YT E R A D I US < M I C R O NS > = · R - DE NS I T Y  C G /M L >  = " D 6  
1 6 0 WR I T E ( 1 5 , 7 0 > . l S T A NT I GE N  D O S E C P FU > = · D o  
1 7 0 F OR �4T E l 0 . 2 . 
1 8 0 W R I TE C l 5 , 1 7 0 > . 2 N D  A NT I �£ N  D OS E  C P FU > = · 0 9 
1 9 0  PR I NT L ! N l " PR O P O RT I ON A L I T Y  C O NS TA NT A G / C E LL = · A  
2 0 0 PR I NT M E L. J M ! NAT I O N RA.T E Yo P E R  H OT..!R = " O C * L  
2 ! 0 P R I NT • LA TE NT PHA S E C H OU R S > F O R  I C C  T O  B E C O M S I A C = " T 5 
2 3 0  PR I NT • LA T E NT PHAS E < H OU RS > F O R I A C T O  B E C O ME A B F C = " T 2  
24 0 PR I NT · c E L L  G E NE RAT I ON T I ME < H O U R S > = " T S  
2 5 0 P R I NT M A B F C  L I F E S PA N  < H OU RS > = M T 9  
2 6 0 P R I ·NT • M_!\ X I M LJ M N O . C E L L D I V I S I O NS = " G S  
2 7 0 R E M  * * * * * * * * * * * * * * * * * * * 
· 2 s o R E M  * * *  I C C T A B LE * * *  
2 9 0  R E M * * * * * * * * * * * * * * * * * * *  
3 0 0  P R I NT L I N4 . E S T I MAT E D  N O . OF i c e · 
3 1 0 W R I T E C l 5 , 3 2 0 > " T I S S U E S  B L O OD T OT A L •  
3 2 0 F OR ��T 1 , 1 , 2 s x ; " L YMPH O I D " , S X , " PE R I P H E RA L · , / , 2 9 X , F · O  
33 0 W R I T E C l 5 , 3 4 0 > L l 
3 4 0 F OR MA T  / , " W I GHT C G R A MS > - , F 2 2 . 3 , 1 o x , · - · , 2 x , · - · 
3 5 0 W R I T E ( 1 5 , 3 6 0 > L4 _ _  .. 
3 6 0  F OR MAT M V OLU ME < ML > · , 2 2 x , · - - , F 1 s . 3 , 1 o x , · - -
3 7 0  W R I T E C l 5 , 3 8 0 > L3 , LS , L3 + L5 
3 8 0  F OR �4T · N o .  L Y M PH OC YT E s · , 1 o x , 3 E l 3 . 4 
3 9 0 W R I T E C l 5 , 4 0 0 > V , V 4 , V5 
4 0 0  F OR MA T  " N O .  T - C E L LS " , 1 4 X , 3 E 1 3 · 4 
4 1 0 W R I T E C I S , 4 2 0 > B , 8 4 , B + 8 4 
4 2 0 F OR MA T " N O .  B - C E L LS " , 1 4 X , 3 E 1 3 . 4 
4 3 0 W R I T E ( 1 5 , 4 4 0 > S I , S 2 , S + S 2  
4 4 0 · F OR MA T  " N O .  WE E S PE C I F I C T � C E L L S  " , E l 3 � 4  
4 5 0 W R I T E C l 5 , 4 6 0 > S J , S 4 , S 3 + 5 4 
4 6 0  F O R MA T  " N O .  WE E S P E C I F I C B - C E LLS · ·, 3 £ 1 3 . 4 
4 7 0 WR I T E  C l S , 4 8 0 > 5 
4 8 0  
4 9 0  
5 0 0 
5 1 0 
5 2 0 
5 3 0 
5 4 0 
5 5 0 
5 6 0 
5 7 0 
5 8 0 
5 9 0 
6 0 0 
6 1 0 
6 2 0 
6 3 0 
64 0 
6 5 0 
6 6 0 
6 7 0  
6 8 0 
6 9 0 
7 0 0 
. 7 1  0 
7 2 0 
. 7 3  0 
74 0 
7 5 0 
7 6 0 
7 7 0  
7 8 0  
7 9 0 
8 0 0 
8 1 0 
8 2 0 
8 3 0 
8 4 0 
8 5 0 
8 6 0 
8 7 0  
8 8 0 
8 9 0 
9 0 0  
9 1 0 
9 2 0 
9 3 0 
9 4 0 
9 5 0 
IMMUNE RESPONSE MODEL PROGRAM - RESULT SECTION 
F OR �4T / , 2 9 x , · T ar A L  T & B S PE C I F I C l C C " , E l J . 4  
R E M * * * * * * * * * * * * * * * * * * * * * * *  
R E M  * * *  F RA C T I O N DAT A * * *  
R E M * * * * * * * * * * * * * * * * * * * * * * *  
P R I NT L I N4 - F RA C T I O N V I R G I N C E LL S  = · F o  
P R I NT " F RA C T I ON L O � - Z O NE T O L E R A NC E  = - F l 
P R I NT M FRA C T I ON A B - F OR M I N G C E LL S  = " F2 
P R I NT " FRA C T I O N H I G H - D OS E  PAR A L YS I S  = " F3 
PR I NT L l N l " I g - M PRE C U RS ORS AT T I ME ZE R O = " A O 
PR I NT " PR I MA R Y  1 3 - G  PRE C U R OR S  = " A 2 
P R I NT " S E C ON D A R Y  1 9 - G  PRE C U R ORS = " A 3 
R M * * * * * * * * * * * * * * * * * * * * *  
R E M  * * *  RE S U LT D AT A  * * *  
R E M * * * * * * * * * * * * * * * * * * * * *  
P R I NT L I N ! , WB YT E 1 2  
WA I T  1 0 0 0  
W R I T E < 1 5 , 7 3 0 > H $ 
W R I T E  < 1 5 , 6 6 0 > " = = = = = = = = = = =  I G - G = = = = = = = = = = =  
F OR MAT / , / , 1 4 X , " = = = = = = = = = = =  I G - M  = = = = = = = = � = = " , 8 X , F . O  
VIA I T  1 5 0  
AB MOL . NA N O G RA MS .. 
1 6 1  
W R I T E  C l S , 6 9 0 > " AB FC 
F OR MAT .. H OU R S  
PR I NT 
ABFC AB MOL . NA N O G R A MS " , 8 X , F l  . O 
F OR J = l T O  N 
WR I T E  C 1 5 , 7 3 0 > D [ J , l  J , D [ J , 2 J , O [ J , 4 J ,  . 4 9 4 2 7E - 0 9 * D ( ..J , 4 J ;  
F OR MAT F 6 . 0 , 2 F l 2 . 3 , E 1 2 . 3  
W R I T E  < I S , 7 S O > D C J , 6 J , D C J , 8 l , 2 . 6 5 6 5 E - 1 0 * D [ J , 8 J  
F OR MAT 2 F l 2 . 3 , E 1 2 . 3  
WA I T  1 5 0 
NE XT J 
RE M * * * * * * * * * * * * * * * * * *  
R M  * * *  G RA PH I N G * * *  
RE M * * * * * * * * * * * * * * * * * *  
R E M : M I N ,  MA X 
Y 0 = Y9 = D C , 3 J 
F OR J = l T O  N 
F OR K= 3 T O  9 S T E P  2 
I F  D C J , K J > = Y O  T H E N  8 7 0  
Y O = D C J , K l  
I F  D C J , K J < =  Y9 T H E N  8 9 0 
Y9 = 0 [ J , K l  
NE XT · K 
N E XT J · 
R E M : S C A L I N G FA C T OR 
I F  Y O = Y9 T H E N 1 1 2 0  
S = F N P ( Y9 - Y O > 
I F S < 4 T HE N  9 7 0 
S = I NT C S + 0 . 9 9 5 > * 0 - C P 0 - 2 >  
-� -- -·· . •· ·· · -- · · � 
IMMUNE RESPON SE MODEL PROGRAM - RESULT PROGRAM 
9 6 0 G OT 0 9 8 0  
9 7 0  S = I NT C 2 . S * S + 0 . 9 8 7 5 > / 2 . S * l . O "" C P 0 - 2 >  
9 8 0 A l = Y9 - 0 0 . S * S  
9 9 0 A 9 = Y 0 + 0 . 5 � S  
� 1 0 0 0  l = O 
1 0 1 0  I F  A l < O  A ND A 9 > 0  T HE N  1 6 0 
1 0 2 0  P U J = l O 
I 0 3  0 P C  2 l = S 
1 0 4 0 p ( 3 )  = 2  
1 0 5 0  F O R D l = l  T O  3 
1 0 6 0  F O R  R O = l  T O  3 
1 0 7 0  ' K = I NT < F NP C O . S * C A l + A 9 > > * 1 0 "" < D l + ) / P ( R 0 l + 0 . 5 >  
1 0 8 0 I =  K* P [ R 0 J * l 0 .... C P 0 - D  1 - 1 > 
1 0 9 0  I F  ! > A l  A ND I < A 9  T HE N  1 1 6 0 · 
1 1 0 0 NE XT R O  
1 1 1  0 NE XT D l 
1 1 2 0 Prt I NT L I N l " G R A P H  S K I P PE D : N OT S C A LE A B L E •  
1 1 3 0 S T  DP 
1 1 4 0  R E M :  G R A PH H E A D I N G S  
1 1 � 0  F OR �JA T  F l 4 . J , 4 F 2 � . 3  
1 1 6 0 PR I NT L l N l , W B YT E 1 2  
. 1 1 7 0 WA I T  1 0 0 0  
1 1 8 0 WR I T E  C 1 5 , 1 1 5 0 > H $  
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1 1 9 0 W R I T E c 1 s , 1 2 0 0 > " G - A B M OL . = o ·  
1 2 0 0  F OR MAT ; , · M - A B F C  = A , M - AB M O L . = B ,  G - AB F C  = C ,  " , F . O  
1 2 1 0 PR I NT L I N l  ; S PA 5 4 " L OG 1 0 S C A LE .  
1 2 2 0  WR I T E C l 5 , 1 1 S O > I , 2 5 * S + I , 5 0 * S + I , 7 5 * S + I , O O * S + I  
1 2 3 0  RE M :  G R A P H  ! N I T 
1 2 4 0 P .£  = .. ABC DE F .. 
1 2 5 0 F OR K = 1 T 0 7 6 S T E P  2 5 
1 2 6 0 0$ C K J = "  • 
1 2 7 0  NE XT K 
1 2 8 0  F OR K = l  T O  8 1  S T E P  2 0  
1 2 9 0  Q :£ C K J = · - - - - - - - . ._. - -
3 0 0  N E XT K 
1 3 1 0 R E M :  w O R K ! N G G R A PH S E C T I O N 
1 3 2 0  L l = 9  
1 3 3 0  F D� L = l T O  N 
1 3 4 0  L l = L l + l  
1 3 5 0 G OT 0 L 1 - 9 OF l 3 8 0 
1 3 6 0  G l  = 01 
1 3 7 0 G OT 0 1 4 1 0 
1 3 8 0  L l = O  
1 3 9 0  G .£ = Q .5 
1 4 0 0  RE M :  DT E R M I NE G RA P H - PT S  
l 4 1 0 F OR J = 1 T 0 4 





IMMUNE RE SPONSE MODEL PROGRAM - RESULT SECTION 
1 4 3 0 NE XT J 
1 4 4 0  RE M :  F I X  G R A PH - PT S  
1 4 5 0  P 9 = 1 0 2  
1 4 6 0  F OR K = l  T. O 4 
J 4 7 0  I F  P [ K J = O T H E N  1 6 4 0  
1 4 8 0  F OR J = K T O  4 
1 4 9 0  I F  P C J J # P C K J  T HE N  1 6 2 0  
1 5 0 0  I F  J = K T H E N  1 6 1 0 
1 5 1 0 G OT 0 D 1 OF 1 5 5 0  
1 5 2 0  P 9 = P 9 + 1  . 
1 5 3 0  G $ C P9 , P 9 J = P $ ( K , K J 
1 5 4 0 P 9 = P9 + 1  
5 5 0 G $ C P9 , P9 J = P$ [ J , J J  
1 5 6 0  P C J J = O  
1 5 7 0  P 9 = P9 + 1 
1 5 8 0  G $ C P9 , P 9 J = M , •  
1 5 9 0  D l = l  
1 6 0 0 G OT 0 1 6 2 0 
1 6 1 0  D l = O  
1 6 2 0  NE XT J 
1 6 3 0  G i C P C K J , P ( K J J = P$ C K J  
1 6 4 0  NE XT K . 
1 6 5  0 WR I T  E C 1 5 , 1 6 7 0 > D [ L ,  1 l , G $  [ , P9 - 1 J 
1 6 6 0  NE XT L 
1 6 7 0  F OR M.4 T  F9 . 2 , 1 X \'IF 1  . O  
1 6 8 0  D I S P  " £ N D " 
1 6 9 0  S T O P 
1 7 0 0  RE MA R K :  P O wE R FU NC T I ON 
1 7 1 0  DE F F NP C X >  
1 7 2 0  P O = O  
1 7 3 0  S 9 = S G NX 
1 7 4 0  X = A B S X 
1 7 5 0  I F  X < l T H E N  1 8 0 0  
1 7 6 0  I F  X < O T HE N  1 8 3 0  
1 7 7 0  X = X / 1 0 
1 7 8 0  P O = P O + l  
1 7 9 0 G OT 0 1 7 6 0 
1 8 0 0  X = X* l O 
1 8 1 0 P O = P 0 -
1 8 2 0  I F  X < l T H E N  1 8 0 0  
1 8 3 0  RET U R N  S 9 * X 
1 8 4 0  E N D 
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